id	sid	tid	token	lemma	pos
ijpds-4398	1	1	d	d	X
ijpds-4398	1	2	kolekar	kolekar	PROPN
ijpds-4398	1	3	et	et	PROPN
ijpds-4398	1	4	al	al	PROPN
ijpds-4398	1	5	.	.	PROPN
ijpds-4398	1	6	chemometric	chemometric	PROPN
ijpds-4398	1	7	assisted	assist	VERB
ijpds-4398	1	8	qbd	qbd	NOUN
ijpds-4398	1	9	method	method	NOUN
ijpds-4398	1	10	for	for	ADP
ijpds-4398	1	11	estimation	estimation	NOUN
ijpds-4398	1	12	of	of	ADP
ijpds-4398	1	13	bilastine	bilastine	NOUN
ijpds-4398	1	14	and	and	CCONJ
ijpds-4398	1	15	montelukast	montelukast	NOUN
ijpds-4398	1	16	sodium	sodium	NOUN
ijpds-4398	1	17	vol	vol	NOUN
ijpds-4398	1	18	3	3	NUM
ijpds-4398	1	19	|	|	NOUN
ijpds-4398	1	20	issue	issue	VERB
ijpds-4398	1	21	1	1	NUM
ijpds-4398	2	1	|	|	ADV
ijpds-4398	2	2	jan	jan	PROPN
ijpds-4398	2	3	–	–	PUNCT
ijpds-4398	2	4	mar	mar	PROPN
ijpds-4398	2	5	2024	2024	NUM
ijpds-4398	3	1	indian	indian	PROPN
ijpds-4398	3	2	j	j	PROPN
ijpds-4398	3	3	pharm	pharm	PROPN
ijpds-4398	3	4	drug	drug	PROPN
ijpds-4398	3	5	studies	study	NOUN
ijpds-4398	3	6	|	|	ADV
ijpds-4398	3	7	16	16	NUM
ijpds-4398	3	8	original	original	ADJ
ijpds-4398	3	9	article	article	NOUN
ijpds-4398	3	10	chemo	chemo	VERB
ijpds-4398	3	11	metric	metric	ADJ
ijpds-4398	3	12	assisted	assist	VERB
ijpds-4398	3	13	spectrophotometric	spectrophotometric	ADJ
ijpds-4398	3	14	method	method	NOUN
ijpds-4398	3	15	development	development	NOUN
ijpds-4398	3	16	through	through	ADP
ijpds-4398	3	17	quality	quality	NOUN
ijpds-4398	3	18	by	by	ADP
ijpds-4398	3	19	design	design	NOUN
ijpds-4398	3	20	approach	approach	NOUN
ijpds-4398	3	21	for	for	ADP
ijpds-4398	3	22	the	the	DET
ijpds-4398	3	23	estimation	estimation	NOUN
ijpds-4398	3	24	of	of	ADP
ijpds-4398	3	25	bilastine	bilastine	NOUN
ijpds-4398	3	26	and	and	CCONJ
ijpds-4398	3	27	montelukast	montelukast	NOUN
ijpds-4398	3	28	sodium	sodium	NOUN
ijpds-4398	3	29	in	in	ADP
ijpds-4398	3	30	combined	combine	VERB
ijpds-4398	3	31	solid	solid	ADJ
ijpds-4398	3	32	dosage	dosage	NOUN
ijpds-4398	3	33	form	form	NOUN
ijpds-4398	3	34	bhagyashri	bhagyashri	PROPN
ijpds-4398	3	35	d	d	PROPN
ijpds-4398	3	36	kolekar1	kolekar1	PROPN
ijpds-4398	3	37	,	,	PUNCT
ijpds-4398	3	38	namrata	namrata	PROPN
ijpds-4398	3	39	n	n	CCONJ
ijpds-4398	3	40	gawade1	gawade1	NOUN
ijpds-4398	3	41	,	,	PUNCT
ijpds-4398	3	42	g	g	PROPN
ijpds-4398	3	43	k	k	PROPN
ijpds-4398	3	44	dyade1	dyade1	PROPN
ijpds-4398	3	45	,	,	PUNCT
ijpds-4398	3	46	nilesh	nilesh	PROPN
ijpds-4398	3	47	y	y	PROPN
ijpds-4398	3	48	jadhav2	jadhav2	PROPN
ijpds-4398	3	49	from	from	ADP
ijpds-4398	3	50	,	,	PUNCT
ijpds-4398	3	51	1dept	1dept	NUM
ijpds-4398	3	52	of	of	ADP
ijpds-4398	3	53	post	post	PROPN
ijpds-4398	3	54	graduate	graduate	NOUN
ijpds-4398	3	55	studies	study	NOUN
ijpds-4398	3	56	in	in	ADP
ijpds-4398	3	57	pharmaceutical	pharmaceutical	ADJ
ijpds-4398	3	58	quality	quality	NOUN
ijpds-4398	3	59	assurance	assurance	NOUN
ijpds-4398	3	60	,	,	PUNCT
ijpds-4398	3	61	svpm	svpm	NOUN
ijpds-4398	3	62	’s	’s	PART
ijpds-4398	3	63	college	college	PROPN
ijpds-4398	3	64	of	of	ADP
ijpds-4398	3	65	pharmacy	pharmacy	NOUN
ijpds-4398	3	66	,	,	PUNCT
ijpds-4398	3	67	malegaon	malegaon	PROPN
ijpds-4398	3	68	(	(	PUNCT
ijpds-4398	3	69	bkii	bkii	ADJ
ijpds-4398	3	70	)	)	PUNCT
ijpds-4398	3	71	,	,	PUNCT
ijpds-4398	3	72	baramati	baramati	PROPN
ijpds-4398	3	73	,	,	PUNCT
ijpds-4398	3	74	pune	pune	NOUN
ijpds-4398	3	75	,	,	PUNCT
ijpds-4398	3	76	2sspm	2sspm	PROPN
ijpds-4398	3	77	’s	’s	NOUN
ijpds-4398	3	78	dr	dr	PROPN
ijpds-4398	3	79	n.	n.	PROPN
ijpds-4398	3	80	j.	j.	PROPN
ijpds-4398	3	81	paulbudhe	paulbudhe	PROPN
ijpds-4398	3	82	college	college	PROPN
ijpds-4398	3	83	of	of	ADP
ijpds-4398	3	84	pharmacy	pharmacy	NOUN
ijpds-4398	3	85	,	,	PUNCT
ijpds-4398	3	86	survey	survey	VERB
ijpds-4398	3	87	no	no	DET
ijpds-4398	3	88	45/1b	45/1b	NUM
ijpds-4398	3	89	,	,	PUNCT
ijpds-4398	3	90	vasant	vasant	ADJ
ijpds-4398	3	91	tekadi	tekadi	NOUN
ijpds-4398	3	92	,	,	PUNCT
ijpds-4398	3	93	savedi	savedi	PROPN
ijpds-4398	3	94	,	,	PUNCT
ijpds-4398	3	95	ahmednagar	ahmednagar	PROPN
ijpds-4398	3	96	,	,	PUNCT
ijpds-4398	3	97	maharashtra	maharashtra	PROPN
ijpds-4398	3	98	,	,	PUNCT
ijpds-4398	3	99	india	india	PROPN
ijpds-4398	3	100	abstract	abstract	ADJ
ijpds-4398	3	101	objective	objective	NOUN
ijpds-4398	3	102	:	:	PUNCT
ijpds-4398	3	103	quality	quality	NOUN
ijpds-4398	3	104	by	by	ADP
ijpds-4398	3	105	design	design	NOUN
ijpds-4398	3	106	(	(	PUNCT
ijpds-4398	3	107	qbd	qbd	PROPN
ijpds-4398	3	108	)	)	PUNCT
ijpds-4398	3	109	is	be	AUX
ijpds-4398	3	110	a	a	DET
ijpds-4398	3	111	systematic	systematic	ADJ
ijpds-4398	3	112	process	process	NOUN
ijpds-4398	3	113	for	for	ADP
ijpds-4398	3	114	pharmaceutical	pharmaceutical	ADJ
ijpds-4398	3	115	development	development	NOUN
ijpds-4398	3	116	recommended	recommend	VERB
ijpds-4398	3	117	by	by	ADP
ijpds-4398	3	118	regulatory	regulatory	ADJ
ijpds-4398	3	119	agencies	agency	NOUN
ijpds-4398	3	120	like	like	ADP
ijpds-4398	3	121	usfda	usfda	PROPN
ijpds-4398	3	122	.	.	PUNCT
ijpds-4398	4	1	development	development	NOUN
ijpds-4398	4	2	of	of	ADP
ijpds-4398	4	3	various	various	ADJ
ijpds-4398	4	4	pharmaceutical	pharmaceutical	NOUN
ijpds-4398	4	5	processes	process	NOUN
ijpds-4398	4	6	including	include	VERB
ijpds-4398	4	7	analytical	analytical	ADJ
ijpds-4398	4	8	methods	method	NOUN
ijpds-4398	4	9	by	by	ADP
ijpds-4398	4	10	applying	apply	VERB
ijpds-4398	4	11	quality	quality	NOUN
ijpds-4398	4	12	by	by	ADP
ijpds-4398	4	13	design	design	NOUN
ijpds-4398	4	14	aids	aid	NOUN
ijpds-4398	4	15	in	in	ADP
ijpds-4398	4	16	ensuring	ensure	VERB
ijpds-4398	4	17	the	the	DET
ijpds-4398	4	18	robustness	robustness	NOUN
ijpds-4398	4	19	of	of	ADP
ijpds-4398	4	20	the	the	DET
ijpds-4398	4	21	method	method	NOUN
ijpds-4398	4	22	.	.	PUNCT
ijpds-4398	5	1	qbd	qbd	AUX
ijpds-4398	5	2	approached	approach	VERB
ijpds-4398	5	3	chemo	chemo	NOUN
ijpds-4398	5	4	metric	metric	ADJ
ijpds-4398	5	5	assisted	assist	VERB
ijpds-4398	5	6	uv	uv	NOUN
ijpds-4398	5	7	-	-	PUNCT
ijpds-4398	5	8	vis	vis	X
ijpds-4398	5	9	spectrophotometric	spectrophotometric	ADJ
ijpds-4398	5	10	analytical	analytical	ADJ
ijpds-4398	5	11	method	method	NOUN
ijpds-4398	5	12	was	be	AUX
ijpds-4398	5	13	developed	develop	VERB
ijpds-4398	5	14	for	for	ADP
ijpds-4398	5	15	the	the	DET
ijpds-4398	5	16	estimation	estimation	NOUN
ijpds-4398	5	17	of	of	ADP
ijpds-4398	5	18	bilastine	bilastine	NOUN
ijpds-4398	5	19	(	(	PUNCT
ijpds-4398	5	20	bse	bse	NOUN
ijpds-4398	5	21	)	)	PUNCT
ijpds-4398	5	22	and	and	CCONJ
ijpds-4398	5	23	montelukast	montelukast	NOUN
ijpds-4398	5	24	sodium	sodium	NOUN
ijpds-4398	5	25	(	(	PUNCT
ijpds-4398	5	26	mks	mks	PROPN
ijpds-4398	5	27	)	)	PUNCT
ijpds-4398	5	28	from	from	ADP
ijpds-4398	5	29	their	their	PRON
ijpds-4398	5	30	combined	combine	VERB
ijpds-4398	5	31	dosage	dosage	NOUN
ijpds-4398	5	32	forms	form	NOUN
ijpds-4398	5	33	.	.	PUNCT
ijpds-4398	6	1	materials	material	NOUN
ijpds-4398	6	2	and	and	CCONJ
ijpds-4398	6	3	method	method	NOUN
ijpds-4398	6	4	:	:	PUNCT
ijpds-4398	6	5	simultaneous	simultaneous	ADJ
ijpds-4398	6	6	equation	equation	NOUN
ijpds-4398	6	7	method	method	NOUN
ijpds-4398	6	8	was	be	AUX
ijpds-4398	6	9	selected	select	VERB
ijpds-4398	6	10	from	from	ADP
ijpds-4398	6	11	the	the	DET
ijpds-4398	6	12	nature	nature	NOUN
ijpds-4398	6	13	of	of	ADP
ijpds-4398	6	14	spectra	spectra	PROPN
ijpds-4398	6	15	,	,	PUNCT
ijpds-4398	6	16	solvent	solvent	ADJ
ijpds-4398	6	17	50	50	NUM
ijpds-4398	6	18	%	%	NOUN
ijpds-4398	6	19	alcohol	alcohol	NOUN
ijpds-4398	6	20	was	be	AUX
ijpds-4398	6	21	utilised	utilise	VERB
ijpds-4398	6	22	;	;	PUNCT
ijpds-4398	6	23	and	and	CCONJ
ijpds-4398	6	24	for	for	ADP
ijpds-4398	6	25	method	method	NOUN
ijpds-4398	6	26	274.5	274.5	NUM
ijpds-4398	6	27	nm	nm	NOUN
ijpds-4398	6	28	and	and	CCONJ
ijpds-4398	6	29	351.5	351.5	NUM
ijpds-4398	6	30	nm	nm	NOUN
ijpds-4398	6	31	was	be	AUX
ijpds-4398	6	32	the	the	DET
ijpds-4398	6	33	wavelength	wavelength	NOUN
ijpds-4398	6	34	for	for	ADP
ijpds-4398	6	35	measurement	measurement	NOUN
ijpds-4398	6	36	of	of	ADP
ijpds-4398	6	37	absorbance	absorbance	NOUN
ijpds-4398	6	38	of	of	ADP
ijpds-4398	6	39	bilastine	bilastine	NOUN
ijpds-4398	6	40	and	and	CCONJ
ijpds-4398	6	41	montelukast	montelukast	NOUN
ijpds-4398	6	42	sodium	sodium	NOUN
ijpds-4398	6	43	respectively	respectively	ADV
ijpds-4398	6	44	.	.	PUNCT
ijpds-4398	7	1	effect	effect	NOUN
ijpds-4398	7	2	of	of	ADP
ijpds-4398	7	3	input	input	NOUN
ijpds-4398	7	4	variables	variable	NOUN
ijpds-4398	7	5	on	on	ADP
ijpds-4398	7	6	spectrum	spectrum	NOUN
ijpds-4398	7	7	characteristics	characteristic	NOUN
ijpds-4398	7	8	were	be	AUX
ijpds-4398	7	9	studied	study	VERB
ijpds-4398	7	10	for	for	ADP
ijpds-4398	7	11	selection	selection	NOUN
ijpds-4398	7	12	of	of	ADP
ijpds-4398	7	13	critical	critical	ADJ
ijpds-4398	7	14	parameters	parameter	NOUN
ijpds-4398	7	15	and	and	CCONJ
ijpds-4398	7	16	developed	develop	VERB
ijpds-4398	7	17	method	method	NOUN
ijpds-4398	7	18	was	be	AUX
ijpds-4398	7	19	validated	validate	VERB
ijpds-4398	7	20	as	as	ADP
ijpds-4398	7	21	per	per	ADP
ijpds-4398	7	22	ich	ich	NOUN
ijpds-4398	7	23	q	q	PROPN
ijpds-4398	7	24	2	2	NUM
ijpds-4398	7	25	r1	r1	NOUN
ijpds-4398	7	26	regulatory	regulatory	ADJ
ijpds-4398	7	27	guidelines	guideline	NOUN
ijpds-4398	7	28	.	.	PUNCT
ijpds-4398	8	1	linearity	linearity	NOUN
ijpds-4398	8	2	of	of	ADP
ijpds-4398	8	3	the	the	DET
ijpds-4398	8	4	drugs	drug	NOUN
ijpds-4398	8	5	was	be	AUX
ijpds-4398	8	6	ascertained	ascertain	VERB
ijpds-4398	8	7	over	over	ADP
ijpds-4398	8	8	the	the	DET
ijpds-4398	8	9	conc	conc	ADJ
ijpds-4398	8	10	range	range	NOUN
ijpds-4398	8	11	1	1	NUM
ijpds-4398	8	12	-	-	SYM
ijpds-4398	8	13	32	32	NUM
ijpds-4398	8	14	mcg	mcg	NOUN
ijpds-4398	8	15	/	/	SYM
ijpds-4398	8	16	ml	ml	PROPN
ijpds-4398	8	17	(	(	PUNCT
ijpds-4398	8	18	microgram	microgram	NOUN
ijpds-4398	8	19	/	/	SYM
ijpds-4398	8	20	ml	ml	NOUN
ijpds-4398	8	21	)	)	PUNCT
ijpds-4398	8	22	for	for	ADP
ijpds-4398	8	23	bse	bse	NOUN
ijpds-4398	8	24	and	and	CCONJ
ijpds-4398	8	25	1	1	NUM
ijpds-4398	8	26	-	-	SYM
ijpds-4398	8	27	20	20	NUM
ijpds-4398	8	28	mcg	mcg	NOUN
ijpds-4398	8	29	/	/	SYM
ijpds-4398	8	30	ml	ml	X
ijpds-4398	8	31	for	for	ADP
ijpds-4398	8	32	mks	mks	PROPN
ijpds-4398	8	33	.	.	PUNCT
ijpds-4398	8	34	results	result	NOUN
ijpds-4398	8	35	and	and	CCONJ
ijpds-4398	8	36	discussion	discussion	NOUN
ijpds-4398	8	37	:	:	PUNCT
ijpds-4398	8	38	the	the	DET
ijpds-4398	8	39	percentage	percentage	NOUN
ijpds-4398	8	40	purity	purity	NOUN
ijpds-4398	8	41	of	of	ADP
ijpds-4398	8	42	assay	assay	NOUN
ijpds-4398	8	43	was	be	AUX
ijpds-4398	8	44	found	find	VERB
ijpds-4398	8	45	98.09	98.09	NUM
ijpds-4398	8	46	%	%	NOUN
ijpds-4398	8	47	for	for	ADP
ijpds-4398	8	48	bse	bse	NOUN
ijpds-4398	8	49	and	and	CCONJ
ijpds-4398	8	50	103.62	103.62	NUM
ijpds-4398	8	51	%	%	NOUN
ijpds-4398	8	52	for	for	ADP
ijpds-4398	8	53	mks	mks	NOUN
ijpds-4398	8	54	;	;	PUNCT
ijpds-4398	8	55	and	and	CCONJ
ijpds-4398	8	56	the	the	DET
ijpds-4398	8	57	accuracy	accuracy	NOUN
ijpds-4398	8	58	study	study	NOUN
ijpds-4398	8	59	data	datum	NOUN
ijpds-4398	8	60	were	be	AUX
ijpds-4398	8	61	varied	varied	ADJ
ijpds-4398	8	62	from	from	ADP
ijpds-4398	8	63	0.2523	0.2523	NUM
ijpds-4398	8	64	to	to	ADP
ijpds-4398	8	65	0.5221	0.5221	NUM
ijpds-4398	8	66	for	for	ADP
ijpds-4398	8	67	bse	bse	NOUN
ijpds-4398	8	68	and	and	CCONJ
ijpds-4398	8	69	0.2512	0.2512	NUM
ijpds-4398	8	70	to	to	ADP
ijpds-4398	8	71	1.2515	1.2515	NUM
ijpds-4398	8	72	for	for	ADP
ijpds-4398	8	73	mks	mks	PROPN
ijpds-4398	8	74	.	.	PROPN
ijpds-4398	9	1	precision	precision	NOUN
ijpds-4398	9	2	study	study	NOUN
ijpds-4398	9	3	was	be	AUX
ijpds-4398	9	4	shown	show	VERB
ijpds-4398	9	5	acceptable	acceptable	ADJ
ijpds-4398	9	6	data	datum	NOUN
ijpds-4398	9	7	as	as	ADP
ijpds-4398	9	8	sd	sd	ADP
ijpds-4398	9	9	data	datum	NOUN
ijpds-4398	9	10	varied	varied	ADJ
ijpds-4398	9	11	from	from	ADP
ijpds-4398	9	12	0.1902	0.1902	NUM
ijpds-4398	9	13	to	to	ADP
ijpds-4398	9	14	0.5773	0.5773	NUM
ijpds-4398	9	15	for	for	ADP
ijpds-4398	9	16	bse	bse	NOUN
ijpds-4398	9	17	and	and	CCONJ
ijpds-4398	9	18	from	from	ADP
ijpds-4398	9	19	0.2828	0.2828	NUM
ijpds-4398	9	20	to	to	ADP
ijpds-4398	9	21	0.5458	0.5458	PROPN
ijpds-4398	9	22	for	for	ADP
ijpds-4398	9	23	mks	mks	PROPN
ijpds-4398	9	24	.	.	PUNCT
ijpds-4398	10	1	conclusion	conclusion	NOUN
ijpds-4398	10	2	:	:	PUNCT
ijpds-4398	10	3	the	the	DET
ijpds-4398	10	4	developed	develop	VERB
ijpds-4398	10	5	method	method	NOUN
ijpds-4398	10	6	is	be	AUX
ijpds-4398	10	7	rigid	rigid	ADJ
ijpds-4398	10	8	,	,	PUNCT
ijpds-4398	10	9	robust	robust	ADJ
ijpds-4398	10	10	and	and	CCONJ
ijpds-4398	10	11	efficient	efficient	ADJ
ijpds-4398	10	12	for	for	ADP
ijpds-4398	10	13	the	the	DET
ijpds-4398	10	14	estimation	estimation	NOUN
ijpds-4398	10	15	of	of	ADP
ijpds-4398	10	16	bse	bse	NOUN
ijpds-4398	10	17	and	and	CCONJ
ijpds-4398	10	18	mks	mks	PROPN
ijpds-4398	10	19	from	from	ADP
ijpds-4398	10	20	the	the	DET
ijpds-4398	10	21	composition	composition	NOUN
ijpds-4398	10	22	of	of	ADP
ijpds-4398	10	23	dosage	dosage	NOUN
ijpds-4398	10	24	form	form	NOUN
ijpds-4398	10	25	.	.	PUNCT
ijpds-4398	11	1	qbd	qbd	PROPN
ijpds-4398	11	2	was	be	AUX
ijpds-4398	11	3	applied	apply	VERB
ijpds-4398	11	4	to	to	PART
ijpds-4398	11	5	build	build	VERB
ijpds-4398	11	6	rigid	rigid	ADJ
ijpds-4398	11	7	robust	robust	ADJ
ijpds-4398	11	8	method	method	NOUN
ijpds-4398	11	9	through	through	ADP
ijpds-4398	11	10	risk	risk	NOUN
ijpds-4398	11	11	assessment	assessment	NOUN
ijpds-4398	11	12	at	at	ADP
ijpds-4398	11	13	early	early	ADJ
ijpds-4398	11	14	stage	stage	NOUN
ijpds-4398	11	15	and	and	CCONJ
ijpds-4398	11	16	defining	define	VERB
ijpds-4398	11	17	the	the	DET
ijpds-4398	11	18	design	design	NOUN
ijpds-4398	11	19	space	space	NOUN
ijpds-4398	11	20	at	at	ADP
ijpds-4398	11	21	the	the	DET
ijpds-4398	11	22	later	later	ADJ
ijpds-4398	11	23	stage	stage	NOUN
ijpds-4398	11	24	.	.	PUNCT
ijpds-4398	12	1	key	key	ADJ
ijpds-4398	12	2	words	word	NOUN
ijpds-4398	12	3	:	:	PUNCT
ijpds-4398	12	4	bilastine	bilastine	ADJ
ijpds-4398	12	5	,	,	PUNCT
ijpds-4398	12	6	montelukast	montelukast	NOUN
ijpds-4398	12	7	sodium	sodium	NOUN
ijpds-4398	12	8	,	,	PUNCT
ijpds-4398	12	9	qbd	qbd	NOUN
ijpds-4398	12	10	,	,	PUNCT
ijpds-4398	12	11	ich	ich	NOUN
ijpds-4398	12	12	,	,	PUNCT
ijpds-4398	12	13	simultaneous	simultaneous	ADJ
ijpds-4398	12	14	equation	equation	NOUN
ijpds-4398	12	15	method	method	NOUN
ijpds-4398	12	16	ilastine	ilastine	NOUN
ijpds-4398	12	17	(	(	PUNCT
ijpds-4398	12	18	bse	bse	NOUN
ijpds-4398	12	19	)	)	PUNCT
ijpds-4398	12	20	chemically	chemically	ADV
ijpds-4398	12	21	4-[2-[4-[1-(2	4-[2-[4-[1-(2	NUM
ijpds-4398	12	22	-	-	PUNCT
ijpds-4398	12	23	ethoxy	ethoxy	ADJ
ijpds-4398	12	24	ethyl)-1h	ethyl)-1h	PROPN
ijpds-4398	12	25	-	-	PUNCT
ijpds-4398	12	26	benzimidazole-2	benzimidazole-2	PROPN
ijpds-4398	12	27	-	-	PUNCT
ijpds-4398	12	28	yl]-1	yl]-1	NOUN
ijpds-4398	12	29	-	-	PUNCT
ijpds-4398	12	30	piperidinyl	piperidinyl	NOUN
ijpds-4398	12	31	]	]	PUNCT
ijpds-4398	12	32	ethyl]α	ethyl]α	PROPN
ijpds-4398	12	33	,	,	PUNCT
ijpds-4398	12	34	α	α	X
ijpds-4398	12	35	-	-	PUNCT
ijpds-4398	12	36	dimethyl	dimethyl	NOUN
ijpds-4398	12	37	benzene	benzene	NOUN
ijpds-4398	12	38	acetic	acetic	ADJ
ijpds-4398	12	39	acid	acid	NOUN
ijpds-4398	13	1	[	[	X
ijpds-4398	13	2	1	1	NUM
ijpds-4398	13	3	]	]	PUNCT
ijpds-4398	13	4	is	be	AUX
ijpds-4398	13	5	an	an	DET
ijpds-4398	13	6	antihistamine	antihistamine	NOUN
ijpds-4398	13	7	,	,	PUNCT
ijpds-4398	13	8	non	non	ADJ
ijpds-4398	13	9	-	-	ADJ
ijpds-4398	13	10	sedative	sedative	ADJ
ijpds-4398	13	11	histamine	histamine	NOUN
ijpds-4398	13	12	h1	h1	NOUN
ijpds-4398	13	13	receptor	receptor	NOUN
ijpds-4398	13	14	antagonist	antagonist	NOUN
ijpds-4398	13	15	;	;	PUNCT
ijpds-4398	13	16	by	by	ADP
ijpds-4398	13	17	binding	bind	VERB
ijpds-4398	13	18	and	and	CCONJ
ijpds-4398	13	19	preventing	prevent	VERB
ijpds-4398	13	20	activation	activation	NOUN
ijpds-4398	13	21	of	of	ADP
ijpds-4398	13	22	h1	h1	ADJ
ijpds-4398	13	23	receptor	receptor	NOUN
ijpds-4398	13	24	bilastine	bilastine	NOUN
ijpds-4398	13	25	reduces	reduce	VERB
ijpds-4398	13	26	development	development	NOUN
ijpds-4398	13	27	of	of	ADP
ijpds-4398	13	28	allergic	allergic	ADJ
ijpds-4398	13	29	symptoms	symptom	NOUN
ijpds-4398	13	30	due	due	ADJ
ijpds-4398	13	31	to	to	ADP
ijpds-4398	13	32	release	release	NOUN
ijpds-4398	13	33	of	of	ADP
ijpds-4398	13	34	histamine	histamine	NOUN
ijpds-4398	13	35	from	from	ADP
ijpds-4398	13	36	mast	mast	NOUN
ijpds-4398	13	37	cell	cell	NOUN
ijpds-4398	13	38	[	[	X
ijpds-4398	13	39	2	2	NUM
ijpds-4398	13	40	]	]	PUNCT
ijpds-4398	13	41	.	.	PUNCT
ijpds-4398	14	1	literature	literature	NOUN
ijpds-4398	14	2	survey	survey	NOUN
ijpds-4398	14	3	revealed	reveal	VERB
ijpds-4398	14	4	that	that	SCONJ
ijpds-4398	14	5	various	various	ADJ
ijpds-4398	14	6	analytical	analytical	ADJ
ijpds-4398	14	7	methods	method	NOUN
ijpds-4398	14	8	have	have	AUX
ijpds-4398	14	9	been	be	AUX
ijpds-4398	14	10	reported	report	VERB
ijpds-4398	14	11	for	for	ADP
ijpds-4398	14	12	estimation	estimation	NOUN
ijpds-4398	14	13	of	of	ADP
ijpds-4398	14	14	bse	bse	NOUN
ijpds-4398	14	15	such	such	ADJ
ijpds-4398	14	16	as	as	ADP
ijpds-4398	14	17	uv	uv	NOUN
ijpds-4398	14	18	spectrophotometric	spectrophotometric	ADJ
ijpds-4398	14	19	methods	method	NOUN
ijpds-4398	14	20	lonely	lonely	VERB
ijpds-4398	15	1	[	[	X
ijpds-4398	15	2	3	3	NUM
ijpds-4398	15	3	-	-	SYM
ijpds-4398	15	4	6	6	NUM
ijpds-4398	15	5	]	]	PUNCT
ijpds-4398	15	6	,	,	PUNCT
ijpds-4398	15	7	uv	uv	NOUN
ijpds-4398	15	8	spectrophotometric	spectrophotometric	ADJ
ijpds-4398	15	9	method	method	NOUN
ijpds-4398	15	10	with	with	ADP
ijpds-4398	15	11	mks	mks	PROPN
ijpds-4398	15	12	or	or	CCONJ
ijpds-4398	15	13	other	other	ADJ
ijpds-4398	15	14	drug	drug	NOUN
ijpds-4398	15	15	[	[	X
ijpds-4398	15	16	7	7	NUM
ijpds-4398	15	17	]	]	PUNCT
ijpds-4398	15	18	,	,	PUNCT
ijpds-4398	15	19	for	for	ADP
ijpds-4398	15	20	estimation	estimation	NOUN
ijpds-4398	15	21	of	of	ADP
ijpds-4398	15	22	bse	bse	NOUN
ijpds-4398	15	23	with	with	ADP
ijpds-4398	15	24	mks	mks	PROPN
ijpds-4398	15	25	or	or	CCONJ
ijpds-4398	15	26	other	other	ADJ
ijpds-4398	15	27	by	by	ADP
ijpds-4398	15	28	rp	rp	NOUN
ijpds-4398	15	29	-	-	PUNCT
ijpds-4398	15	30	hplc	hplc	NOUN
ijpds-4398	15	31	[	[	X
ijpds-4398	15	32	8	8	NUM
ijpds-4398	15	33	-	-	SYM
ijpds-4398	15	34	14	14	NUM
ijpds-4398	15	35	]	]	PUNCT
ijpds-4398	15	36	,	,	PUNCT
ijpds-4398	15	37	stability	stability	NOUN
ijpds-4398	15	38	indicating	indicate	VERB
ijpds-4398	15	39	rp	rp	NOUN
ijpds-4398	15	40	-	-	PUNCT
ijpds-4398	15	41	hplc	hplc	NOUN
ijpds-4398	15	42	[	[	X
ijpds-4398	15	43	15	15	NUM
ijpds-4398	15	44	-	-	SYM
ijpds-4398	15	45	17	17	NUM
ijpds-4398	15	46	]	]	PUNCT
ijpds-4398	15	47	,	,	PUNCT
ijpds-4398	15	48	green	green	PROPN
ijpds-4398	15	49	qbd	qbd	PROPN
ijpds-4398	15	50	hplc	hplc	PROPN
ijpds-4398	16	1	[	[	X
ijpds-4398	16	2	18	18	NUM
ijpds-4398	16	3	]	]	PUNCT
ijpds-4398	16	4	,	,	PUNCT
ijpds-4398	16	5	lc	lc	PROPN
ijpds-4398	16	6	-	-	PUNCT
ijpds-4398	16	7	ms	ms	PROPN
ijpds-4398	16	8	/	/	SYM
ijpds-4398	16	9	ms	ms	NOUN
ijpds-4398	17	1	[	[	X
ijpds-4398	17	2	19	19	NUM
ijpds-4398	17	3	]	]	PUNCT
ijpds-4398	17	4	,	,	PUNCT
ijpds-4398	17	5	stability	stability	NOUN
ijpds-4398	17	6	indicating	indicate	VERB
ijpds-4398	17	7	uplc	uplc	ADJ
ijpds-4398	17	8	[	[	X
ijpds-4398	17	9	20	20	NUM
ijpds-4398	17	10	]	]	PUNCT
ijpds-4398	17	11	and	and	CCONJ
ijpds-4398	17	12	rpuflc	rpuflc	VERB
ijpds-4398	18	1	[	[	X
ijpds-4398	18	2	21	21	NUM
ijpds-4398	18	3	]	]	PUNCT
ijpds-4398	18	4	alone	alone	ADJ
ijpds-4398	18	5	or	or	CCONJ
ijpds-4398	18	6	in	in	ADP
ijpds-4398	18	7	combination	combination	NOUN
ijpds-4398	18	8	with	with	ADP
ijpds-4398	18	9	other	other	ADJ
ijpds-4398	18	10	drugs	drug	NOUN
ijpds-4398	18	11	.	.	PUNCT
ijpds-4398	19	1	access	access	NOUN
ijpds-4398	19	2	this	this	DET
ijpds-4398	19	3	article	article	NOUN
ijpds-4398	19	4	online	online	ADV
ijpds-4398	19	5	received	receive	VERB
ijpds-4398	19	6	–	–	PUNCT
ijpds-4398	19	7	21th	21th	ADJ
ijpds-4398	19	8	dec	dec	PROPN
ijpds-4398	19	9	2023	2023	NUM
ijpds-4398	19	10	initial	initial	ADJ
ijpds-4398	19	11	review	review	NOUN
ijpds-4398	19	12	–	–	PUNCT
ijpds-4398	19	13	30th	30th	ADJ
ijpds-4398	19	14	dec	dec	PROPN
ijpds-4398	19	15	2023	2023	NUM
ijpds-4398	19	16	accepted	accept	VERB
ijpds-4398	19	17	–	–	PUNCT
ijpds-4398	19	18	08th	08th	NOUN
ijpds-4398	19	19	jan	jan	PROPN
ijpds-4398	19	20	2024	2024	NUM
ijpds-4398	19	21	quick	quick	ADJ
ijpds-4398	19	22	response	response	NOUN
ijpds-4398	19	23	code	code	NOUN
ijpds-4398	19	24	montelukast	montelukast	NOUN
ijpds-4398	19	25	sodium	sodium	NOUN
ijpds-4398	19	26	(	(	PUNCT
ijpds-4398	19	27	mks	mks	NOUN
ijpds-4398	19	28	)	)	PUNCT
ijpds-4398	19	29	chemically	chemically	ADV
ijpds-4398	19	30	sodium	sodium	NOUN
ijpds-4398	20	1	[	[	X
ijpds-4398	20	2	1-[[[(1	1-[[[(1	NUM
ijpds-4398	20	3	r)-1-(3-[(e	r)-1-(3-[(e	NOUN
ijpds-4398	20	4	)	)	PUNCT
ijpds-4398	20	5	2-(7	2-(7	PROPN
ijpds-4398	20	6	-	-	PUNCT
ijpds-4398	20	7	chloroquinoline-2	chloroquinoline-2	NUM
ijpds-4398	20	8	-	-	PUNCT
ijpds-4398	20	9	yl	yl	NOUN
ijpds-4398	20	10	)	)	PUNCT
ijpds-4398	20	11	ethenyl	ethenyl	NOUN
ijpds-4398	20	12	]	]	PUNCT
ijpds-4398	20	13	phenyl)-3-[2(1	phenyl)-3-[2(1	NOUN
ijpds-4398	20	14	-	-	PUNCT
ijpds-4398	20	15	hydroxy-1	hydroxy-1	NOUN
ijpds-4398	20	16	-	-	PUNCT
ijpds-4398	20	17	methylethyl	methylethyl	NOUN
ijpds-4398	20	18	)	)	PUNCT
ijpds-4398	20	19	phenyl	phenyl	NOUN
ijpds-4398	20	20	]	]	PUNCT
ijpds-4398	20	21	propyl	propyl	NOUN
ijpds-4398	20	22	]	]	PUNCT
ijpds-4398	20	23	sulfanyl	sulfanyl	NOUN
ijpds-4398	20	24	]	]	X
ijpds-4398	20	25	methyl	methyl	NOUN
ijpds-4398	20	26	]	]	PUNCT
ijpds-4398	20	27	cyclopropyl	cyclopropyl	PROPN
ijpds-4398	20	28	]	]	PUNCT
ijpds-4398	20	29	acetate	acetate	NOUN
ijpds-4398	21	1	[	[	X
ijpds-4398	21	2	1	1	NUM
ijpds-4398	21	3	]	]	PUNCT
ijpds-4398	21	4	is	be	AUX
ijpds-4398	21	5	an	an	DET
ijpds-4398	21	6	anti	anti	ADJ
ijpds-4398	21	7	-	-	ADJ
ijpds-4398	21	8	asthmatic	asthmatic	ADJ
ijpds-4398	21	9	,	,	PUNCT
ijpds-4398	21	10	leukotriene	leukotriene	NOUN
ijpds-4398	21	11	receptor	receptor	NOUN
ijpds-4398	21	12	antagonist	antagonist	NOUN
ijpds-4398	21	13	.	.	PUNCT
ijpds-4398	22	1	it	it	PRON
ijpds-4398	22	2	can	can	AUX
ijpds-4398	22	3	completely	completely	ADV
ijpds-4398	22	4	block	block	VERB
ijpds-4398	22	5	the	the	DET
ijpds-4398	22	6	binding	binding	NOUN
ijpds-4398	22	7	of	of	ADP
ijpds-4398	22	8	cyslt	cyslt	PROPN
ijpds-4398	22	9	’s	’s	NOUN
ijpds-4398	22	10	to	to	ADP
ijpds-4398	22	11	receptor	receptor	NOUN
ijpds-4398	22	12	that	that	SCONJ
ijpds-4398	22	13	they	they	PRON
ijpds-4398	22	14	can	can	AUX
ijpds-4398	22	15	inhibit	inhibit	VERB
ijpds-4398	22	16	the	the	DET
ijpds-4398	22	17	binding	binding	NOUN
ijpds-4398	22	18	of	of	ADP
ijpds-4398	22	19	inflammation	inflammation	ADJ
ijpds-4398	22	20	mediator	mediator	NOUN
ijpds-4398	22	21	ltd4	ltd4	PROPN
ijpds-4398	23	1	[	[	X
ijpds-4398	23	2	2	2	NUM
ijpds-4398	23	3	]	]	PUNCT
ijpds-4398	23	4	.	.	PUNCT
ijpds-4398	24	1	literature	literature	NOUN
ijpds-4398	24	2	survey	survey	NOUN
ijpds-4398	24	3	revealed	reveal	VERB
ijpds-4398	24	4	that	that	SCONJ
ijpds-4398	24	5	various	various	ADJ
ijpds-4398	24	6	analytical	analytical	ADJ
ijpds-4398	24	7	methods	method	NOUN
ijpds-4398	24	8	have	have	AUX
ijpds-4398	24	9	been	be	AUX
ijpds-4398	24	10	reported	report	VERB
ijpds-4398	24	11	for	for	ADP
ijpds-4398	24	12	estimation	estimation	NOUN
ijpds-4398	24	13	of	of	ADP
ijpds-4398	24	14	mks	mks	PROPN
ijpds-4398	24	15	includes	include	VERB
ijpds-4398	24	16	uv	uv	NOUN
ijpds-4398	24	17	spectrophotometric	spectrophotometric	ADJ
ijpds-4398	24	18	method	method	NOUN
ijpds-4398	25	1	lonely	lonely	ADJ
ijpds-4398	25	2	[	[	X
ijpds-4398	25	3	22	22	NUM
ijpds-4398	25	4	-	-	SYM
ijpds-4398	25	5	28	28	NUM
ijpds-4398	25	6	]	]	PUNCT
ijpds-4398	25	7	,	,	PUNCT
ijpds-4398	25	8	uv	uv	NOUN
ijpds-4398	25	9	spectrophotometric	spectrophotometric	ADJ
ijpds-4398	25	10	method	method	NOUN
ijpds-4398	25	11	with	with	ADP
ijpds-4398	25	12	bse	bse	NOUN
ijpds-4398	25	13	or	or	CCONJ
ijpds-4398	25	14	other	other	ADJ
ijpds-4398	25	15	drug	drug	NOUN
ijpds-4398	25	16	[	[	X
ijpds-4398	25	17	29	29	NUM
ijpds-4398	25	18	-	-	SYM
ijpds-4398	25	19	33	33	NUM
ijpds-4398	25	20	]	]	PUNCT
ijpds-4398	25	21	,	,	PUNCT
ijpds-4398	25	22	for	for	ADP
ijpds-4398	25	23	estimation	estimation	NOUN
ijpds-4398	25	24	of	of	ADP
ijpds-4398	25	25	mks	mks	PROPN
ijpds-4398	25	26	qbd	qbd	NOUN
ijpds-4398	25	27	technique	technique	NOUN
ijpds-4398	25	28	[	[	X
ijpds-4398	25	29	34	34	NUM
ijpds-4398	25	30	]	]	PUNCT
ijpds-4398	25	31	,	,	PUNCT
ijpds-4398	25	32	rp	rp	NOUN
ijpds-4398	25	33	-	-	PUNCT
ijpds-4398	25	34	hplc	hplc	NOUN
ijpds-4398	25	35	methods	method	NOUN
ijpds-4398	25	36	[	[	PUNCT
ijpds-4398	25	37	35	35	NUM
ijpds-4398	25	38	-	-	SYM
ijpds-4398	25	39	40	40	NUM
ijpds-4398	25	40	]	]	PUNCT
ijpds-4398	25	41	,	,	PUNCT
ijpds-4398	25	42	stability	stability	NOUN
ijpds-4398	25	43	indicating	indicate	VERB
ijpds-4398	25	44	hplc	hplc	NOUN
ijpds-4398	25	45	with	with	ADP
ijpds-4398	25	46	other	other	ADJ
ijpds-4398	25	47	[	[	X
ijpds-4398	25	48	41	41	NUM
ijpds-4398	25	49	-	-	SYM
ijpds-4398	25	50	43	43	NUM
ijpds-4398	25	51	]	]	PUNCT
ijpds-4398	25	52	and	and	CCONJ
ijpds-4398	25	53	hptlc	hptlc	NOUN
ijpds-4398	25	54	[	[	X
ijpds-4398	25	55	44	44	NUM
ijpds-4398	25	56	]	]	PUNCT
ijpds-4398	25	57	alone	alone	ADJ
ijpds-4398	25	58	or	or	CCONJ
ijpds-4398	25	59	in	in	ADP
ijpds-4398	25	60	combination	combination	NOUN
ijpds-4398	25	61	with	with	ADP
ijpds-4398	25	62	other	other	ADJ
ijpds-4398	25	63	drugs	drug	NOUN
ijpds-4398	25	64	.	.	PUNCT
ijpds-4398	26	1	montelukast	montelukast	NOUN
ijpds-4398	26	2	sodium	sodium	NOUN
ijpds-4398	26	3	is	be	AUX
ijpds-4398	26	4	official	official	ADJ
ijpds-4398	26	5	in	in	ADP
ijpds-4398	26	6	indian	indian	ADJ
ijpds-4398	26	7	and	and	CCONJ
ijpds-4398	26	8	british	british	ADJ
ijpds-4398	26	9	pharmacopoeia	pharmacopoeia	NOUN
ijpds-4398	27	1	[	[	X
ijpds-4398	27	2	45	45	NUM
ijpds-4398	27	3	,	,	PUNCT
ijpds-4398	27	4	46	46	NUM
ijpds-4398	27	5	]	]	PUNCT
ijpds-4398	27	6	.	.	PUNCT
ijpds-4398	28	1	chemical	chemical	ADJ
ijpds-4398	28	2	structure	structure	NOUN
ijpds-4398	28	3	of	of	ADP
ijpds-4398	28	4	both	both	DET
ijpds-4398	28	5	these	these	DET
ijpds-4398	28	6	drugs	drug	NOUN
ijpds-4398	28	7	is	be	AUX
ijpds-4398	28	8	shown	show	VERB
ijpds-4398	28	9	in	in	ADP
ijpds-4398	28	10	(	(	PUNCT
ijpds-4398	28	11	figure	figure	NOUN
ijpds-4398	28	12	1	1	NUM
ijpds-4398	28	13	)	)	PUNCT
ijpds-4398	28	14	.	.	PUNCT
ijpds-4398	29	1	_	_	PUNCT
ijpds-4398	30	1	_	_	PUNCT
ijpds-4398	31	1	_	_	PUNCT
ijpds-4398	32	1	_	_	PUNCT
ijpds-4398	33	1	_	_	PUNCT
ijpds-4398	34	1	_	_	PUNCT
ijpds-4398	35	1	_	_	PUNCT
ijpds-4398	36	1	_	_	PUNCT
ijpds-4398	37	1	_	_	PUNCT
ijpds-4398	38	1	_	_	PUNCT
ijpds-4398	39	1	_	_	PUNCT
ijpds-4398	40	1	_	_	PUNCT
ijpds-4398	41	1	_	_	PUNCT
ijpds-4398	42	1	_	_	PUNCT
ijpds-4398	43	1	_	_	PUNCT
ijpds-4398	44	1	_	_	PUNCT
ijpds-4398	45	1	_	_	PUNCT
ijpds-4398	46	1	_	_	PUNCT
ijpds-4398	47	1	_	_	PUNCT
ijpds-4398	48	1	_	_	PUNCT
ijpds-4398	49	1	_	_	PUNCT
ijpds-4398	50	1	_	_	PUNCT
ijpds-4398	51	1	_	_	PUNCT
ijpds-4398	52	1	_	_	PUNCT
ijpds-4398	53	1	_	_	PUNCT
ijpds-4398	54	1	_	_	PUNCT
ijpds-4398	55	1	_	_	PUNCT
ijpds-4398	56	1	_	_	PUNCT
ijpds-4398	57	1	_	_	PUNCT
ijpds-4398	58	1	_	_	PUNCT
ijpds-4398	59	1	_	_	PUNCT
ijpds-4398	60	1	_	_	PUNCT
ijpds-4398	61	1	_	_	PUNCT
ijpds-4398	62	1	_	_	PUNCT
ijpds-4398	63	1	_	_	PUNCT
ijpds-4398	64	1	_	_	PUNCT
ijpds-4398	65	1	_	_	PUNCT
ijpds-4398	66	1	_	_	PUNCT
ijpds-4398	67	1	_	_	PUNCT
ijpds-4398	68	1	_	_	PUNCT
ijpds-4398	69	1	_	_	PUNCT
ijpds-4398	69	2	correspondence	correspondence	NOUN
ijpds-4398	69	3	to	to	ADP
ijpds-4398	69	4	:	:	PUNCT
ijpds-4398	69	5	g	g	PROPN
ijpds-4398	69	6	k	k	PROPN
ijpds-4398	69	7	dyade	dyade	PROPN
ijpds-4398	69	8	,	,	PUNCT
ijpds-4398	69	9	department	department	NOUN
ijpds-4398	69	10	of	of	ADP
ijpds-4398	69	11	pg	pg	PROPN
ijpds-4398	69	12	studies	study	NOUN
ijpds-4398	69	13	in	in	ADP
ijpds-4398	69	14	pharm	pharm	NOUN
ijpds-4398	69	15	quality	quality	NOUN
ijpds-4398	69	16	assurance	assurance	NOUN
ijpds-4398	69	17	,	,	PUNCT
ijpds-4398	69	18	svpm	svpm	NOUN
ijpds-4398	69	19	’s	’s	PART
ijpds-4398	69	20	college	college	PROPN
ijpds-4398	69	21	of	of	ADP
ijpds-4398	69	22	pharmacy	pharmacy	NOUN
ijpds-4398	69	23	,	,	PUNCT
ijpds-4398	69	24	malegaon	malegaon	PROPN
ijpds-4398	69	25	(	(	PUNCT
ijpds-4398	69	26	bkii	bkii	ADJ
ijpds-4398	69	27	)	)	PUNCT
ijpds-4398	69	28	,	,	PUNCT
ijpds-4398	69	29	baramati	baramati	PROPN
ijpds-4398	69	30	,	,	PUNCT
ijpds-4398	69	31	pune	pune	NOUN
ijpds-4398	69	32	,	,	PUNCT
ijpds-4398	69	33	maharashtra	maharashtra	PROPN
ijpds-4398	69	34	,	,	PUNCT
ijpds-4398	69	35	india	india	PROPN
ijpds-4398	69	36	.	.	PUNCT
ijpds-4398	69	37	email	email	NOUN
ijpds-4398	69	38	:	:	PUNCT
ijpds-4398	70	1	pharmacyresearchsvpmcop@gmail.com	pharmacyresearchsvpmcop@gmail.com	X
ijpds-4398	70	2	b	b	PUNCT
ijpds-4398	70	3	mailto:pharmacyresearchsvpmcop@gmail.com	mailto:pharmacyresearchsvpmcop@gmail.com	PROPN
ijpds-4398	71	1	d	d	PROPN
ijpds-4398	71	2	kolekar	kolekar	PROPN
ijpds-4398	71	3	et	et	PROPN
ijpds-4398	71	4	al	al	PROPN
ijpds-4398	71	5	.	.	PROPN
ijpds-4398	71	6	chemometric	chemometric	PROPN
ijpds-4398	71	7	assisted	assist	VERB
ijpds-4398	71	8	qbd	qbd	NOUN
ijpds-4398	71	9	method	method	NOUN
ijpds-4398	71	10	for	for	ADP
ijpds-4398	71	11	estimation	estimation	NOUN
ijpds-4398	71	12	of	of	ADP
ijpds-4398	71	13	bilastine	bilastine	NOUN
ijpds-4398	71	14	and	and	CCONJ
ijpds-4398	71	15	montelukast	montelukast	NOUN
ijpds-4398	71	16	sodium	sodium	NOUN
ijpds-4398	71	17	vol	vol	NOUN
ijpds-4398	71	18	3	3	NUM
ijpds-4398	71	19	|	|	NOUN
ijpds-4398	71	20	issue	issue	VERB
ijpds-4398	71	21	1	1	NUM
ijpds-4398	71	22	|	|	ADV
ijpds-4398	71	23	jan	jan	PROPN
ijpds-4398	71	24	–	–	PUNCT
ijpds-4398	71	25	mar	mar	PROPN
ijpds-4398	71	26	2024	2024	NUM
ijpds-4398	71	27	indian	indian	PROPN
ijpds-4398	71	28	j	j	PROPN
ijpds-4398	71	29	pharm	pharm	PROPN
ijpds-4398	71	30	drug	drug	PROPN
ijpds-4398	71	31	studies	study	NOUN
ijpds-4398	71	32	|	|	ADV
ijpds-4398	71	33	17	17	NUM
ijpds-4398	71	34	figure	figure	NOUN
ijpds-4398	71	35	1	1	NUM
ijpds-4398	71	36	:	:	PUNCT
ijpds-4398	71	37	chemical	chemical	ADJ
ijpds-4398	71	38	structure	structure	NOUN
ijpds-4398	71	39	of	of	ADP
ijpds-4398	71	40	drug	drug	NOUN
ijpds-4398	71	41	molecule	molecule	NOUN
ijpds-4398	71	42	quality	quality	NOUN
ijpds-4398	71	43	by	by	ADP
ijpds-4398	71	44	design	design	NOUN
ijpds-4398	71	45	concept	concept	NOUN
ijpds-4398	71	46	is	be	AUX
ijpds-4398	71	47	applied	apply	VERB
ijpds-4398	71	48	for	for	ADP
ijpds-4398	71	49	the	the	DET
ijpds-4398	71	50	development	development	NOUN
ijpds-4398	71	51	of	of	ADP
ijpds-4398	71	52	pharmaceutical	pharmaceutical	NOUN
ijpds-4398	71	53	processes	process	NOUN
ijpds-4398	71	54	to	to	PART
ijpds-4398	71	55	assure	assure	VERB
ijpds-4398	71	56	a	a	DET
ijpds-4398	71	57	predefined	predefine	VERB
ijpds-4398	71	58	product	product	NOUN
ijpds-4398	71	59	quality	quality	NOUN
ijpds-4398	71	60	.	.	PUNCT
ijpds-4398	72	1	qbd	qbd	PROPN
ijpds-4398	72	2	concepts	concept	NOUN
ijpds-4398	72	3	are	be	AUX
ijpds-4398	72	4	mentioned	mention	VERB
ijpds-4398	72	5	in	in	ADP
ijpds-4398	72	6	ich	ich	NOUN
ijpds-4398	72	7	guidelines	guideline	NOUN
ijpds-4398	72	8	q8	q8	PROPN
ijpds-4398	72	9	(	(	PUNCT
ijpds-4398	72	10	r2	r2	PROPN
ijpds-4398	72	11	)	)	PUNCT
ijpds-4398	72	12	(	(	PUNCT
ijpds-4398	72	13	pharmaceutical	pharmaceutical	NOUN
ijpds-4398	72	14	development	development	NOUN
ijpds-4398	72	15	)	)	PUNCT
ijpds-4398	72	16	,	,	PUNCT
ijpds-4398	72	17	q9	q9	PROPN
ijpds-4398	72	18	(	(	PUNCT
ijpds-4398	72	19	quality	quality	NOUN
ijpds-4398	72	20	risk	risk	NOUN
ijpds-4398	72	21	management	management	NOUN
ijpds-4398	72	22	)	)	PUNCT
ijpds-4398	72	23	,	,	PUNCT
ijpds-4398	72	24	and	and	CCONJ
ijpds-4398	72	25	q10	q10	PROPN
ijpds-4398	72	26	(	(	PUNCT
ijpds-4398	72	27	pharmaceutical	pharmaceutical	ADJ
ijpds-4398	72	28	quality	quality	NOUN
ijpds-4398	72	29	system	system	NOUN
ijpds-4398	72	30	)	)	PUNCT
ijpds-4398	73	1	[	[	X
ijpds-4398	73	2	4749	4749	NUM
ijpds-4398	73	3	]	]	PUNCT
ijpds-4398	73	4	shown	show	VERB
ijpds-4398	73	5	in	in	ADP
ijpds-4398	73	6	(	(	PUNCT
ijpds-4398	73	7	figure	figure	NOUN
ijpds-4398	73	8	2	2	NUM
ijpds-4398	73	9	)	)	PUNCT
ijpds-4398	73	10	.	.	PUNCT
ijpds-4398	74	1	ich	ich	NOUN
ijpds-4398	74	2	guidelines	guideline	VERB
ijpds-4398	74	3	q8	q8	PROPN
ijpds-4398	74	4	(	(	PUNCT
ijpds-4398	74	5	r2	r2	PROPN
ijpds-4398	74	6	)	)	PUNCT
ijpds-4398	74	7	defines	define	VERB
ijpds-4398	74	8	qbd	qbd	NOUN
ijpds-4398	74	9	as	as	ADP
ijpds-4398	74	10	a	a	DET
ijpds-4398	74	11	“	"	PUNCT
ijpds-4398	74	12	a	a	DET
ijpds-4398	74	13	systematic	systematic	ADJ
ijpds-4398	74	14	approach	approach	NOUN
ijpds-4398	74	15	to	to	ADP
ijpds-4398	74	16	development	development	NOUN
ijpds-4398	74	17	that	that	PRON
ijpds-4398	74	18	begins	begin	VERB
ijpds-4398	74	19	with	with	ADP
ijpds-4398	74	20	predefined	predefine	VERB
ijpds-4398	74	21	objectives	objective	NOUN
ijpds-4398	74	22	and	and	CCONJ
ijpds-4398	74	23	emphasizes	emphasize	VERB
ijpds-4398	74	24	product	product	NOUN
ijpds-4398	74	25	and	and	CCONJ
ijpds-4398	74	26	process	process	NOUN
ijpds-4398	74	27	understanding	understanding	NOUN
ijpds-4398	74	28	and	and	CCONJ
ijpds-4398	74	29	process	process	NOUN
ijpds-4398	74	30	control	control	NOUN
ijpds-4398	74	31	,	,	PUNCT
ijpds-4398	74	32	based	base	VERB
ijpds-4398	74	33	on	on	ADP
ijpds-4398	74	34	sound	sound	ADJ
ijpds-4398	74	35	science	science	NOUN
ijpds-4398	74	36	and	and	CCONJ
ijpds-4398	74	37	quality	quality	NOUN
ijpds-4398	74	38	risk	risk	NOUN
ijpds-4398	74	39	management”[50	management”[50	NOUN
ijpds-4398	74	40	]	]	PUNCT
ijpds-4398	74	41	.	.	PUNCT
ijpds-4398	75	1	qbd	qbd	PROPN
ijpds-4398	75	2	approach	approach	NOUN
ijpds-4398	75	3	in	in	ADP
ijpds-4398	75	4	analytical	analytical	ADJ
ijpds-4398	75	5	method	method	NOUN
ijpds-4398	75	6	summarizes	summarize	VERB
ijpds-4398	75	7	a	a	DET
ijpds-4398	75	8	complete	complete	ADJ
ijpds-4398	75	9	understanding	understanding	NOUN
ijpds-4398	75	10	of	of	ADP
ijpds-4398	75	11	how	how	SCONJ
ijpds-4398	75	12	the	the	DET
ijpds-4398	75	13	analytical	analytical	ADJ
ijpds-4398	75	14	technique	technique	NOUN
ijpds-4398	75	15	attributes	attribute	NOUN
ijpds-4398	75	16	and	and	CCONJ
ijpds-4398	75	17	operating	operating	NOUN
ijpds-4398	75	18	conditions	condition	NOUN
ijpds-4398	75	19	affect	affect	VERB
ijpds-4398	75	20	the	the	DET
ijpds-4398	75	21	analytical	analytical	ADJ
ijpds-4398	75	22	performance	performance	NOUN
ijpds-4398	75	23	.	.	PUNCT
ijpds-4398	76	1	factors	factor	NOUN
ijpds-4398	76	2	to	to	PART
ijpds-4398	76	3	study	study	VERB
ijpds-4398	76	4	in	in	ADP
ijpds-4398	76	5	analytical	analytical	ADJ
ijpds-4398	76	6	quality	quality	NOUN
ijpds-4398	76	7	by	by	ADP
ijpds-4398	76	8	design	design	NOUN
ijpds-4398	76	9	(	(	PUNCT
ijpds-4398	76	10	aqbd	aqbd	NOUN
ijpds-4398	76	11	)	)	PUNCT
ijpds-4398	76	12	approach	approach	NOUN
ijpds-4398	76	13	may	may	AUX
ijpds-4398	76	14	include	include	VERB
ijpds-4398	76	15	the	the	DET
ijpds-4398	76	16	type	type	NOUN
ijpds-4398	76	17	of	of	ADP
ijpds-4398	76	18	analytical	analytical	ADJ
ijpds-4398	76	19	technique	technique	NOUN
ijpds-4398	76	20	chosen	choose	VERB
ijpds-4398	76	21	,	,	PUNCT
ijpds-4398	76	22	reagents	reagent	NOUN
ijpds-4398	76	23	used	use	VERB
ijpds-4398	76	24	and	and	CCONJ
ijpds-4398	76	25	instrument	instrument	NOUN
ijpds-4398	76	26	parameters	parameter	NOUN
ijpds-4398	76	27	.	.	PUNCT
ijpds-4398	77	1	fig	fig	NOUN
ijpds-4398	77	2	no	no	DET
ijpds-4398	77	3	2	2	NUM
ijpds-4398	77	4	:	:	PUNCT
ijpds-4398	77	5	analytical	analytical	ADJ
ijpds-4398	77	6	qbd	qbd	NOUN
ijpds-4398	77	7	approach	approach	NOUN
ijpds-4398	77	8	there	there	PRON
ijpds-4398	77	9	are	be	AUX
ijpds-4398	77	10	similar	similar	ADJ
ijpds-4398	77	11	advantages	advantage	NOUN
ijpds-4398	77	12	of	of	ADP
ijpds-4398	77	13	applying	apply	VERB
ijpds-4398	77	14	qbd	qbd	NOUN
ijpds-4398	77	15	principles	principle	NOUN
ijpds-4398	77	16	to	to	ADP
ijpds-4398	77	17	analytical	analytical	ADJ
ijpds-4398	77	18	methods	method	NOUN
ijpds-4398	77	19	as	as	ADP
ijpds-4398	77	20	to	to	ADP
ijpds-4398	77	21	manufacturing	manufacturing	NOUN
ijpds-4398	77	22	processes	process	NOUN
ijpds-4398	77	23	and	and	CCONJ
ijpds-4398	77	24	product	product	NOUN
ijpds-4398	77	25	[	[	X
ijpds-4398	77	26	51	51	NUM
ijpds-4398	77	27	]	]	PUNCT
ijpds-4398	77	28	.	.	PUNCT
ijpds-4398	78	1	a	a	DET
ijpds-4398	78	2	qbd	qbd	NOUN
ijpds-4398	78	3	approach	approach	NOUN
ijpds-4398	78	4	can	can	AUX
ijpds-4398	78	5	be	be	AUX
ijpds-4398	78	6	beneficial	beneficial	ADJ
ijpds-4398	78	7	in	in	ADP
ijpds-4398	78	8	the	the	DET
ijpds-4398	78	9	development	development	NOUN
ijpds-4398	78	10	of	of	ADP
ijpds-4398	78	11	suitable	suitable	ADJ
ijpds-4398	78	12	,	,	PUNCT
ijpds-4398	78	13	robust	robust	ADJ
ijpds-4398	78	14	,	,	PUNCT
ijpds-4398	78	15	low	low	ADJ
ijpds-4398	78	16	cost	cost	NOUN
ijpds-4398	78	17	and	and	CCONJ
ijpds-4398	78	18	eco	eco	NOUN
ijpds-4398	78	19	-	-	PUNCT
ijpds-4398	78	20	friendly	friendly	ADJ
ijpds-4398	78	21	(	(	PUNCT
ijpds-4398	78	22	eco	eco	NOUN
ijpds-4398	78	23	-	-	PUNCT
ijpds-4398	78	24	friendly	friendly	ADJ
ijpds-4398	78	25	solvent	solvent	NOUN
ijpds-4398	78	26	,	,	PUNCT
ijpds-4398	78	27	chemicals	chemical	NOUN
ijpds-4398	78	28	)	)	PUNCT
ijpds-4398	78	29	method	method	NOUN
ijpds-4398	78	30	which	which	PRON
ijpds-4398	78	31	is	be	AUX
ijpds-4398	78	32	applicable	applicable	ADJ
ijpds-4398	78	33	at	at	ADP
ijpds-4398	78	34	any	any	DET
ijpds-4398	78	35	stage	stage	NOUN
ijpds-4398	78	36	of	of	ADP
ijpds-4398	78	37	the	the	DET
ijpds-4398	78	38	lifecycle	lifecycle	NOUN
ijpds-4398	78	39	of	of	ADP
ijpds-4398	78	40	the	the	DET
ijpds-4398	78	41	product	product	NOUN
ijpds-4398	78	42	.	.	PUNCT
ijpds-4398	79	1	also	also	ADV
ijpds-4398	79	2	some	some	DET
ijpds-4398	79	3	regulatory	regulatory	ADJ
ijpds-4398	79	4	guidelines	guideline	NOUN
ijpds-4398	79	5	have	have	AUX
ijpds-4398	79	6	mentioned	mention	VERB
ijpds-4398	79	7	flexibility	flexibility	NOUN
ijpds-4398	79	8	of	of	ADP
ijpds-4398	79	9	changing	change	VERB
ijpds-4398	79	10	analytical	analytical	ADJ
ijpds-4398	79	11	method	method	NOUN
ijpds-4398	79	12	without	without	ADP
ijpds-4398	79	13	revalidation	revalidation	NOUN
ijpds-4398	79	14	if	if	SCONJ
ijpds-4398	79	15	the	the	DET
ijpds-4398	79	16	aqbd	aqbd	PROPN
ijpds-4398	79	17	approach	approach	NOUN
ijpds-4398	79	18	has	have	AUX
ijpds-4398	79	19	been	be	AUX
ijpds-4398	79	20	implemented	implement	VERB
ijpds-4398	79	21	during	during	ADP
ijpds-4398	79	22	analytical	analytical	ADJ
ijpds-4398	79	23	method	method	NOUN
ijpds-4398	79	24	development	development	NOUN
ijpds-4398	79	25	.	.	PUNCT
ijpds-4398	80	1	the	the	DET
ijpds-4398	80	2	first	first	ADJ
ijpds-4398	80	3	stage	stage	NOUN
ijpds-4398	80	4	of	of	ADP
ijpds-4398	80	5	aqbd	aqbd	PROPN
ijpds-4398	80	6	approach	approach	NOUN
ijpds-4398	80	7	is	be	AUX
ijpds-4398	80	8	to	to	PART
ijpds-4398	80	9	fix	fix	VERB
ijpds-4398	80	10	an	an	DET
ijpds-4398	80	11	analytical	analytical	ADJ
ijpds-4398	80	12	target	target	NOUN
ijpds-4398	80	13	profile	profile	NOUN
ijpds-4398	80	14	(	(	PUNCT
ijpds-4398	80	15	atp	atp	PROPN
ijpds-4398	80	16	)	)	PUNCT
ijpds-4398	80	17	for	for	ADP
ijpds-4398	80	18	the	the	DET
ijpds-4398	80	19	method	method	NOUN
ijpds-4398	80	20	.	.	PUNCT
ijpds-4398	81	1	atp	atp	PROPN
ijpds-4398	81	2	defines	define	VERB
ijpds-4398	81	3	the	the	DET
ijpds-4398	81	4	goal	goal	NOUN
ijpds-4398	81	5	of	of	ADP
ijpds-4398	81	6	the	the	DET
ijpds-4398	81	7	analytical	analytical	ADJ
ijpds-4398	81	8	method	method	NOUN
ijpds-4398	81	9	development	development	NOUN
ijpds-4398	81	10	process	process	NOUN
ijpds-4398	81	11	and	and	CCONJ
ijpds-4398	81	12	it	it	PRON
ijpds-4398	81	13	is	be	AUX
ijpds-4398	81	14	the	the	DET
ijpds-4398	81	15	sign	sign	NOUN
ijpds-4398	81	16	of	of	ADP
ijpds-4398	81	17	method	method	NOUN
ijpds-4398	81	18	performance	performance	NOUN
ijpds-4398	81	19	[	[	X
ijpds-4398	81	20	52	52	NUM
ijpds-4398	81	21	,	,	PUNCT
ijpds-4398	81	22	53	53	NUM
ijpds-4398	81	23	]	]	PUNCT
ijpds-4398	81	24	.	.	PUNCT
ijpds-4398	82	1	for	for	ADP
ijpds-4398	82	2	analytical	analytical	ADJ
ijpds-4398	82	3	method	method	NOUN
ijpds-4398	82	4	validation	validation	NOUN
ijpds-4398	82	5	ich	ich	PROPN
ijpds-4398	82	6	q2	q2	NOUN
ijpds-4398	82	7	(	(	PUNCT
ijpds-4398	82	8	r1	r1	PROPN
ijpds-4398	82	9	)	)	PUNCT
ijpds-4398	82	10	has	have	AUX
ijpds-4398	82	11	given	give	VERB
ijpds-4398	82	12	various	various	ADJ
ijpds-4398	82	13	method	method	NOUN
ijpds-4398	82	14	performance	performance	NOUN
ijpds-4398	82	15	characteristics	characteristic	NOUN
ijpds-4398	82	16	for	for	ADP
ijpds-4398	82	17	an	an	DET
ijpds-4398	82	18	analytical	analytical	ADJ
ijpds-4398	82	19	method	method	NOUN
ijpds-4398	82	20	.	.	PUNCT
ijpds-4398	83	1	in	in	ADP
ijpds-4398	83	2	development	development	NOUN
ijpds-4398	83	3	of	of	ADP
ijpds-4398	83	4	uv	uv	NOUN
ijpds-4398	83	5	-	-	PUNCT
ijpds-4398	83	6	vis	vis	X
ijpds-4398	83	7	spectrophotometric	spectrophotometric	ADJ
ijpds-4398	83	8	method	method	NOUN
ijpds-4398	83	9	,	,	PUNCT
ijpds-4398	83	10	qbd	qbd	PROPN
ijpds-4398	83	11	approach	approach	NOUN
ijpds-4398	83	12	was	be	AUX
ijpds-4398	83	13	implemented	implement	VERB
ijpds-4398	83	14	with	with	ADP
ijpds-4398	83	15	the	the	DET
ijpds-4398	83	16	study	study	NOUN
ijpds-4398	83	17	of	of	ADP
ijpds-4398	83	18	the	the	DET
ijpds-4398	83	19	effect	effect	NOUN
ijpds-4398	83	20	of	of	ADP
ijpds-4398	83	21	method	method	ADJ
ijpds-4398	83	22	input	input	NOUN
ijpds-4398	83	23	variables	variable	NOUN
ijpds-4398	83	24	on	on	ADP
ijpds-4398	83	25	spectral	spectral	ADJ
ijpds-4398	83	26	shape	shape	NOUN
ijpds-4398	83	27	,	,	PUNCT
ijpds-4398	83	28	intensity	intensity	NOUN
ijpds-4398	83	29	of	of	ADP
ijpds-4398	83	30	absorbance	absorbance	NOUN
ijpds-4398	83	31	,	,	PUNCT
ijpds-4398	83	32	and	and	CCONJ
ijpds-4398	83	33	absorbance	absorbance	NOUN
ijpds-4398	83	34	maxima	maxima	NOUN
ijpds-4398	83	35	λmax	λmax	NOUN
ijpds-4398	83	36	and	and	CCONJ
ijpds-4398	83	37	critical	critical	ADJ
ijpds-4398	83	38	parameters	parameter	NOUN
ijpds-4398	83	39	were	be	AUX
ijpds-4398	83	40	selected	select	VERB
ijpds-4398	83	41	for	for	ADP
ijpds-4398	83	42	the	the	DET
ijpds-4398	83	43	proposed	propose	VERB
ijpds-4398	83	44	method	method	NOUN
ijpds-4398	83	45	and	and	CCONJ
ijpds-4398	83	46	method	method	NOUN
ijpds-4398	83	47	was	be	AUX
ijpds-4398	83	48	validated	validate	VERB
ijpds-4398	83	49	as	as	ADP
ijpds-4398	83	50	per	per	ADP
ijpds-4398	83	51	ich	ich	NOUN
ijpds-4398	83	52	guidelines	guideline	NOUN
ijpds-4398	83	53	q2	q2	NOUN
ijpds-4398	83	54	(	(	PUNCT
ijpds-4398	83	55	r1	r1	PROPN
ijpds-4398	83	56	)	)	PUNCT
ijpds-4398	83	57	.	.	PUNCT
ijpds-4398	84	1	materials	material	NOUN
ijpds-4398	84	2	and	and	CCONJ
ijpds-4398	84	3	methods	method	NOUN
ijpds-4398	84	4	instrumentation	instrumentation	NOUN
ijpds-4398	84	5	:	:	PUNCT
ijpds-4398	84	6	analysis	analysis	NOUN
ijpds-4398	84	7	was	be	AUX
ijpds-4398	84	8	performed	perform	VERB
ijpds-4398	84	9	with	with	ADP
ijpds-4398	84	10	a	a	DET
ijpds-4398	84	11	shimadzu	shimadzu	ADJ
ijpds-4398	84	12	double	double	ADJ
ijpds-4398	84	13	beam	beam	NOUN
ijpds-4398	84	14	uv	uv	NOUN
ijpds-4398	84	15	-	-	PUNCT
ijpds-4398	84	16	visible	visible	ADJ
ijpds-4398	84	17	spectrophotometer	spectrophotometer	NOUN
ijpds-4398	84	18	(	(	PUNCT
ijpds-4398	84	19	shimadzu	shimadzu	PROPN
ijpds-4398	84	20	,	,	PUNCT
ijpds-4398	84	21	kyoto	kyoto	PROPN
ijpds-4398	84	22	,	,	PUNCT
ijpds-4398	84	23	japan	japan	PROPN
ijpds-4398	84	24	)	)	PUNCT
ijpds-4398	84	25	with	with	ADP
ijpds-4398	84	26	spectral	spectral	ADJ
ijpds-4398	84	27	bandwidth	bandwidth	NOUN
ijpds-4398	84	28	of	of	ADP
ijpds-4398	84	29	2	2	NUM
ijpds-4398	84	30	nm	nm	NOUN
ijpds-4398	84	31	and	and	CCONJ
ijpds-4398	84	32	wavelength	wavelength	NOUN
ijpds-4398	84	33	accuracy	accuracy	NOUN
ijpds-4398	84	34	of	of	ADP
ijpds-4398	84	35	±	±	NUM
ijpds-4398	84	36	1	1	NUM
ijpds-4398	84	37	nm	nm	NOUN
ijpds-4398	84	38	with	with	SCONJ
ijpds-4398	84	39	10	10	NUM
ijpds-4398	84	40	mm	mm	NUM
ijpds-4398	84	41	matched	match	VERB
ijpds-4398	84	42	quartz	quartz	NOUN
ijpds-4398	84	43	cells	cell	NOUN
ijpds-4398	84	44	was	be	AUX
ijpds-4398	84	45	used	use	VERB
ijpds-4398	84	46	.	.	PUNCT
ijpds-4398	85	1	electronic	electronic	ADJ
ijpds-4398	85	2	balance	balance	NOUN
ijpds-4398	85	3	afcoset	afcoset	NOUN
ijpds-4398	85	4	balance	balance	NOUN
ijpds-4398	85	5	(	(	PUNCT
ijpds-4398	85	6	the	the	DET
ijpds-4398	85	7	bombay	bombay	PROPN
ijpds-4398	85	8	burmah	burmah	PROPN
ijpds-4398	85	9	trading	trading	PROPN
ijpds-4398	85	10	corpo	corpo	PROPN
ijpds-4398	85	11	ltd	ltd	PROPN
ijpds-4398	85	12	)	)	PUNCT
ijpds-4398	85	13	with	with	ADP
ijpds-4398	85	14	accuracy	accuracy	NOUN
ijpds-4398	85	15	±0.1	±0.1	PROPN
ijpds-4398	85	16	mg	mg	PROPN
ijpds-4398	85	17	model	model	NOUN
ijpds-4398	85	18	no	no	INTJ
ijpds-4398	85	19	.	.	PUNCT
ijpds-4398	86	1	er	er	INTJ
ijpds-4398	86	2	200a	200a	PROPN
ijpds-4398	86	3	was	be	AUX
ijpds-4398	86	4	utilised	utilise	VERB
ijpds-4398	86	5	for	for	ADP
ijpds-4398	86	6	weighing	weigh	VERB
ijpds-4398	86	7	and	and	CCONJ
ijpds-4398	86	8	for	for	ADP
ijpds-4398	86	9	degassing	degas	VERB
ijpds-4398	86	10	the	the	DET
ijpds-4398	86	11	solution	solution	NOUN
ijpds-4398	86	12	digital	digital	ADJ
ijpds-4398	86	13	ultrasonic	ultrasonic	ADJ
ijpds-4398	86	14	cleaner	cleaner	NOUN
ijpds-4398	86	15	1.8	1.8	NUM
ijpds-4398	86	16	ltr	ltr	NOUN
ijpds-4398	86	17	(	(	PUNCT
ijpds-4398	86	18	labman	labman	ADJ
ijpds-4398	86	19	scientific	scientific	ADJ
ijpds-4398	86	20	instruments	instrument	NOUN
ijpds-4398	86	21	chennai	chennai	PROPN
ijpds-4398	86	22	)	)	PUNCT
ijpds-4398	86	23	was	be	AUX
ijpds-4398	86	24	used	use	VERB
ijpds-4398	86	25	.	.	PUNCT
ijpds-4398	87	1	reagents	reagent	NOUN
ijpds-4398	87	2	and	and	CCONJ
ijpds-4398	87	3	chemicals	chemical	NOUN
ijpds-4398	87	4	:	:	PUNCT
ijpds-4398	87	5	pharmaceutically	pharmaceutically	ADV
ijpds-4398	87	6	pure	pure	ADJ
ijpds-4398	87	7	samples	sample	NOUN
ijpds-4398	87	8	of	of	ADP
ijpds-4398	87	9	bse	bse	NOUN
ijpds-4398	87	10	and	and	CCONJ
ijpds-4398	87	11	mks	mks	PROPN
ijpds-4398	87	12	from	from	ADP
ijpds-4398	87	13	glenmark	glenmark	ADJ
ijpds-4398	87	14	pharmaceuticals	pharmaceutical	NOUN
ijpds-4398	87	15	,	,	PUNCT
ijpds-4398	87	16	nashik	nashik	PROPN
ijpds-4398	87	17	,	,	PUNCT
ijpds-4398	87	18	maharashtra	maharashtra	PROPN
ijpds-4398	87	19	,	,	PUNCT
ijpds-4398	87	20	india	india	PROPN
ijpds-4398	87	21	were	be	AUX
ijpds-4398	87	22	procured	procure	VERB
ijpds-4398	87	23	as	as	ADP
ijpds-4398	87	24	a	a	DET
ijpds-4398	87	25	gift	gift	NOUN
ijpds-4398	87	26	sample	sample	NOUN
ijpds-4398	87	27	and	and	CCONJ
ijpds-4398	87	28	the	the	DET
ijpds-4398	87	29	commercial	commercial	ADJ
ijpds-4398	87	30	formulation	formulation	NOUN
ijpds-4398	87	31	bilafav	bilafav	PROPN
ijpds-4398	87	32	-	-	PUNCT
ijpds-4398	87	33	m	m	PROPN
ijpds-4398	87	34	tablet	tablet	NOUN
ijpds-4398	87	35	containing	contain	VERB
ijpds-4398	87	36	bilastine	bilastine	NOUN
ijpds-4398	87	37	20	20	NUM
ijpds-4398	87	38	mg	mg	NOUN
ijpds-4398	87	39	and	and	CCONJ
ijpds-4398	87	40	montelukast	montelukast	NOUN
ijpds-4398	87	41	sodium	sodium	NOUN
ijpds-4398	87	42	10	10	NUM
ijpds-4398	87	43	mg	mg	NOUN
ijpds-4398	87	44	was	be	AUX
ijpds-4398	87	45	procured	procure	VERB
ijpds-4398	87	46	from	from	ADP
ijpds-4398	87	47	the	the	DET
ijpds-4398	87	48	local	local	ADJ
ijpds-4398	87	49	market	market	NOUN
ijpds-4398	87	50	.	.	PUNCT
ijpds-4398	88	1	aqbd	aqbd	PROPN
ijpds-4398	88	2	approach	approach	NOUN
ijpds-4398	88	3	application	application	NOUN
ijpds-4398	88	4	in	in	ADP
ijpds-4398	88	5	method	method	NOUN
ijpds-4398	88	6	development	development	NOUN
ijpds-4398	88	7	:	:	PUNCT
ijpds-4398	88	8	aqbd	aqbd	PROPN
ijpds-4398	88	9	approach	approach	NOUN
ijpds-4398	88	10	was	be	AUX
ijpds-4398	88	11	applied	apply	VERB
ijpds-4398	88	12	to	to	PART
ijpds-4398	88	13	study	study	VERB
ijpds-4398	88	14	the	the	DET
ijpds-4398	88	15	influence	influence	NOUN
ijpds-4398	88	16	of	of	ADP
ijpds-4398	88	17	input	input	ADJ
ijpds-4398	88	18	variable	variable	ADJ
ijpds-4398	88	19	parameters	parameter	NOUN
ijpds-4398	88	20	on	on	ADP
ijpds-4398	88	21	spectrophotometric	spectrophotometric	ADJ
ijpds-4398	88	22	analytical	analytical	ADJ
ijpds-4398	88	23	method	method	NOUN
ijpds-4398	88	24	performance	performance	NOUN
ijpds-4398	88	25	shown	show	VERB
ijpds-4398	88	26	in	in	ADP
ijpds-4398	88	27	(	(	PUNCT
ijpds-4398	88	28	figure	figure	NOUN
ijpds-4398	88	29	3	3	NUM
ijpds-4398	88	30	)	)	PUNCT
ijpds-4398	88	31	.	.	PUNCT
ijpds-4398	89	1	figure	figure	VERB
ijpds-4398	89	2	3	3	NUM
ijpds-4398	89	3	:	:	PUNCT
ijpds-4398	89	4	diagram	diagram	NOUN
ijpds-4398	89	5	showing	show	VERB
ijpds-4398	89	6	the	the	DET
ijpds-4398	89	7	relationship	relationship	NOUN
ijpds-4398	89	8	between	between	ADP
ijpds-4398	89	9	input	input	NOUN
ijpds-4398	89	10	variable	variable	ADJ
ijpds-4398	89	11	parameters	parameter	NOUN
ijpds-4398	89	12	and	and	CCONJ
ijpds-4398	89	13	the	the	DET
ijpds-4398	89	14	spectrophotometric	spectrophotometric	ADJ
ijpds-4398	89	15	method	method	NOUN
ijpds-4398	89	16	performance	performance	NOUN
ijpds-4398	89	17	characteristics	characteristic	NOUN
ijpds-4398	90	1	d	d	PROPN
ijpds-4398	90	2	kolekar	kolekar	PROPN
ijpds-4398	90	3	et	et	PROPN
ijpds-4398	90	4	al	al	PROPN
ijpds-4398	90	5	.	.	PROPN
ijpds-4398	90	6	chemometric	chemometric	PROPN
ijpds-4398	90	7	assisted	assist	VERB
ijpds-4398	90	8	qbd	qbd	NOUN
ijpds-4398	90	9	method	method	NOUN
ijpds-4398	90	10	for	for	ADP
ijpds-4398	90	11	estimation	estimation	NOUN
ijpds-4398	90	12	of	of	ADP
ijpds-4398	90	13	bilastine	bilastine	NOUN
ijpds-4398	90	14	and	and	CCONJ
ijpds-4398	90	15	montelukast	montelukast	NOUN
ijpds-4398	90	16	sodium	sodium	NOUN
ijpds-4398	90	17	vol	vol	NOUN
ijpds-4398	90	18	3	3	NUM
ijpds-4398	90	19	|	|	NOUN
ijpds-4398	90	20	issue	issue	VERB
ijpds-4398	90	21	1	1	NUM
ijpds-4398	90	22	|	|	ADV
ijpds-4398	90	23	jan	jan	PROPN
ijpds-4398	90	24	–	–	PUNCT
ijpds-4398	90	25	mar	mar	PROPN
ijpds-4398	90	26	2024	2024	NUM
ijpds-4398	90	27	indian	indian	PROPN
ijpds-4398	90	28	j	j	PROPN
ijpds-4398	90	29	pharm	pharm	PROPN
ijpds-4398	90	30	drug	drug	PROPN
ijpds-4398	90	31	studies	study	NOUN
ijpds-4398	90	32	|	|	ADV
ijpds-4398	90	33	18	18	NUM
ijpds-4398	90	34	solvent	solvent	ADJ
ijpds-4398	90	35	selection	selection	NOUN
ijpds-4398	90	36	:	:	PUNCT
ijpds-4398	90	37	bse	bse	NOUN
ijpds-4398	90	38	is	be	AUX
ijpds-4398	90	39	freely	freely	ADV
ijpds-4398	90	40	soluble	soluble	ADJ
ijpds-4398	90	41	in	in	ADP
ijpds-4398	90	42	10	10	NUM
ijpds-4398	90	43	%	%	NOUN
ijpds-4398	90	44	acetic	acetic	ADJ
ijpds-4398	90	45	acid	acid	NOUN
ijpds-4398	90	46	glacial	glacial	NOUN
ijpds-4398	90	47	,	,	PUNCT
ijpds-4398	90	48	chloroform	chloroform	NOUN
ijpds-4398	90	49	and	and	CCONJ
ijpds-4398	90	50	in	in	ADP
ijpds-4398	90	51	ethanol	ethanol	NOUN
ijpds-4398	90	52	,	,	PUNCT
ijpds-4398	90	53	slightly	slightly	ADV
ijpds-4398	90	54	soluble	soluble	ADJ
ijpds-4398	90	55	in	in	ADP
ijpds-4398	90	56	1	1	NUM
ijpds-4398	90	57	n	n	NOUN
ijpds-4398	90	58	hcl	hcl	NOUN
ijpds-4398	90	59	and	and	CCONJ
ijpds-4398	90	60	soluble	soluble	ADJ
ijpds-4398	90	61	in	in	ADP
ijpds-4398	90	62	1n	1n	NUM
ijpds-4398	90	63	naoh	naoh	NOUN
ijpds-4398	90	64	and	and	CCONJ
ijpds-4398	90	65	sparingly	sparingly	ADV
ijpds-4398	90	66	soluble	soluble	ADJ
ijpds-4398	90	67	in	in	ADP
ijpds-4398	90	68	water	water	NOUN
ijpds-4398	90	69	;	;	PUNCT
ijpds-4398	90	70	whereas	whereas	SCONJ
ijpds-4398	90	71	mks	mks	PROPN
ijpds-4398	90	72	is	be	AUX
ijpds-4398	90	73	very	very	ADV
ijpds-4398	90	74	soluble	soluble	ADJ
ijpds-4398	90	75	in	in	ADP
ijpds-4398	90	76	water	water	NOUN
ijpds-4398	90	77	,	,	PUNCT
ijpds-4398	90	78	methylene	methylene	ADJ
ijpds-4398	90	79	chloride	chloride	NOUN
ijpds-4398	90	80	and	and	CCONJ
ijpds-4398	90	81	ethanol	ethanol	NOUN
ijpds-4398	90	82	.	.	PUNCT
ijpds-4398	91	1	although	although	SCONJ
ijpds-4398	91	2	the	the	DET
ijpds-4398	91	3	solubility	solubility	NOUN
ijpds-4398	91	4	of	of	ADP
ijpds-4398	91	5	the	the	DET
ijpds-4398	91	6	procured	procure	VERB
ijpds-4398	91	7	drugs	drug	NOUN
ijpds-4398	91	8	were	be	AUX
ijpds-4398	91	9	studied	study	VERB
ijpds-4398	91	10	in	in	ADP
ijpds-4398	91	11	alcohol	alcohol	NOUN
ijpds-4398	91	12	90	90	NUM
ijpds-4398	91	13	%	%	NOUN
ijpds-4398	91	14	,	,	PUNCT
ijpds-4398	91	15	0.1	0.1	NUM
ijpds-4398	91	16	n	n	PRON
ijpds-4398	91	17	hcl	hcl	PROPN
ijpds-4398	91	18	and	and	CCONJ
ijpds-4398	91	19	0.1	0.1	NUM
ijpds-4398	91	20	n	n	PRON
ijpds-4398	91	21	naoh	naoh	NOUN
ijpds-4398	91	22	separately	separately	ADV
ijpds-4398	91	23	;	;	PUNCT
ijpds-4398	91	24	and	and	CCONJ
ijpds-4398	91	25	found	find	VERB
ijpds-4398	91	26	that	that	SCONJ
ijpds-4398	91	27	bse	bse	NOUN
ijpds-4398	91	28	is	be	AUX
ijpds-4398	91	29	soluble	soluble	ADJ
ijpds-4398	91	30	in	in	ADP
ijpds-4398	91	31	ethanol	ethanol	NOUN
ijpds-4398	91	32	,	,	PUNCT
ijpds-4398	91	33	0.1	0.1	NUM
ijpds-4398	91	34	n	n	PRON
ijpds-4398	91	35	naoh	naoh	NOUN
ijpds-4398	91	36	,	,	PUNCT
ijpds-4398	91	37	slightly	slightly	ADV
ijpds-4398	91	38	soluble	soluble	ADJ
ijpds-4398	91	39	in	in	ADP
ijpds-4398	91	40	0.1	0.1	NUM
ijpds-4398	91	41	hcl	hcl	PROPN
ijpds-4398	91	42	however	however	ADV
ijpds-4398	91	43	mks	mks	PROPN
ijpds-4398	91	44	soluble	soluble	ADJ
ijpds-4398	91	45	in	in	ADP
ijpds-4398	91	46	ethanol	ethanol	NOUN
ijpds-4398	91	47	and	and	CCONJ
ijpds-4398	91	48	insoluble	insoluble	ADJ
ijpds-4398	91	49	in	in	ADP
ijpds-4398	91	50	naoh	naoh	NOUN
ijpds-4398	91	51	and	and	CCONJ
ijpds-4398	91	52	hcl	hcl	PROPN
ijpds-4398	91	53	.	.	PUNCT
ijpds-4398	92	1	both	both	DET
ijpds-4398	92	2	drugs	drug	NOUN
ijpds-4398	92	3	solubilises	solubilise	VERB
ijpds-4398	92	4	in	in	ADP
ijpds-4398	92	5	50	50	NUM
ijpds-4398	92	6	%	%	NOUN
ijpds-4398	92	7	alcohol	alcohol	NOUN
ijpds-4398	92	8	,	,	PUNCT
ijpds-4398	92	9	hence	hence	ADV
ijpds-4398	92	10	selected	select	VERB
ijpds-4398	92	11	as	as	ADP
ijpds-4398	92	12	a	a	DET
ijpds-4398	92	13	common	common	ADJ
ijpds-4398	92	14	solvent	solvent	NOUN
ijpds-4398	92	15	.	.	PUNCT
ijpds-4398	93	1	each	each	DET
ijpds-4398	93	2	drugs	drug	NOUN
ijpds-4398	93	3	solution	solution	NOUN
ijpds-4398	93	4	with	with	ADP
ijpds-4398	93	5	known	know	VERB
ijpds-4398	93	6	conc	conc	NOUN
ijpds-4398	93	7	was	be	AUX
ijpds-4398	93	8	scanned	scan	VERB
ijpds-4398	93	9	in	in	ADP
ijpds-4398	93	10	uv	uv	NOUN
ijpds-4398	93	11	range	range	NOUN
ijpds-4398	93	12	of	of	ADP
ijpds-4398	93	13	400	400	NUM
ijpds-4398	93	14	nm	nm	NOUN
ijpds-4398	93	15	to	to	ADP
ijpds-4398	93	16	200	200	NUM
ijpds-4398	93	17	nm	nm	NOUN
ijpds-4398	93	18	.	.	PUNCT
ijpds-4398	94	1	it	it	PRON
ijpds-4398	94	2	was	be	AUX
ijpds-4398	94	3	found	find	VERB
ijpds-4398	94	4	that	that	SCONJ
ijpds-4398	94	5	alcohol	alcohol	NOUN
ijpds-4398	94	6	50	50	NUM
ijpds-4398	94	7	%	%	NOUN
ijpds-4398	94	8	is	be	AUX
ijpds-4398	94	9	suitable	suitable	ADJ
ijpds-4398	94	10	with	with	ADP
ijpds-4398	94	11	respect	respect	NOUN
ijpds-4398	94	12	to	to	ADP
ijpds-4398	94	13	stable	stable	ADJ
ijpds-4398	94	14	,	,	PUNCT
ijpds-4398	94	15	robust	robust	ADJ
ijpds-4398	94	16	and	and	CCONJ
ijpds-4398	94	17	precise	precise	ADJ
ijpds-4398	94	18	in	in	ADP
ijpds-4398	94	19	producing	produce	VERB
ijpds-4398	94	20	result	result	NOUN
ijpds-4398	94	21	.	.	PUNCT
ijpds-4398	95	1	preparation	preparation	NOUN
ijpds-4398	95	2	of	of	ADP
ijpds-4398	95	3	stock	stock	NOUN
ijpds-4398	95	4	solutions	solution	NOUN
ijpds-4398	95	5	and	and	CCONJ
ijpds-4398	95	6	standard	standard	ADJ
ijpds-4398	95	7	solutions	solution	NOUN
ijpds-4398	95	8	:	:	PUNCT
ijpds-4398	95	9	10	10	NUM
ijpds-4398	95	10	mg	mg	NOUN
ijpds-4398	95	11	each	each	PRON
ijpds-4398	95	12	of	of	ADP
ijpds-4398	95	13	drug	drug	NOUN
ijpds-4398	95	14	bse	bse	PROPN
ijpds-4398	95	15	and	and	CCONJ
ijpds-4398	95	16	mks	mks	PROPN
ijpds-4398	95	17	were	be	AUX
ijpds-4398	95	18	separately	separately	ADV
ijpds-4398	95	19	and	and	CCONJ
ijpds-4398	95	20	accurately	accurately	ADV
ijpds-4398	95	21	weighed	weigh	VERB
ijpds-4398	95	22	;	;	PUNCT
ijpds-4398	95	23	and	and	CCONJ
ijpds-4398	95	24	transferred	transfer	VERB
ijpds-4398	95	25	into	into	ADP
ijpds-4398	95	26	separate	separate	ADJ
ijpds-4398	95	27	25	25	NUM
ijpds-4398	95	28	ml	ml	NOUN
ijpds-4398	95	29	volumetric	volumetric	ADJ
ijpds-4398	95	30	flask	flask	NOUN
ijpds-4398	95	31	.	.	PUNCT
ijpds-4398	96	1	dissolved	dissolve	VERB
ijpds-4398	96	2	into	into	ADP
ijpds-4398	96	3	solvent	solvent	ADJ
ijpds-4398	96	4	alcohol	alcohol	NOUN
ijpds-4398	96	5	50	50	NUM
ijpds-4398	96	6	%	%	NOUN
ijpds-4398	96	7	and	and	CCONJ
ijpds-4398	96	8	volume	volume	NOUN
ijpds-4398	96	9	was	be	AUX
ijpds-4398	96	10	made	make	VERB
ijpds-4398	96	11	to	to	ADP
ijpds-4398	96	12	25	25	NUM
ijpds-4398	96	13	ml	ml	NOUN
ijpds-4398	96	14	with	with	ADP
ijpds-4398	96	15	this	this	DET
ijpds-4398	96	16	solvent	solvent	NOUN
ijpds-4398	96	17	.	.	PUNCT
ijpds-4398	97	1	working	work	VERB
ijpds-4398	97	2	standard	standard	ADJ
ijpds-4398	97	3	solution	solution	NOUN
ijpds-4398	97	4	was	be	AUX
ijpds-4398	97	5	prepared	prepare	VERB
ijpds-4398	97	6	by	by	ADP
ijpds-4398	97	7	diluting	dilute	VERB
ijpds-4398	97	8	5	5	NUM
ijpds-4398	97	9	ml	ml	NOUN
ijpds-4398	97	10	to	to	ADP
ijpds-4398	97	11	10	10	NUM
ijpds-4398	97	12	ml	ml	NOUN
ijpds-4398	97	13	with	with	ADP
ijpds-4398	97	14	50	50	NUM
ijpds-4398	97	15	%	%	NOUN
ijpds-4398	97	16	alcohol	alcohol	NOUN
ijpds-4398	97	17	.	.	PUNCT
ijpds-4398	98	1	subsequent	subsequent	ADJ
ijpds-4398	98	2	standard	standard	ADJ
ijpds-4398	98	3	solution	solution	NOUN
ijpds-4398	98	4	of	of	ADP
ijpds-4398	98	5	each	each	DET
ijpds-4398	98	6	drug	drug	NOUN
ijpds-4398	98	7	with	with	ADP
ijpds-4398	98	8	conc	conc	ADJ
ijpds-4398	98	9	16μg	16μg	NOUN
ijpds-4398	98	10	/	/	SYM
ijpds-4398	98	11	ml	ml	NOUN
ijpds-4398	98	12	was	be	AUX
ijpds-4398	98	13	prepared	prepare	VERB
ijpds-4398	98	14	by	by	ADP
ijpds-4398	98	15	diluting	dilute	VERB
ijpds-4398	98	16	aliquot	aliquot	NOUN
ijpds-4398	98	17	of	of	ADP
ijpds-4398	98	18	stock	stock	NOUN
ijpds-4398	98	19	solution	solution	NOUN
ijpds-4398	98	20	to	to	ADP
ijpds-4398	98	21	10	10	NUM
ijpds-4398	98	22	ml	ml	NOUN
ijpds-4398	98	23	with	with	ADP
ijpds-4398	98	24	50	50	NUM
ijpds-4398	98	25	%	%	NOUN
ijpds-4398	98	26	alcohol	alcohol	NOUN
ijpds-4398	98	27	into	into	ADP
ijpds-4398	98	28	10	10	NUM
ijpds-4398	98	29	ml	ml	NOUN
ijpds-4398	98	30	capacity	capacity	NOUN
ijpds-4398	98	31	volumetric	volumetric	NOUN
ijpds-4398	98	32	flask	flask	NOUN
ijpds-4398	98	33	.	.	PUNCT
ijpds-4398	99	1	selection	selection	NOUN
ijpds-4398	99	2	of	of	ADP
ijpds-4398	99	3	wavelength	wavelength	NOUN
ijpds-4398	99	4	and	and	CCONJ
ijpds-4398	99	5	conc	conc	ADJ
ijpds-4398	99	6	range	range	NOUN
ijpds-4398	99	7	:	:	PUNCT
ijpds-4398	99	8	from	from	ADP
ijpds-4398	99	9	uv	uv	NOUN
ijpds-4398	99	10	spectra	spectra	NOUN
ijpds-4398	99	11	it	it	PRON
ijpds-4398	99	12	was	be	AUX
ijpds-4398	99	13	found	find	VERB
ijpds-4398	99	14	that	that	SCONJ
ijpds-4398	99	15	bse	bse	NOUN
ijpds-4398	99	16	has	have	VERB
ijpds-4398	99	17	measurable	measurable	ADJ
ijpds-4398	99	18	absorbance	absorbance	NOUN
ijpds-4398	99	19	at	at	ADP
ijpds-4398	99	20	274.5	274.5	NUM
ijpds-4398	99	21	nm	nm	NOUN
ijpds-4398	99	22	and	and	CCONJ
ijpds-4398	99	23	281.5	281.5	NUM
ijpds-4398	99	24	nm	nm	NOUN
ijpds-4398	99	25	(	(	PUNCT
ijpds-4398	99	26	figure	figure	NOUN
ijpds-4398	99	27	4	4	NUM
ijpds-4398	99	28	)	)	PUNCT
ijpds-4398	99	29	and	and	CCONJ
ijpds-4398	99	30	less	less	ADJ
ijpds-4398	99	31	interference	interference	NOUN
ijpds-4398	99	32	was	be	AUX
ijpds-4398	99	33	observed	observe	VERB
ijpds-4398	99	34	by	by	ADP
ijpds-4398	99	35	mks	mks	PROPN
ijpds-4398	99	36	;	;	PUNCT
ijpds-4398	99	37	similarly	similarly	ADV
ijpds-4398	99	38	mks	mks	PROPN
ijpds-4398	99	39	has	have	VERB
ijpds-4398	99	40	maximum	maximum	ADJ
ijpds-4398	99	41	absorbance	absorbance	NOUN
ijpds-4398	99	42	at	at	ADP
ijpds-4398	99	43	351.5	351.5	NUM
ijpds-4398	99	44	nm	nm	ADJ
ijpds-4398	99	45	and	and	CCONJ
ijpds-4398	99	46	negligible	negligible	ADJ
ijpds-4398	99	47	interference	interference	NOUN
ijpds-4398	99	48	by	by	ADP
ijpds-4398	99	49	bse	bse	NOUN
ijpds-4398	99	50	was	be	AUX
ijpds-4398	99	51	accounted	account	VERB
ijpds-4398	99	52	.	.	PUNCT
ijpds-4398	100	1	chemometric	chemometric	ADJ
ijpds-4398	100	2	method	method	NOUN
ijpds-4398	100	3	using	use	VERB
ijpds-4398	100	4	simultaneous	simultaneous	ADJ
ijpds-4398	100	5	equation	equation	NOUN
ijpds-4398	100	6	was	be	AUX
ijpds-4398	100	7	applied	apply	VERB
ijpds-4398	100	8	and	and	CCONJ
ijpds-4398	100	9	which	which	PRON
ijpds-4398	100	10	was	be	AUX
ijpds-4398	100	11	reasonable	reasonable	ADJ
ijpds-4398	100	12	remedy	remedy	NOUN
ijpds-4398	100	13	to	to	PART
ijpds-4398	100	14	overcome	overcome	VERB
ijpds-4398	100	15	interference	interference	NOUN
ijpds-4398	100	16	at	at	ADP
ijpds-4398	100	17	each	each	DET
ijpds-4398	100	18	other	other	ADJ
ijpds-4398	100	19	’s	’s	PART
ijpds-4398	100	20	absorbance	absorbance	NOUN
ijpds-4398	100	21	.	.	PUNCT
ijpds-4398	101	1	to	to	PART
ijpds-4398	101	2	study	study	VERB
ijpds-4398	101	3	linearity	linearity	NOUN
ijpds-4398	101	4	,	,	PUNCT
ijpds-4398	101	5	working	work	VERB
ijpds-4398	101	6	conc	conc	VERB
ijpds-4398	101	7	range	range	NOUN
ijpds-4398	101	8	1	1	NUM
ijpds-4398	101	9	to	to	ADP
ijpds-4398	101	10	32μg	32μg	NUM
ijpds-4398	101	11	/	/	SYM
ijpds-4398	101	12	ml	ml	X
ijpds-4398	101	13	for	for	ADP
ijpds-4398	101	14	bse	bse	NOUN
ijpds-4398	101	15	and	and	CCONJ
ijpds-4398	101	16	1	1	NUM
ijpds-4398	101	17	to	to	ADP
ijpds-4398	101	18	20μg	20μg	NOUN
ijpds-4398	101	19	/	/	SYM
ijpds-4398	101	20	ml	ml	X
ijpds-4398	101	21	for	for	ADP
ijpds-4398	101	22	mks	mks	PROPN
ijpds-4398	101	23	was	be	AUX
ijpds-4398	101	24	selected	select	VERB
ijpds-4398	101	25	.	.	PUNCT
ijpds-4398	102	1	also	also	ADV
ijpds-4398	102	2	combined	combine	VERB
ijpds-4398	102	3	drug	drug	NOUN
ijpds-4398	102	4	solution	solution	NOUN
ijpds-4398	102	5	was	be	AUX
ijpds-4398	102	6	prepared	prepare	VERB
ijpds-4398	102	7	simulated	simulate	VERB
ijpds-4398	102	8	to	to	PART
ijpds-4398	102	9	marketed	market	VERB
ijpds-4398	102	10	formulation	formulation	NOUN
ijpds-4398	102	11	.	.	PUNCT
ijpds-4398	103	1	selected	select	VERB
ijpds-4398	103	2	critical	critical	ADJ
ijpds-4398	103	3	parameters	parameter	NOUN
ijpds-4398	103	4	based	base	VERB
ijpds-4398	103	5	upon	upon	SCONJ
ijpds-4398	103	6	above	above	ADP
ijpds-4398	103	7	discussion	discussion	NOUN
ijpds-4398	103	8	,	,	PUNCT
ijpds-4398	103	9	observations	observation	NOUN
ijpds-4398	103	10	were	be	AUX
ijpds-4398	103	11	listed	list	VERB
ijpds-4398	103	12	in	in	ADP
ijpds-4398	103	13	(	(	PUNCT
ijpds-4398	103	14	table	table	NOUN
ijpds-4398	103	15	1	1	NUM
ijpds-4398	103	16	)	)	PUNCT
ijpds-4398	103	17	and	and	CCONJ
ijpds-4398	103	18	by	by	ADP
ijpds-4398	103	19	using	use	VERB
ijpds-4398	103	20	these	these	PRON
ijpds-4398	103	21	;	;	PUNCT
ijpds-4398	103	22	method	method	NOUN
ijpds-4398	103	23	was	be	AUX
ijpds-4398	103	24	validated	validate	VERB
ijpds-4398	103	25	as	as	ADP
ijpds-4398	103	26	per	per	ADP
ijpds-4398	103	27	ich	ich	NOUN
ijpds-4398	103	28	guidelines	guideline	NOUN
ijpds-4398	103	29	and	and	CCONJ
ijpds-4398	103	30	by	by	ADP
ijpds-4398	103	31	analysing	analyse	VERB
ijpds-4398	103	32	marketed	market	VERB
ijpds-4398	103	33	preparations	preparation	NOUN
ijpds-4398	103	34	.	.	PUNCT
ijpds-4398	104	1	experimental	experimental	ADJ
ijpds-4398	104	2	method	method	NOUN
ijpds-4398	104	3	for	for	ADP
ijpds-4398	104	4	estimation	estimation	NOUN
ijpds-4398	104	5	:	:	PUNCT
ijpds-4398	104	6	from	from	ADP
ijpds-4398	104	7	the	the	DET
ijpds-4398	104	8	overlain	overlain	ADJ
ijpds-4398	104	9	spectra	spectra	ADJ
ijpds-4398	104	10	simultaneous	simultaneous	ADJ
ijpds-4398	104	11	equation	equation	NOUN
ijpds-4398	104	12	method	method	NOUN
ijpds-4398	104	13	was	be	AUX
ijpds-4398	104	14	applied	apply	VERB
ijpds-4398	104	15	for	for	ADP
ijpds-4398	104	16	estimation	estimation	NOUN
ijpds-4398	104	17	of	of	ADP
ijpds-4398	104	18	both	both	CCONJ
ijpds-4398	104	19	the	the	DET
ijpds-4398	104	20	analytes	analyte	NOUN
ijpds-4398	104	21	from	from	ADP
ijpds-4398	104	22	their	their	PRON
ijpds-4398	104	23	combined	combine	VERB
ijpds-4398	104	24	dosage	dosage	NOUN
ijpds-4398	104	25	form	form	NOUN
ijpds-4398	104	26	.	.	PUNCT
ijpds-4398	105	1	figure	figure	NOUN
ijpds-4398	105	2	4	4	NUM
ijpds-4398	105	3	:	:	PUNCT
ijpds-4398	105	4	overlaid	overlay	VERB
ijpds-4398	105	5	spectra	spectra	NOUN
ijpds-4398	105	6	of	of	ADP
ijpds-4398	105	7	bse	bse	PROPN
ijpds-4398	105	8	and	and	CCONJ
ijpds-4398	105	9	mks	mks	PROPN
ijpds-4398	105	10	table	table	NOUN
ijpds-4398	105	11	no	no	DET
ijpds-4398	105	12	1	1	NUM
ijpds-4398	105	13	:	:	PUNCT
ijpds-4398	105	14	selected	select	VERB
ijpds-4398	105	15	critical	critical	ADJ
ijpds-4398	105	16	parameter	parameter	NOUN
ijpds-4398	105	17	for	for	ADP
ijpds-4398	105	18	uv	uv	NOUN
ijpds-4398	105	19	-	-	PUNCT
ijpds-4398	105	20	vis	vis	X
ijpds-4398	105	21	analytical	analytical	ADJ
ijpds-4398	105	22	method	method	NOUN
ijpds-4398	105	23	of	of	ADP
ijpds-4398	105	24	bse	bse	NOUN
ijpds-4398	105	25	and	and	CCONJ
ijpds-4398	105	26	mks	mks	PROPN
ijpds-4398	105	27	parameter	parameter	NOUN
ijpds-4398	105	28	selected	select	VERB
ijpds-4398	105	29	variables	variable	NOUN
ijpds-4398	105	30	for	for	ADP
ijpds-4398	105	31	simultaneous	simultaneous	ADJ
ijpds-4398	105	32	equation	equation	NOUN
ijpds-4398	105	33	method	method	NOUN
ijpds-4398	105	34	bse	bse	PROPN
ijpds-4398	105	35	mks	mks	PROPN
ijpds-4398	105	36	wavelength	wavelength	VERB
ijpds-4398	105	37	274.5	274.5	NUM
ijpds-4398	105	38	351.5	351.5	NUM
ijpds-4398	105	39	solvent	solvent	NOUN
ijpds-4398	105	40	50	50	NUM
ijpds-4398	105	41	%	%	NOUN
ijpds-4398	105	42	alcohol	alcohol	NOUN
ijpds-4398	105	43	50	50	NUM
ijpds-4398	105	44	%	%	NOUN
ijpds-4398	106	1	alcohol	alcohol	NOUN
ijpds-4398	106	2	scan	scan	NOUN
ijpds-4398	106	3	speed	speed	PROPN
ijpds-4398	106	4	fast	fast	ADV
ijpds-4398	106	5	fast	fast	ADJ
ijpds-4398	106	6	sampling	sampling	NOUN
ijpds-4398	106	7	interval	interval	NOUN
ijpds-4398	106	8	0.2	0.2	NUM
ijpds-4398	106	9	nm	nm	NOUN
ijpds-4398	106	10	0.2	0.2	NUM
ijpds-4398	106	11	nm	nm	ADV
ijpds-4398	106	12	simultaneous	simultaneous	ADJ
ijpds-4398	106	13	equation	equation	NOUN
ijpds-4398	106	14	method	method	NOUN
ijpds-4398	106	15	for	for	ADP
ijpds-4398	106	16	estimation	estimation	NOUN
ijpds-4398	106	17	of	of	ADP
ijpds-4398	106	18	bilastine	bilastine	NOUN
ijpds-4398	106	19	and	and	CCONJ
ijpds-4398	106	20	montelukast	montelukast	NOUN
ijpds-4398	106	21	sodium	sodium	NOUN
ijpds-4398	106	22	:	:	PUNCT
ijpds-4398	106	23	bse	bse	PROPN
ijpds-4398	106	24	was	be	AUX
ijpds-4398	106	25	shown	show	VERB
ijpds-4398	106	26	maximum	maximum	ADJ
ijpds-4398	106	27	absorbance	absorbance	NOUN
ijpds-4398	106	28	i.e.	i.e.	X
ijpds-4398	106	29	λmax	λmax	NOUN
ijpds-4398	106	30	at	at	ADP
ijpds-4398	106	31	274.5	274.5	NUM
ijpds-4398	106	32	nm	nm	NOUN
ijpds-4398	106	33	where	where	SCONJ
ijpds-4398	106	34	moderate	moderate	ADJ
ijpds-4398	106	35	interference	interference	NOUN
ijpds-4398	106	36	by	by	ADP
ijpds-4398	106	37	mks	mks	PROPN
ijpds-4398	106	38	found	find	VERB
ijpds-4398	106	39	and	and	CCONJ
ijpds-4398	106	40	mks	mks	PROPN
ijpds-4398	106	41	has	have	VERB
ijpds-4398	106	42	maximum	maximum	ADJ
ijpds-4398	106	43	absorbance	absorbance	NOUN
ijpds-4398	106	44	i.e.	i.e.	X
ijpds-4398	106	45	λmax	λmax	NOUN
ijpds-4398	106	46	at	at	ADP
ijpds-4398	106	47	351.5	351.5	NUM
ijpds-4398	106	48	nm	nm	NOUN
ijpds-4398	106	49	where	where	SCONJ
ijpds-4398	106	50	negligible	negligible	ADJ
ijpds-4398	106	51	interference	interference	NOUN
ijpds-4398	106	52	by	by	ADP
ijpds-4398	106	53	bse	bse	NOUN
ijpds-4398	106	54	observed	observe	VERB
ijpds-4398	106	55	.	.	PUNCT
ijpds-4398	107	1	at	at	ADP
ijpds-4398	107	2	274.5	274.5	NUM
ijpds-4398	107	3	nm	nm	NOUN
ijpds-4398	107	4	the	the	DET
ijpds-4398	107	5	λmax	λmax	NOUN
ijpds-4398	107	6	of	of	ADP
ijpds-4398	107	7	bse	bse	PROPN
ijpds-4398	107	8	,	,	PUNCT
ijpds-4398	107	9	the	the	DET
ijpds-4398	107	10	mks	mks	PROPN
ijpds-4398	107	11	was	be	AUX
ijpds-4398	107	12	shown	show	VERB
ijpds-4398	107	13	consistency	consistency	NOUN
ijpds-4398	107	14	in	in	ADP
ijpds-4398	107	15	the	the	DET
ijpds-4398	107	16	absorptivity	absorptivity	NOUN
ijpds-4398	107	17	;	;	PUNCT
ijpds-4398	107	18	hence	hence	ADV
ijpds-4398	107	19	two	two	NUM
ijpds-4398	107	20	wavelengths	wavelength	NOUN
ijpds-4398	107	21	274.5	274.5	NUM
ijpds-4398	107	22	and	and	CCONJ
ijpds-4398	107	23	351.5	351.5	NUM
ijpds-4398	107	24	nm	nm	NOUN
ijpds-4398	107	25	were	be	AUX
ijpds-4398	107	26	considered	consider	VERB
ijpds-4398	107	27	as	as	ADP
ijpds-4398	107	28	1	1	NUM
ijpds-4398	107	29	and	and	CCONJ
ijpds-4398	107	30	2	2	NUM
ijpds-4398	107	31	respectively	respectively	ADV
ijpds-4398	107	32	for	for	SCONJ
ijpds-4398	107	33	the	the	DET
ijpds-4398	107	34	said	say	VERB
ijpds-4398	107	35	method	method	NOUN
ijpds-4398	107	36	to	to	PART
ijpds-4398	107	37	estimate	estimate	VERB
ijpds-4398	107	38	bse	bse	NOUN
ijpds-4398	107	39	and	and	CCONJ
ijpds-4398	107	40	mks	mks	PROPN
ijpds-4398	107	41	.	.	PUNCT
ijpds-4398	108	1	the	the	DET
ijpds-4398	108	2	equation	equation	NOUN
ijpds-4398	108	3	a=	a=	VERB
ijpds-4398	108	4	abc	abc	PROPN
ijpds-4398	108	5	was	be	AUX
ijpds-4398	108	6	applied	apply	VERB
ijpds-4398	108	7	for	for	ADP
ijpds-4398	108	8	x	x	SYM
ijpds-4398	108	9	(	(	PUNCT
ijpds-4398	108	10	bse	bse	NOUN
ijpds-4398	108	11	)	)	PUNCT
ijpds-4398	108	12	and	and	CCONJ
ijpds-4398	108	13	y	y	PROPN
ijpds-4398	108	14	(	(	PUNCT
ijpds-4398	108	15	mks	mks	PROPN
ijpds-4398	108	16	)	)	PUNCT
ijpds-4398	108	17	determination	determination	NOUN
ijpds-4398	108	18	.	.	PUNCT
ijpds-4398	109	1	working	work	VERB
ijpds-4398	109	2	standard	standard	ADJ
ijpds-4398	109	3	solutions	solution	NOUN
ijpds-4398	109	4	of	of	ADP
ijpds-4398	109	5	bse	bse	NOUN
ijpds-4398	109	6	and	and	CCONJ
ijpds-4398	109	7	mks	mks	PROPN
ijpds-4398	109	8	containing	contain	VERB
ijpds-4398	109	9	12μg	12μg	NOUN
ijpds-4398	109	10	/	/	SYM
ijpds-4398	109	11	ml	ml	NOUN
ijpds-4398	109	12	conc	conc	NOUN
ijpds-4398	109	13	were	be	AUX
ijpds-4398	109	14	separately	separately	ADV
ijpds-4398	109	15	prepared	prepare	VERB
ijpds-4398	109	16	and	and	CCONJ
ijpds-4398	109	17	used	use	VERB
ijpds-4398	109	18	for	for	ADP
ijpds-4398	109	19	the	the	DET
ijpds-4398	109	20	method	method	NOUN
ijpds-4398	109	21	.	.	PUNCT
ijpds-4398	110	1	where	where	SCONJ
ijpds-4398	110	2	cx	cx	NOUN
ijpds-4398	110	3	=	=	SYM
ijpds-4398	110	4	conc	conc	NOUN
ijpds-4398	110	5	of	of	ADP
ijpds-4398	110	6	bse	bse	NOUN
ijpds-4398	110	7	in	in	ADP
ijpds-4398	110	8	sample	sample	NOUN
ijpds-4398	110	9	solution	solution	NOUN
ijpds-4398	110	10	a1	a1	NOUN
ijpds-4398	110	11	and	and	CCONJ
ijpds-4398	110	12	a2	a2	NOUN
ijpds-4398	110	13	=	=	SYM
ijpds-4398	110	14	absorbance	absorbance	NOUN
ijpds-4398	110	15	of	of	ADP
ijpds-4398	110	16	sample	sample	NOUN
ijpds-4398	110	17	solution	solution	NOUN
ijpds-4398	110	18	at	at	ADP
ijpds-4398	110	19	1	1	NUM
ijpds-4398	110	20	and	and	CCONJ
ijpds-4398	110	21	2	2	NUM
ijpds-4398	110	22	wavelength	wavelength	NOUN
ijpds-4398	110	23	ay1	ay1	NOUN
ijpds-4398	110	24	and	and	CCONJ
ijpds-4398	110	25	ay2	ay2	NOUN
ijpds-4398	110	26	=	=	SYM
ijpds-4398	110	27	absorptivity	absorptivity	NOUN
ijpds-4398	110	28	of	of	ADP
ijpds-4398	110	29	mks	mks	PROPN
ijpds-4398	110	30	at	at	ADP
ijpds-4398	110	31	1	1	NUM
ijpds-4398	110	32	and	and	CCONJ
ijpds-4398	110	33	2	2	NUM
ijpds-4398	110	34	wavelength	wavelength	NOUN
ijpds-4398	110	35	of	of	ADP
ijpds-4398	110	36	standard	standard	ADJ
ijpds-4398	110	37	solution	solution	NOUN
ijpds-4398	110	38	ax1	ax1	NOUN
ijpds-4398	110	39	and	and	CCONJ
ijpds-4398	110	40	ax2	ax2	NOUN
ijpds-4398	110	41	=	=	PUNCT
ijpds-4398	110	42	absorptivity	absorptivity	NOUN
ijpds-4398	110	43	of	of	ADP
ijpds-4398	110	44	bse	bse	NOUN
ijpds-4398	110	45	at	at	ADP
ijpds-4398	110	46	1	1	NUM
ijpds-4398	110	47	and	and	CCONJ
ijpds-4398	110	48	2	2	NUM
ijpds-4398	110	49	wavelength	wavelength	NOUN
ijpds-4398	110	50	of	of	ADP
ijpds-4398	110	51	standard	standard	ADJ
ijpds-4398	110	52	solution	solution	NOUN
ijpds-4398	110	53	cy	cy	NOUN
ijpds-4398	110	54	=	=	PUNCT
ijpds-4398	110	55	conc	conc	NOUN
ijpds-4398	110	56	of	of	ADP
ijpds-4398	110	57	mks	mks	PROPN
ijpds-4398	110	58	in	in	ADP
ijpds-4398	110	59	sample	sample	NOUN
ijpds-4398	110	60	solution	solution	NOUN
ijpds-4398	110	61	as	as	SCONJ
ijpds-4398	110	62	=	=	SYM
ijpds-4398	110	63	absorbance	absorbance	NOUN
ijpds-4398	110	64	of	of	ADP
ijpds-4398	110	65	sample	sample	NOUN
ijpds-4398	110	66	solution	solution	NOUN
ijpds-4398	110	67	at	at	ADP
ijpds-4398	110	68	2	2	NUM
ijpds-4398	110	69	wavelength	wavelength	NOUN
ijpds-4398	110	70	validation	validation	NOUN
ijpds-4398	110	71	of	of	ADP
ijpds-4398	110	72	the	the	DET
ijpds-4398	110	73	method	method	NOUN
ijpds-4398	110	74	selected	select	VERB
ijpds-4398	110	75	critical	critical	ADJ
ijpds-4398	110	76	parameters	parameter	NOUN
ijpds-4398	110	77	should	should	AUX
ijpds-4398	110	78	meet	meet	VERB
ijpds-4398	110	79	the	the	DET
ijpds-4398	110	80	performance	performance	NOUN
ijpds-4398	110	81	characteristics	characteristic	NOUN
ijpds-4398	110	82	of	of	ADP
ijpds-4398	110	83	the	the	DET
ijpds-4398	110	84	analytical	analytical	ADJ
ijpds-4398	110	85	method	method	NOUN
ijpds-4398	110	86	so	so	SCONJ
ijpds-4398	110	87	as	as	SCONJ
ijpds-4398	110	88	to	to	PART
ijpds-4398	110	89	attain	attain	VERB
ijpds-4398	110	90	analytical	analytical	ADJ
ijpds-4398	110	91	target	target	NOUN
ijpds-4398	110	92	profile	profile	NOUN
ijpds-4398	110	93	of	of	ADP
ijpds-4398	110	94	the	the	DET
ijpds-4398	110	95	method	method	NOUN
ijpds-4398	110	96	.	.	PUNCT
ijpds-4398	111	1	an	an	DET
ijpds-4398	111	2	ich	ich	PROPN
ijpds-4398	111	3	guideline	guideline	NOUN
ijpds-4398	111	4	q2	q2	PROPN
ijpds-4398	111	5	r1	r1	PROPN
ijpds-4398	111	6	was	be	AUX
ijpds-4398	111	7	applied	apply	VERB
ijpds-4398	111	8	to	to	PART
ijpds-4398	111	9	study	study	VERB
ijpds-4398	111	10	methods	method	NOUN
ijpds-4398	111	11	performance	performance	NOUN
ijpds-4398	111	12	with	with	ADP
ijpds-4398	111	13	critical	critical	ADJ
ijpds-4398	111	14	parameters	parameter	NOUN
ijpds-4398	111	15	in	in	ADP
ijpds-4398	111	16	order	order	NOUN
ijpds-4398	111	17	to	to	PART
ijpds-4398	111	18	implement	implement	VERB
ijpds-4398	111	19	aqbd	aqbd	NOUN
ijpds-4398	111	20	approach	approach	NOUN
ijpds-4398	111	21	.	.	PUNCT
ijpds-4398	112	1	the	the	DET
ijpds-4398	112	2	method	method	NOUN
ijpds-4398	112	3	was	be	AUX
ijpds-4398	112	4	validated	validate	VERB
ijpds-4398	112	5	as	as	ADP
ijpds-4398	112	6	per	per	ADP
ijpds-4398	112	7	ich	ich	NOUN
ijpds-4398	112	8	guidelines	guideline	NOUN
ijpds-4398	112	9	system	system	NOUN
ijpds-4398	112	10	suitability	suitability	NOUN
ijpds-4398	112	11	:	:	PUNCT
ijpds-4398	112	12	system	system	NOUN
ijpds-4398	112	13	suitability	suitability	NOUN
ijpds-4398	112	14	is	be	AUX
ijpds-4398	112	15	studied	study	VERB
ijpds-4398	112	16	to	to	PART
ijpds-4398	112	17	demonstrate	demonstrate	VERB
ijpds-4398	112	18	the	the	DET
ijpds-4398	112	19	suitability	suitability	NOUN
ijpds-4398	112	20	of	of	ADP
ijpds-4398	112	21	the	the	DET
ijpds-4398	112	22	developed	develop	VERB
ijpds-4398	112	23	procedure	procedure	NOUN
ijpds-4398	112	24	under	under	ADP
ijpds-4398	112	25	consideration	consideration	NOUN
ijpds-4398	112	26	for	for	ADP
ijpds-4398	112	27	the	the	DET
ijpds-4398	112	28	analytical	analytical	ADJ
ijpds-4398	112	29	method	method	NOUN
ijpds-4398	112	30	.	.	PUNCT
ijpds-4398	113	1	six	six	NUM
ijpds-4398	113	2	replicates	replicate	NOUN
ijpds-4398	113	3	of	of	ADP
ijpds-4398	113	4	working	work	VERB
ijpds-4398	113	5	standard	standard	ADJ
ijpds-4398	113	6	solutions	solution	NOUN
ijpds-4398	113	7	with	with	ADP
ijpds-4398	113	8	conc	conc	ADJ
ijpds-4398	113	9	20μg	20μg	NOUN
ijpds-4398	113	10	/	/	SYM
ijpds-4398	113	11	ml	ml	NOUN
ijpds-4398	113	12	and	and	CCONJ
ijpds-4398	113	13	16μg	16μg	NOUN
ijpds-4398	113	14	/	/	SYM
ijpds-4398	113	15	ml	ml	X
ijpds-4398	113	16	of	of	ADP
ijpds-4398	113	17	bse	bse	NOUN
ijpds-4398	113	18	and	and	CCONJ
ijpds-4398	113	19	mks	mks	PROPN
ijpds-4398	113	20	respectively	respectively	ADV
ijpds-4398	113	21	were	be	AUX
ijpds-4398	113	22	prepared	prepare	VERB
ijpds-4398	113	23	separately	separately	ADV
ijpds-4398	113	24	and	and	CCONJ
ijpds-4398	113	25	absorbance	absorbance	NOUN
ijpds-4398	113	26	was	be	AUX
ijpds-4398	113	27	recorded	record	VERB
ijpds-4398	113	28	,	,	PUNCT
ijpds-4398	113	29	calculated	calculate	VERB
ijpds-4398	113	30	sd	sd	ADP
ijpds-4398	113	31	and	and	CCONJ
ijpds-4398	113	32	%	%	NOUN
ijpds-4398	113	33	rsd	rsd	NOUN
ijpds-4398	113	34	of	of	ADP
ijpds-4398	113	35	the	the	DET
ijpds-4398	113	36	response	response	NOUN
ijpds-4398	113	37	.	.	PUNCT
ijpds-4398	114	1	d	d	X
ijpds-4398	114	2	kolekar	kolekar	PROPN
ijpds-4398	114	3	et	et	PROPN
ijpds-4398	114	4	al	al	PROPN
ijpds-4398	114	5	.	.	PROPN
ijpds-4398	114	6	chemometric	chemometric	PROPN
ijpds-4398	114	7	assisted	assist	VERB
ijpds-4398	114	8	qbd	qbd	NOUN
ijpds-4398	114	9	method	method	NOUN
ijpds-4398	114	10	for	for	ADP
ijpds-4398	114	11	estimation	estimation	NOUN
ijpds-4398	114	12	of	of	ADP
ijpds-4398	114	13	bilastine	bilastine	NOUN
ijpds-4398	114	14	and	and	CCONJ
ijpds-4398	114	15	montelukast	montelukast	NOUN
ijpds-4398	114	16	sodium	sodium	NOUN
ijpds-4398	114	17	vol	vol	NOUN
ijpds-4398	114	18	3	3	NUM
ijpds-4398	114	19	|	|	NOUN
ijpds-4398	114	20	issue	issue	VERB
ijpds-4398	114	21	1	1	NUM
ijpds-4398	115	1	|	|	ADV
ijpds-4398	115	2	jan	jan	PROPN
ijpds-4398	115	3	–	–	PUNCT
ijpds-4398	115	4	mar	mar	PROPN
ijpds-4398	115	5	2024	2024	NUM
ijpds-4398	116	1	indian	indian	PROPN
ijpds-4398	116	2	j	j	PROPN
ijpds-4398	116	3	pharm	pharm	PROPN
ijpds-4398	116	4	drug	drug	PROPN
ijpds-4398	116	5	studies	study	NOUN
ijpds-4398	116	6	|	|	ADV
ijpds-4398	116	7	19	19	NUM
ijpds-4398	116	8	linearity	linearity	NOUN
ijpds-4398	116	9	:	:	PUNCT
ijpds-4398	116	10	the	the	DET
ijpds-4398	116	11	linearity	linearity	NOUN
ijpds-4398	116	12	of	of	ADP
ijpds-4398	116	13	an	an	DET
ijpds-4398	116	14	analytical	analytical	ADJ
ijpds-4398	116	15	method	method	NOUN
ijpds-4398	116	16	is	be	AUX
ijpds-4398	116	17	its	its	PRON
ijpds-4398	116	18	ability	ability	NOUN
ijpds-4398	116	19	to	to	PART
ijpds-4398	116	20	obtain	obtain	VERB
ijpds-4398	116	21	response	response	NOUN
ijpds-4398	116	22	i.e.	i.e.	X
ijpds-4398	116	23	absorbance	absorbance	NOUN
ijpds-4398	116	24	which	which	PRON
ijpds-4398	116	25	is	be	AUX
ijpds-4398	116	26	directly	directly	ADV
ijpds-4398	116	27	proportional	proportional	ADJ
ijpds-4398	116	28	to	to	ADP
ijpds-4398	116	29	the	the	DET
ijpds-4398	116	30	conc	conc	NOUN
ijpds-4398	116	31	of	of	ADP
ijpds-4398	116	32	analyte	analyte	NOUN
ijpds-4398	116	33	.	.	PUNCT
ijpds-4398	117	1	series	series	NOUN
ijpds-4398	117	2	of	of	ADP
ijpds-4398	117	3	working	work	VERB
ijpds-4398	117	4	standard	standard	ADJ
ijpds-4398	117	5	solutions	solution	NOUN
ijpds-4398	117	6	were	be	AUX
ijpds-4398	117	7	prepared	prepare	VERB
ijpds-4398	117	8	in	in	ADP
ijpds-4398	117	9	conc	conc	NOUN
ijpds-4398	117	10	.	.	PUNCT
ijpds-4398	118	1	range	range	NOUN
ijpds-4398	118	2	of	of	ADP
ijpds-4398	118	3	1	1	NUM
ijpds-4398	118	4	-	-	SYM
ijpds-4398	118	5	32	32	NUM
ijpds-4398	118	6	μg	μg	NOUN
ijpds-4398	118	7	/	/	SYM
ijpds-4398	118	8	ml	ml	X
ijpds-4398	118	9	for	for	ADP
ijpds-4398	118	10	bse	bse	NOUN
ijpds-4398	118	11	and	and	CCONJ
ijpds-4398	118	12	1	1	NUM
ijpds-4398	118	13	-	-	SYM
ijpds-4398	118	14	20	20	NUM
ijpds-4398	118	15	μg	μg	NOUN
ijpds-4398	118	16	/	/	SYM
ijpds-4398	118	17	ml	ml	X
ijpds-4398	118	18	for	for	ADP
ijpds-4398	118	19	mks	mks	PROPN
ijpds-4398	118	20	and	and	CCONJ
ijpds-4398	118	21	scanned	scan	VERB
ijpds-4398	118	22	in	in	ADP
ijpds-4398	118	23	400	400	NUM
ijpds-4398	118	24	to	to	PART
ijpds-4398	118	25	200	200	NUM
ijpds-4398	118	26	nm	nm	ADJ
ijpds-4398	118	27	range	range	NOUN
ijpds-4398	118	28	in	in	ADP
ijpds-4398	118	29	spectrum	spectrum	NOUN
ijpds-4398	118	30	mode	mode	NOUN
ijpds-4398	118	31	of	of	ADP
ijpds-4398	118	32	the	the	DET
ijpds-4398	118	33	spectrophotometer	spectrophotometer	NOUN
ijpds-4398	118	34	,	,	PUNCT
ijpds-4398	118	35	absorbance	absorbance	NOUN
ijpds-4398	118	36	of	of	ADP
ijpds-4398	118	37	the	the	DET
ijpds-4398	118	38	standard	standard	ADJ
ijpds-4398	118	39	solutions	solution	NOUN
ijpds-4398	118	40	were	be	AUX
ijpds-4398	118	41	recorded	record	VERB
ijpds-4398	118	42	at	at	ADP
ijpds-4398	118	43	their	their	PRON
ijpds-4398	118	44	respective	respective	ADJ
ijpds-4398	118	45	wavelength	wavelength	NOUN
ijpds-4398	118	46	;	;	PUNCT
ijpds-4398	118	47	i.e.	i.e.	X
ijpds-4398	118	48	274.5	274.5	NUM
ijpds-4398	118	49	for	for	ADP
ijpds-4398	118	50	bse	bse	NOUN
ijpds-4398	118	51	and	and	CCONJ
ijpds-4398	118	52	351.5	351.5	NUM
ijpds-4398	118	53	nm	nm	NOUN
ijpds-4398	118	54	for	for	ADP
ijpds-4398	118	55	mks	mks	PROPN
ijpds-4398	118	56	in	in	ADP
ijpds-4398	118	57	spectrum	spectrum	NOUN
ijpds-4398	118	58	order	order	NOUN
ijpds-4398	118	59	.	.	PUNCT
ijpds-4398	119	1	microsoft	microsoft	PROPN
ijpds-4398	119	2	office	office	PROPN
ijpds-4398	119	3	excel	excel	PROPN
ijpds-4398	119	4	software	software	NOUN
ijpds-4398	119	5	tool	tool	NOUN
ijpds-4398	119	6	was	be	AUX
ijpds-4398	119	7	used	use	VERB
ijpds-4398	119	8	to	to	PART
ijpds-4398	119	9	obtain	obtain	VERB
ijpds-4398	119	10	the	the	DET
ijpds-4398	119	11	standard	standard	ADJ
ijpds-4398	119	12	regression	regression	NOUN
ijpds-4398	119	13	curve	curve	NOUN
ijpds-4398	119	14	and	and	CCONJ
ijpds-4398	119	15	its	its	PRON
ijpds-4398	119	16	analysis	analysis	NOUN
ijpds-4398	119	17	as	as	ADP
ijpds-4398	119	18	slope	slope	NOUN
ijpds-4398	119	19	,	,	PUNCT
ijpds-4398	119	20	intercept	intercept	NOUN
ijpds-4398	119	21	,	,	PUNCT
ijpds-4398	119	22	and	and	CCONJ
ijpds-4398	119	23	correlation	correlation	NOUN
ijpds-4398	119	24	coefficient	coefficient	NOUN
ijpds-4398	119	25	.	.	PUNCT
ijpds-4398	120	1	assay	assay	NOUN
ijpds-4398	120	2	of	of	ADP
ijpds-4398	120	3	formulation	formulation	NOUN
ijpds-4398	120	4	:	:	PUNCT
ijpds-4398	120	5	assay	assay	PROPN
ijpds-4398	120	6	was	be	AUX
ijpds-4398	120	7	carried	carry	VERB
ijpds-4398	120	8	out	out	ADP
ijpds-4398	120	9	by	by	ADP
ijpds-4398	120	10	proposed	propose	VERB
ijpds-4398	120	11	methods	method	NOUN
ijpds-4398	120	12	and	and	CCONJ
ijpds-4398	120	13	assay	assay	PROPN
ijpds-4398	120	14	was	be	AUX
ijpds-4398	120	15	validated	validate	VERB
ijpds-4398	120	16	by	by	ADP
ijpds-4398	120	17	statistical	statistical	ADJ
ijpds-4398	120	18	parameters	parameter	NOUN
ijpds-4398	120	19	.	.	PUNCT
ijpds-4398	121	1	estimation	estimation	NOUN
ijpds-4398	121	2	of	of	ADP
ijpds-4398	121	3	formulations	formulation	NOUN
ijpds-4398	121	4	by	by	ADP
ijpds-4398	121	5	simultaneous	simultaneous	ADJ
ijpds-4398	121	6	equation	equation	NOUN
ijpds-4398	121	7	method	method	NOUN
ijpds-4398	121	8	:	:	PUNCT
ijpds-4398	121	9	tablet	tablet	NOUN
ijpds-4398	121	10	powder	powder	NOUN
ijpds-4398	121	11	equivalent	equivalent	ADJ
ijpds-4398	121	12	to	to	ADP
ijpds-4398	121	13	10	10	NUM
ijpds-4398	121	14	mg	mg	PROPN
ijpds-4398	121	15	bse	bse	NOUN
ijpds-4398	121	16	and	and	CCONJ
ijpds-4398	121	17	5	5	NUM
ijpds-4398	121	18	mg	mg	PROPN
ijpds-4398	121	19	mks	mks	PROPN
ijpds-4398	121	20	was	be	AUX
ijpds-4398	121	21	weighed	weigh	VERB
ijpds-4398	121	22	and	and	CCONJ
ijpds-4398	121	23	transferred	transfer	VERB
ijpds-4398	121	24	into	into	ADP
ijpds-4398	121	25	25	25	NUM
ijpds-4398	121	26	ml	ml	NOUN
ijpds-4398	121	27	volumetric	volumetric	ADJ
ijpds-4398	121	28	flask	flask	NOUN
ijpds-4398	121	29	.	.	PUNCT
ijpds-4398	122	1	dissolved	dissolve	VERB
ijpds-4398	122	2	into	into	ADP
ijpds-4398	122	3	50	50	NUM
ijpds-4398	122	4	%	%	NOUN
ijpds-4398	122	5	alcohol	alcohol	NOUN
ijpds-4398	122	6	,	,	PUNCT
ijpds-4398	122	7	mixed	mix	VERB
ijpds-4398	122	8	well	well	ADV
ijpds-4398	122	9	for	for	ADP
ijpds-4398	122	10	10	10	NUM
ijpds-4398	122	11	mins	min	NOUN
ijpds-4398	122	12	and	and	CCONJ
ijpds-4398	122	13	volume	volume	NOUN
ijpds-4398	122	14	was	be	AUX
ijpds-4398	122	15	made	make	VERB
ijpds-4398	122	16	to	to	ADP
ijpds-4398	122	17	25	25	NUM
ijpds-4398	122	18	ml	ml	NOUN
ijpds-4398	122	19	with	with	ADP
ijpds-4398	122	20	the	the	DET
ijpds-4398	122	21	solvent	solvent	NOUN
ijpds-4398	122	22	.	.	PUNCT
ijpds-4398	123	1	solution	solution	NOUN
ijpds-4398	123	2	was	be	AUX
ijpds-4398	123	3	filtered	filter	VERB
ijpds-4398	123	4	through	through	ADP
ijpds-4398	123	5	what	what	PRON
ijpds-4398	123	6	man	man	NOUN
ijpds-4398	123	7	filter	filter	NOUN
ijpds-4398	123	8	paper	paper	NOUN
ijpds-4398	123	9	and	and	CCONJ
ijpds-4398	123	10	aliquots	aliquot	NOUN
ijpds-4398	123	11	of	of	ADP
ijpds-4398	123	12	solution	solution	NOUN
ijpds-4398	123	13	were	be	AUX
ijpds-4398	123	14	further	far	ADV
ijpds-4398	123	15	diluted	dilute	VERB
ijpds-4398	123	16	with	with	ADP
ijpds-4398	123	17	the	the	DET
ijpds-4398	123	18	50	50	NUM
ijpds-4398	123	19	%	%	NOUN
ijpds-4398	123	20	alcohol	alcohol	NOUN
ijpds-4398	123	21	to	to	PART
ijpds-4398	123	22	obtain	obtain	VERB
ijpds-4398	123	23	tablet	tablet	NOUN
ijpds-4398	123	24	sample	sample	NOUN
ijpds-4398	123	25	solution	solution	NOUN
ijpds-4398	123	26	.	.	PUNCT
ijpds-4398	124	1	solution	solution	NOUN
ijpds-4398	124	2	was	be	AUX
ijpds-4398	124	3	scanned	scan	VERB
ijpds-4398	124	4	in	in	ADP
ijpds-4398	124	5	the	the	DET
ijpds-4398	124	6	range	range	NOUN
ijpds-4398	124	7	of	of	ADP
ijpds-4398	124	8	400	400	NUM
ijpds-4398	124	9	to	to	PART
ijpds-4398	124	10	200	200	NUM
ijpds-4398	124	11	nm	nm	NOUN
ijpds-4398	124	12	to	to	PART
ijpds-4398	124	13	obtain	obtain	VERB
ijpds-4398	124	14	absorbance	absorbance	NOUN
ijpds-4398	124	15	of	of	ADP
ijpds-4398	124	16	tablet	tablet	ADJ
ijpds-4398	124	17	solution	solution	NOUN
ijpds-4398	124	18	at	at	ADP
ijpds-4398	124	19	274.5	274.5	NUM
ijpds-4398	124	20	nm	nm	NOUN
ijpds-4398	124	21	and	and	CCONJ
ijpds-4398	124	22	351.5	351.5	NUM
ijpds-4398	124	23	nm	nm	NOUN
ijpds-4398	124	24	in	in	ADP
ijpds-4398	124	25	spectrum	spectrum	NOUN
ijpds-4398	124	26	order	order	NOUN
ijpds-4398	124	27	.	.	PUNCT
ijpds-4398	125	1	obtained	obtain	VERB
ijpds-4398	125	2	absorbance	absorbance	NOUN
ijpds-4398	125	3	were	be	AUX
ijpds-4398	125	4	utilised	utilise	VERB
ijpds-4398	125	5	to	to	PART
ijpds-4398	125	6	estimate	estimate	VERB
ijpds-4398	125	7	unknown	unknown	ADJ
ijpds-4398	125	8	conc	conc	NOUN
ijpds-4398	125	9	of	of	ADP
ijpds-4398	125	10	formulation	formulation	NOUN
ijpds-4398	125	11	;	;	PUNCT
ijpds-4398	125	12	and	and	CCONJ
ijpds-4398	125	13	results	result	NOUN
ijpds-4398	125	14	were	be	AUX
ijpds-4398	125	15	statistically	statistically	ADV
ijpds-4398	125	16	validated	validate	VERB
ijpds-4398	125	17	to	to	PART
ijpds-4398	125	18	obtain	obtain	VERB
ijpds-4398	125	19	%	%	NOUN
ijpds-4398	125	20	of	of	ADP
ijpds-4398	125	21	nominal	nominal	ADJ
ijpds-4398	125	22	conc	conc	NOUN
ijpds-4398	125	23	,	,	PUNCT
ijpds-4398	125	24	standard	standard	ADJ
ijpds-4398	125	25	deviation	deviation	NOUN
ijpds-4398	125	26	and	and	CCONJ
ijpds-4398	125	27	%	%	NOUN
ijpds-4398	125	28	of	of	ADP
ijpds-4398	125	29	rsd	rsd	PROPN
ijpds-4398	125	30	.	.	PUNCT
ijpds-4398	126	1	accuracy	accuracy	NOUN
ijpds-4398	126	2	and	and	CCONJ
ijpds-4398	126	3	precision	precision	NOUN
ijpds-4398	126	4	:	:	PUNCT
ijpds-4398	126	5	the	the	DET
ijpds-4398	126	6	accuracy	accuracy	NOUN
ijpds-4398	126	7	of	of	ADP
ijpds-4398	126	8	an	an	DET
ijpds-4398	126	9	analytical	analytical	ADJ
ijpds-4398	126	10	method	method	NOUN
ijpds-4398	126	11	expresses	express	VERB
ijpds-4398	126	12	the	the	DET
ijpds-4398	126	13	closeness	closeness	NOUN
ijpds-4398	126	14	of	of	ADP
ijpds-4398	126	15	an	an	DET
ijpds-4398	126	16	agreement	agreement	NOUN
ijpds-4398	126	17	between	between	ADP
ijpds-4398	126	18	test	test	NOUN
ijpds-4398	126	19	result	result	NOUN
ijpds-4398	126	20	and	and	CCONJ
ijpds-4398	126	21	true	true	ADJ
ijpds-4398	126	22	result	result	NOUN
ijpds-4398	126	23	.	.	PUNCT
ijpds-4398	127	1	accuracy	accuracy	NOUN
ijpds-4398	127	2	study	study	NOUN
ijpds-4398	127	3	was	be	AUX
ijpds-4398	127	4	performed	perform	VERB
ijpds-4398	127	5	by	by	ADP
ijpds-4398	127	6	recovery	recovery	NOUN
ijpds-4398	127	7	study	study	NOUN
ijpds-4398	127	8	i.e.	i.e.	X
ijpds-4398	127	9	standard	standard	ADJ
ijpds-4398	127	10	addition	addition	NOUN
ijpds-4398	127	11	method	method	NOUN
ijpds-4398	127	12	;	;	PUNCT
ijpds-4398	127	13	diluted	dilute	VERB
ijpds-4398	127	14	standard	standard	ADJ
ijpds-4398	127	15	solutions	solution	NOUN
ijpds-4398	127	16	of	of	ADP
ijpds-4398	127	17	bse	bse	NOUN
ijpds-4398	127	18	and	and	CCONJ
ijpds-4398	127	19	mks	mks	PROPN
ijpds-4398	127	20	were	be	AUX
ijpds-4398	127	21	prepared	prepared	ADJ
ijpds-4398	127	22	and	and	CCONJ
ijpds-4398	127	23	standard	standard	ADJ
ijpds-4398	127	24	solutions	solution	NOUN
ijpds-4398	127	25	added	add	VERB
ijpds-4398	127	26	in	in	ADP
ijpds-4398	127	27	80,100	80,100	NUM
ijpds-4398	127	28	and	and	CCONJ
ijpds-4398	127	29	120	120	NUM
ijpds-4398	127	30	%	%	NOUN
ijpds-4398	127	31	proportionate	proportionate	ADJ
ijpds-4398	127	32	to	to	ADP
ijpds-4398	127	33	the	the	DET
ijpds-4398	127	34	tablet	tablet	NOUN
ijpds-4398	127	35	solution	solution	NOUN
ijpds-4398	127	36	.	.	PUNCT
ijpds-4398	128	1	three	three	NUM
ijpds-4398	128	2	replicates	replicate	NOUN
ijpds-4398	128	3	at	at	ADP
ijpds-4398	128	4	each	each	PRON
ijpds-4398	128	5	of	of	ADP
ijpds-4398	128	6	these	these	DET
ijpds-4398	128	7	three	three	NUM
ijpds-4398	128	8	levels	level	NOUN
ijpds-4398	128	9	were	be	AUX
ijpds-4398	128	10	prepared	prepare	VERB
ijpds-4398	128	11	,	,	PUNCT
ijpds-4398	128	12	measured	measure	VERB
ijpds-4398	128	13	and	and	CCONJ
ijpds-4398	128	14	%	%	NOUN
ijpds-4398	128	15	of	of	ADP
ijpds-4398	128	16	conc	conc	NOUN
ijpds-4398	128	17	,	,	PUNCT
ijpds-4398	128	18	sd	sd	NOUN
ijpds-4398	128	19	and	and	CCONJ
ijpds-4398	128	20	rsd	rsd	NOUN
ijpds-4398	128	21	were	be	AUX
ijpds-4398	128	22	calculated	calculate	VERB
ijpds-4398	128	23	.	.	PUNCT
ijpds-4398	129	1	the	the	DET
ijpds-4398	129	2	precision	precision	NOUN
ijpds-4398	129	3	study	study	NOUN
ijpds-4398	129	4	was	be	AUX
ijpds-4398	129	5	carried	carry	VERB
ijpds-4398	129	6	out	out	ADP
ijpds-4398	129	7	by	by	ADP
ijpds-4398	129	8	performing	perform	VERB
ijpds-4398	129	9	assay	assay	NOUN
ijpds-4398	129	10	of	of	ADP
ijpds-4398	129	11	tablet	tablet	NOUN
ijpds-4398	129	12	six	six	NUM
ijpds-4398	129	13	times	time	NOUN
ijpds-4398	129	14	;	;	PUNCT
ijpds-4398	129	15	also	also	ADV
ijpds-4398	129	16	the	the	DET
ijpds-4398	129	17	reproducibility	reproducibility	NOUN
ijpds-4398	129	18	in	in	ADP
ijpds-4398	129	19	result	result	NOUN
ijpds-4398	129	20	was	be	AUX
ijpds-4398	129	21	studied	study	VERB
ijpds-4398	129	22	by	by	ADP
ijpds-4398	129	23	inter	inter	ADJ
ijpds-4398	129	24	day	day	NOUN
ijpds-4398	129	25	and	and	CCONJ
ijpds-4398	129	26	intraday	intraday	NOUN
ijpds-4398	129	27	precision	precision	NOUN
ijpds-4398	129	28	.	.	PUNCT
ijpds-4398	130	1	limit	limit	NOUN
ijpds-4398	130	2	of	of	ADP
ijpds-4398	130	3	detection	detection	NOUN
ijpds-4398	130	4	(	(	PUNCT
ijpds-4398	130	5	lod	lod	PROPN
ijpds-4398	130	6	)	)	PUNCT
ijpds-4398	130	7	and	and	CCONJ
ijpds-4398	130	8	limit	limit	NOUN
ijpds-4398	130	9	of	of	ADP
ijpds-4398	130	10	quantitation	quantitation	NOUN
ijpds-4398	130	11	(	(	PUNCT
ijpds-4398	130	12	loq	loq	PROPN
ijpds-4398	130	13	):	):	PUNCT
ijpds-4398	130	14	the	the	DET
ijpds-4398	130	15	lod	lod	PROPN
ijpds-4398	130	16	and	and	CCONJ
ijpds-4398	130	17	loq	loq	PROPN
ijpds-4398	130	18	of	of	ADP
ijpds-4398	130	19	bse	bse	PROPN
ijpds-4398	130	20	and	and	CCONJ
ijpds-4398	130	21	mks	mks	PROPN
ijpds-4398	130	22	by	by	ADP
ijpds-4398	130	23	the	the	DET
ijpds-4398	130	24	proposed	propose	VERB
ijpds-4398	130	25	method	method	NOUN
ijpds-4398	130	26	were	be	AUX
ijpds-4398	130	27	determined	determine	VERB
ijpds-4398	130	28	using	use	VERB
ijpds-4398	130	29	calibration	calibration	NOUN
ijpds-4398	130	30	graph	graph	NOUN
ijpds-4398	130	31	method	method	NOUN
ijpds-4398	130	32	and	and	CCONJ
ijpds-4398	130	33	calculated	calculate	VERB
ijpds-4398	130	34	as	as	ADP
ijpds-4398	130	35	3.3σ	3.3σ	NUM
ijpds-4398	130	36	/	/	SYM
ijpds-4398	130	37	s	s	NOUN
ijpds-4398	130	38	and	and	CCONJ
ijpds-4398	130	39	10	10	NUM
ijpds-4398	130	40	σ	σ	NOUN
ijpds-4398	130	41	/	/	SYM
ijpds-4398	130	42	s	s	PROPN
ijpds-4398	130	43	for	for	ADP
ijpds-4398	130	44	lod	lod	PROPN
ijpds-4398	130	45	and	and	CCONJ
ijpds-4398	130	46	loq	loq	PROPN
ijpds-4398	130	47	respectively	respectively	ADV
ijpds-4398	130	48	;	;	PUNCT
ijpds-4398	130	49	σ	σ	PROPN
ijpds-4398	130	50	is	be	AUX
ijpds-4398	130	51	the	the	DET
ijpds-4398	130	52	standard	standard	ADJ
ijpds-4398	130	53	deviation	deviation	NOUN
ijpds-4398	130	54	of	of	ADP
ijpds-4398	130	55	calibration	calibration	NOUN
ijpds-4398	130	56	curve	curve	NOUN
ijpds-4398	130	57	and	and	CCONJ
ijpds-4398	130	58	s	s	NOUN
ijpds-4398	130	59	is	be	AUX
ijpds-4398	130	60	the	the	DET
ijpds-4398	130	61	slope	slope	NOUN
ijpds-4398	130	62	of	of	ADP
ijpds-4398	130	63	regression	regression	NOUN
ijpds-4398	130	64	line	line	NOUN
ijpds-4398	130	65	.	.	PUNCT
ijpds-4398	131	1	robustness	robustness	NOUN
ijpds-4398	131	2	and	and	CCONJ
ijpds-4398	131	3	ruggedness	ruggedness	NOUN
ijpds-4398	131	4	:	:	PUNCT
ijpds-4398	131	5	it	it	PRON
ijpds-4398	131	6	is	be	AUX
ijpds-4398	131	7	measure	measure	NOUN
ijpds-4398	131	8	of	of	ADP
ijpds-4398	131	9	capacity	capacity	NOUN
ijpds-4398	131	10	of	of	ADP
ijpds-4398	131	11	analytical	analytical	ADJ
ijpds-4398	131	12	procedure	procedure	NOUN
ijpds-4398	131	13	to	to	PART
ijpds-4398	131	14	remain	remain	VERB
ijpds-4398	131	15	unaffected	unaffected	ADJ
ijpds-4398	131	16	by	by	ADP
ijpds-4398	131	17	small	small	ADJ
ijpds-4398	131	18	but	but	CCONJ
ijpds-4398	131	19	deliberate	deliberate	ADJ
ijpds-4398	131	20	variations	variation	NOUN
ijpds-4398	131	21	in	in	ADP
ijpds-4398	131	22	method	method	NOUN
ijpds-4398	131	23	parameter	parameter	NOUN
ijpds-4398	131	24	.	.	PUNCT
ijpds-4398	132	1	results	result	NOUN
ijpds-4398	132	2	and	and	CCONJ
ijpds-4398	132	3	discussion	discussion	NOUN
ijpds-4398	132	4	method	method	NOUN
ijpds-4398	132	5	development	development	NOUN
ijpds-4398	132	6	comprises	comprise	VERB
ijpds-4398	132	7	numerous	numerous	ADJ
ijpds-4398	132	8	steps	step	NOUN
ijpds-4398	132	9	,	,	PUNCT
ijpds-4398	132	10	and	and	CCONJ
ijpds-4398	132	11	of	of	ADP
ijpds-4398	132	12	which	which	PRON
ijpds-4398	132	13	solvent	solvent	ADJ
ijpds-4398	132	14	selection	selection	NOUN
ijpds-4398	132	15	,	,	PUNCT
ijpds-4398	132	16	selection	selection	NOUN
ijpds-4398	132	17	of	of	ADP
ijpds-4398	132	18	method	method	NOUN
ijpds-4398	132	19	for	for	ADP
ijpds-4398	132	20	measurement	measurement	NOUN
ijpds-4398	132	21	are	be	AUX
ijpds-4398	132	22	significant	significant	ADJ
ijpds-4398	132	23	one	one	NUM
ijpds-4398	132	24	.	.	PUNCT
ijpds-4398	133	1	uses	use	NOUN
ijpds-4398	133	2	of	of	ADP
ijpds-4398	133	3	aqueous	aqueous	ADJ
ijpds-4398	133	4	solvents	solvent	NOUN
ijpds-4398	133	5	,	,	PUNCT
ijpds-4398	133	6	eco	eco	NOUN
ijpds-4398	133	7	-	-	PUNCT
ijpds-4398	133	8	friendly	friendly	ADJ
ijpds-4398	133	9	solvents	solvent	NOUN
ijpds-4398	133	10	like	like	ADP
ijpds-4398	133	11	hydrotropic	hydrotropic	NOUN
ijpds-4398	133	12	have	have	AUX
ijpds-4398	133	13	got	get	VERB
ijpds-4398	133	14	remarkable	remarkable	ADJ
ijpds-4398	133	15	weightage	weightage	NOUN
ijpds-4398	133	16	due	due	ADP
ijpds-4398	133	17	to	to	ADP
ijpds-4398	133	18	low	low	ADJ
ijpds-4398	133	19	cost	cost	NOUN
ijpds-4398	133	20	,	,	PUNCT
ijpds-4398	133	21	readily	readily	ADV
ijpds-4398	133	22	available	available	ADJ
ijpds-4398	133	23	and	and	CCONJ
ijpds-4398	133	24	environmentally	environmentally	ADV
ijpds-4398	133	25	sound	sound	ADJ
ijpds-4398	133	26	.	.	PUNCT
ijpds-4398	134	1	drugs	drug	NOUN
ijpds-4398	134	2	underlying	underlie	VERB
ijpds-4398	134	3	analysis	analysis	NOUN
ijpds-4398	134	4	must	must	AUX
ijpds-4398	134	5	have	have	VERB
ijpds-4398	134	6	appreciable	appreciable	ADJ
ijpds-4398	134	7	solubility	solubility	NOUN
ijpds-4398	134	8	in	in	ADP
ijpds-4398	134	9	the	the	DET
ijpds-4398	134	10	selected	select	VERB
ijpds-4398	134	11	solvent	solvent	NOUN
ijpds-4398	134	12	.	.	PUNCT
ijpds-4398	135	1	chemical	chemical	ADJ
ijpds-4398	135	2	structure	structure	NOUN
ijpds-4398	135	3	of	of	ADP
ijpds-4398	135	4	the	the	DET
ijpds-4398	135	5	drug	drug	NOUN
ijpds-4398	135	6	and	and	CCONJ
ijpds-4398	135	7	physico	physico	NOUN
ijpds-4398	135	8	-	-	PUNCT
ijpds-4398	135	9	chemical	chemical	NOUN
ijpds-4398	135	10	properties	property	NOUN
ijpds-4398	135	11	available	available	ADJ
ijpds-4398	135	12	in	in	ADP
ijpds-4398	135	13	the	the	DET
ijpds-4398	135	14	literature	literature	NOUN
ijpds-4398	135	15	guides	guide	NOUN
ijpds-4398	135	16	about	about	ADP
ijpds-4398	135	17	use	use	NOUN
ijpds-4398	135	18	of	of	ADP
ijpds-4398	135	19	appropriate	appropriate	ADJ
ijpds-4398	135	20	solvent	solvent	NOUN
ijpds-4398	135	21	in	in	ADP
ijpds-4398	135	22	the	the	DET
ijpds-4398	135	23	method	method	NOUN
ijpds-4398	135	24	.	.	PUNCT
ijpds-4398	136	1	from	from	ADP
ijpds-4398	136	2	uv	uv	PROPN
ijpds-4398	136	3	spectra	spectra	NOUN
ijpds-4398	136	4	two	two	NUM
ijpds-4398	136	5	wavelengths	wavelength	NOUN
ijpds-4398	136	6	were	be	AUX
ijpds-4398	136	7	selected	select	VERB
ijpds-4398	136	8	as	as	ADP
ijpds-4398	136	9	274.5	274.5	NUM
ijpds-4398	136	10	nm	nm	NOUN
ijpds-4398	136	11	(	(	PUNCT
ijpds-4398	136	12	λmax	λmax	NOUN
ijpds-4398	136	13	of	of	ADP
ijpds-4398	136	14	bse	bse	PROPN
ijpds-4398	136	15	)	)	PUNCT
ijpds-4398	136	16	and	and	CCONJ
ijpds-4398	136	17	351.5	351.5	NUM
ijpds-4398	136	18	nm	nm	NOUN
ijpds-4398	136	19	(	(	PUNCT
ijpds-4398	136	20	λmax	λmax	NOUN
ijpds-4398	136	21	of	of	ADP
ijpds-4398	136	22	mks	mks	PROPN
ijpds-4398	136	23	)	)	PUNCT
ijpds-4398	136	24	for	for	ADP
ijpds-4398	136	25	calculation	calculation	NOUN
ijpds-4398	136	26	of	of	ADP
ijpds-4398	136	27	both	both	DET
ijpds-4398	136	28	drugs	drug	NOUN
ijpds-4398	136	29	in	in	ADP
ijpds-4398	136	30	combined	combined	ADJ
ijpds-4398	136	31	solution	solution	NOUN
ijpds-4398	136	32	shown	show	VERB
ijpds-4398	136	33	in	in	ADP
ijpds-4398	136	34	(	(	PUNCT
ijpds-4398	136	35	fig	fig	NOUN
ijpds-4398	136	36	no	no	DET
ijpds-4398	136	37	4	4	NUM
ijpds-4398	136	38	)	)	PUNCT
ijpds-4398	136	39	.	.	PUNCT
ijpds-4398	137	1	system	system	NOUN
ijpds-4398	137	2	suitability	suitability	NOUN
ijpds-4398	137	3	:	:	PUNCT
ijpds-4398	137	4	the	the	DET
ijpds-4398	137	5	absorbances	absorbance	NOUN
ijpds-4398	137	6	of	of	ADP
ijpds-4398	137	7	six	six	NUM
ijpds-4398	137	8	replicates	replicate	NOUN
ijpds-4398	137	9	of	of	ADP
ijpds-4398	137	10	standard	standard	ADJ
ijpds-4398	137	11	solutions	solution	NOUN
ijpds-4398	137	12	of	of	ADP
ijpds-4398	137	13	respective	respective	ADJ
ijpds-4398	137	14	drugs	drug	NOUN
ijpds-4398	137	15	conc	conc	NOUN
ijpds-4398	137	16	are	be	AUX
ijpds-4398	137	17	reported	report	VERB
ijpds-4398	137	18	in	in	ADP
ijpds-4398	137	19	(	(	PUNCT
ijpds-4398	137	20	table	table	NOUN
ijpds-4398	137	21	no	no	DET
ijpds-4398	137	22	2	2	NUM
ijpds-4398	137	23	)	)	PUNCT
ijpds-4398	137	24	.	.	PUNCT
ijpds-4398	138	1	the	the	DET
ijpds-4398	138	2	sd	sd	NOUN
ijpds-4398	138	3	and	and	CCONJ
ijpds-4398	138	4	%	%	NOUN
ijpds-4398	138	5	rsd	rsd	PROPN
ijpds-4398	138	6	was	be	AUX
ijpds-4398	138	7	found	find	VERB
ijpds-4398	138	8	for	for	ADP
ijpds-4398	138	9	bse	bse	NOUN
ijpds-4398	138	10	and	and	CCONJ
ijpds-4398	138	11	mks	mks	PROPN
ijpds-4398	138	12	and	and	CCONJ
ijpds-4398	138	13	meets	meet	VERB
ijpds-4398	138	14	the	the	DET
ijpds-4398	138	15	system	system	NOUN
ijpds-4398	138	16	suitability	suitability	NOUN
ijpds-4398	138	17	requirements	requirement	NOUN
ijpds-4398	138	18	indicate	indicate	VERB
ijpds-4398	138	19	method	method	NOUN
ijpds-4398	138	20	was	be	AUX
ijpds-4398	138	21	suitable	suitable	ADJ
ijpds-4398	138	22	for	for	ADP
ijpds-4398	138	23	analysis	analysis	NOUN
ijpds-4398	138	24	.	.	PUNCT
ijpds-4398	139	1	table	table	NOUN
ijpds-4398	139	2	no	no	DET
ijpds-4398	139	3	2	2	NUM
ijpds-4398	139	4	:	:	PUNCT
ijpds-4398	139	5	system	system	NOUN
ijpds-4398	139	6	suitability	suitability	NOUN
ijpds-4398	139	7	study	study	NOUN
ijpds-4398	139	8	of	of	ADP
ijpds-4398	139	9	bse	bse	PROPN
ijpds-4398	139	10	and	and	CCONJ
ijpds-4398	139	11	mks	mks	PROPN
ijpds-4398	139	12	conc	conc	NOUN
ijpds-4398	139	13	in	in	ADP
ijpds-4398	139	14	μg	μg	PROPN
ijpds-4398	139	15	/ml	/ml	PUNCT
ijpds-4398	139	16	absorbance	absorbance	NOUN
ijpds-4398	139	17	of	of	ADP
ijpds-4398	139	18	bse	bse	NOUN
ijpds-4398	139	19	conc	conc	VERB
ijpds-4398	139	20	in	in	ADP
ijpds-4398	139	21	μg	μg	PROPN
ijpds-4398	139	22	/ml	/ml	PUNCT
ijpds-4398	139	23	absorbance	absorbance	NOUN
ijpds-4398	139	24	of	of	ADP
ijpds-4398	139	25	mks	mks	PROPN
ijpds-4398	139	26	20	20	NUM
ijpds-4398	139	27	μg	μg	NOUN
ijpds-4398	139	28	/ml	/ml	PUNCT
ijpds-4398	140	1	0.3124	0.3124	NUM
ijpds-4398	140	2	16	16	NUM
ijpds-4398	140	3	μg	μg	X
ijpds-4398	140	4	/ml	/ml	PUNCT
ijpds-4398	140	5	0.5269	0.5269	NUM
ijpds-4398	140	6	20	20	NUM
ijpds-4398	140	7	μg	μg	NOUN
ijpds-4398	140	8	/ml	/ml	PUNCT
ijpds-4398	141	1	0.3110	0.3110	NUM
ijpds-4398	141	2	16	16	NUM
ijpds-4398	141	3	μg	μg	NOUN
ijpds-4398	141	4	/ml	/ml	PROPN
ijpds-4398	141	5	0.5443	0.5443	NUM
ijpds-4398	141	6	20	20	NUM
ijpds-4398	141	7	μg	μg	NOUN
ijpds-4398	141	8	/ml	/ml	PUNCT
ijpds-4398	141	9	0.3281	0.3281	NUM
ijpds-4398	141	10	16	16	NUM
ijpds-4398	141	11	μg	μg	NOUN
ijpds-4398	141	12	/ml	/ml	PUNCT
ijpds-4398	141	13	0.5146	0.5146	NUM
ijpds-4398	141	14	20	20	NUM
ijpds-4398	141	15	μg	μg	NOUN
ijpds-4398	141	16	/ml	/ml	PROPN
ijpds-4398	141	17	0.3115	0.3115	NUM
ijpds-4398	141	18	16	16	NUM
ijpds-4398	141	19	μg	μg	NOUN
ijpds-4398	141	20	/ml	/ml	PROPN
ijpds-4398	141	21	0.5156	0.5156	NUM
ijpds-4398	142	1	20	20	NUM
ijpds-4398	142	2	μg	μg	NOUN
ijpds-4398	142	3	/ml	/ml	PUNCT
ijpds-4398	142	4	0.3395	0.3395	NUM
ijpds-4398	142	5	16	16	NUM
ijpds-4398	142	6	μg	μg	NOUN
ijpds-4398	142	7	/ml	/ml	PUNCT
ijpds-4398	142	8	0.5332	0.5332	NUM
ijpds-4398	142	9	20	20	NUM
ijpds-4398	142	10	μg	μg	NOUN
ijpds-4398	142	11	/ml	/ml	PUNCT
ijpds-4398	142	12	0.3292	0.3292	NUM
ijpds-4398	142	13	16	16	NUM
ijpds-4398	142	14	μg	μg	NOUN
ijpds-4398	142	15	/ml	/ml	PUNCT
ijpds-4398	142	16	0.5581	0.5581	NUM
ijpds-4398	142	17	sd	sd	ADP
ijpds-4398	142	18	rsd	rsd	PROPN
ijpds-4398	142	19	0.006662	0.006662	NUM
ijpds-4398	142	20	0.41972	0.41972	NUM
ijpds-4398	142	21	sd	sd	ADP
ijpds-4398	142	22	rsd	rsd	PROPN
ijpds-4398	142	23	0.01281	0.01281	NUM
ijpds-4398	142	24	0.29142	0.29142	NUM
ijpds-4398	142	25	linearity	linearity	NOUN
ijpds-4398	142	26	:	:	PUNCT
ijpds-4398	142	27	the	the	DET
ijpds-4398	142	28	calibration	calibration	NOUN
ijpds-4398	142	29	curve	curve	NOUN
ijpds-4398	142	30	of	of	ADP
ijpds-4398	142	31	both	both	DET
ijpds-4398	142	32	drugs	drug	NOUN
ijpds-4398	142	33	was	be	AUX
ijpds-4398	142	34	found	find	VERB
ijpds-4398	142	35	to	to	PART
ijpds-4398	142	36	be	be	AUX
ijpds-4398	142	37	linear	linear	ADJ
ijpds-4398	142	38	shown	show	VERB
ijpds-4398	142	39	in	in	ADP
ijpds-4398	142	40	(	(	PUNCT
ijpds-4398	142	41	figure	figure	NOUN
ijpds-4398	142	42	5	5	NUM
ijpds-4398	142	43	)	)	PUNCT
ijpds-4398	142	44	in	in	ADP
ijpds-4398	142	45	the	the	DET
ijpds-4398	142	46	conc	conc	ADJ
ijpds-4398	142	47	range	range	NOUN
ijpds-4398	142	48	of	of	ADP
ijpds-4398	142	49	1	1	NUM
ijpds-4398	142	50	-	-	SYM
ijpds-4398	142	51	32	32	NUM
ijpds-4398	142	52	μg	μg	NOUN
ijpds-4398	142	53	/	/	SYM
ijpds-4398	142	54	ml	ml	X
ijpds-4398	142	55	for	for	ADP
ijpds-4398	142	56	bse	bse	NOUN
ijpds-4398	142	57	and	and	CCONJ
ijpds-4398	142	58	1	1	NUM
ijpds-4398	142	59	-	-	SYM
ijpds-4398	142	60	20	20	NUM
ijpds-4398	142	61	μg	μg	NOUN
ijpds-4398	142	62	/	/	SYM
ijpds-4398	142	63	ml	ml	X
ijpds-4398	142	64	for	for	ADP
ijpds-4398	142	65	mks	mks	PROPN
ijpds-4398	142	66	as	as	SCONJ
ijpds-4398	142	67	shown	show	VERB
ijpds-4398	142	68	in	in	ADP
ijpds-4398	142	69	(	(	PUNCT
ijpds-4398	142	70	figure	figure	NOUN
ijpds-4398	142	71	6	6	NUM
ijpds-4398	142	72	)	)	PUNCT
ijpds-4398	142	73	.	.	PUNCT
ijpds-4398	143	1	the	the	DET
ijpds-4398	143	2	regression	regression	NOUN
ijpds-4398	143	3	equation	equation	NOUN
ijpds-4398	143	4	of	of	ADP
ijpds-4398	143	5	line	line	NOUN
ijpds-4398	143	6	and	and	CCONJ
ijpds-4398	143	7	parameters	parameter	NOUN
ijpds-4398	143	8	slope	slope	VERB
ijpds-4398	143	9	,	,	PUNCT
ijpds-4398	143	10	r2	r2	NOUN
ijpds-4398	143	11	value	value	NOUN
ijpds-4398	143	12	and	and	CCONJ
ijpds-4398	143	13	intercept	intercept	NOUN
ijpds-4398	143	14	(	(	PUNCT
ijpds-4398	143	15	figure	figure	NOUN
ijpds-4398	143	16	7	7	NUM
ijpds-4398	143	17	)	)	PUNCT
ijpds-4398	143	18	are	be	AUX
ijpds-4398	143	19	tabulated	tabulate	VERB
ijpds-4398	143	20	in	in	ADP
ijpds-4398	143	21	(	(	PUNCT
ijpds-4398	143	22	table	table	NOUN
ijpds-4398	143	23	3	3	NUM
ijpds-4398	143	24	)	)	PUNCT
ijpds-4398	143	25	,	,	PUNCT
ijpds-4398	143	26	which	which	PRON
ijpds-4398	143	27	proved	prove	VERB
ijpds-4398	143	28	the	the	DET
ijpds-4398	143	29	linear	linear	ADJ
ijpds-4398	143	30	relationship	relationship	NOUN
ijpds-4398	143	31	between	between	ADP
ijpds-4398	143	32	conc	conc	NOUN
ijpds-4398	143	33	and	and	CCONJ
ijpds-4398	143	34	obtained	obtain	VERB
ijpds-4398	143	35	response	response	NOUN
ijpds-4398	143	36	.	.	PUNCT
ijpds-4398	144	1	assay	assay	VERB
ijpds-4398	144	2	:	:	PUNCT
ijpds-4398	144	3	the	the	DET
ijpds-4398	144	4	assay	assay	NOUN
ijpds-4398	144	5	was	be	AUX
ijpds-4398	144	6	carried	carry	VERB
ijpds-4398	144	7	out	out	ADP
ijpds-4398	144	8	by	by	ADP
ijpds-4398	144	9	the	the	DET
ijpds-4398	144	10	proposed	propose	VERB
ijpds-4398	144	11	method	method	NOUN
ijpds-4398	144	12	.	.	PUNCT
ijpds-4398	145	1	the	the	DET
ijpds-4398	145	2	spectrum	spectrum	NOUN
ijpds-4398	145	3	of	of	ADP
ijpds-4398	145	4	formulation	formulation	NOUN
ijpds-4398	145	5	by	by	ADP
ijpds-4398	145	6	method	method	NOUN
ijpds-4398	145	7	was	be	AUX
ijpds-4398	145	8	shown	show	VERB
ijpds-4398	145	9	in	in	ADP
ijpds-4398	145	10	(	(	PUNCT
ijpds-4398	145	11	fig	fig	NOUN
ijpds-4398	145	12	no	no	DET
ijpds-4398	145	13	8)	8)	NOUN
ijpds-4398	145	14	.	.	PUNCT
ijpds-4398	146	1	the	the	DET
ijpds-4398	146	2	assay	assay	NOUN
ijpds-4398	146	3	of	of	ADP
ijpds-4398	146	4	formulation	formulation	NOUN
ijpds-4398	146	5	was	be	AUX
ijpds-4398	146	6	carried	carry	VERB
ijpds-4398	146	7	out	out	ADP
ijpds-4398	146	8	by	by	ADP
ijpds-4398	146	9	proposed	propose	VERB
ijpds-4398	146	10	method	method	NOUN
ijpds-4398	146	11	and	and	CCONJ
ijpds-4398	146	12	calculated	calculate	VERB
ijpds-4398	146	13	%	%	NOUN
ijpds-4398	146	14	of	of	ADP
ijpds-4398	146	15	nominal	nominal	ADJ
ijpds-4398	146	16	conc	conc	NOUN
ijpds-4398	146	17	and	and	CCONJ
ijpds-4398	146	18	rsd	rsd	NOUN
ijpds-4398	146	19	was	be	AUX
ijpds-4398	146	20	found	find	VERB
ijpds-4398	146	21	within	within	ADP
ijpds-4398	146	22	acceptable	acceptable	ADJ
ijpds-4398	146	23	limits	limit	NOUN
ijpds-4398	146	24	are	be	AUX
ijpds-4398	146	25	summarized	summarize	VERB
ijpds-4398	146	26	in	in	ADP
ijpds-4398	146	27	(	(	PUNCT
ijpds-4398	146	28	table	table	NOUN
ijpds-4398	146	29	no	no	DET
ijpds-4398	146	30	4	4	NUM
ijpds-4398	146	31	)	)	PUNCT
ijpds-4398	146	32	.	.	PUNCT
ijpds-4398	147	1	the	the	DET
ijpds-4398	147	2	results	result	NOUN
ijpds-4398	147	3	indicated	indicate	VERB
ijpds-4398	147	4	applicability	applicability	NOUN
ijpds-4398	147	5	of	of	ADP
ijpds-4398	147	6	the	the	DET
ijpds-4398	147	7	method	method	NOUN
ijpds-4398	147	8	for	for	ADP
ijpds-4398	147	9	estimation	estimation	NOUN
ijpds-4398	147	10	of	of	ADP
ijpds-4398	147	11	formulation	formulation	NOUN
ijpds-4398	147	12	.	.	PUNCT
ijpds-4398	148	1	accuracy	accuracy	NOUN
ijpds-4398	148	2	and	and	CCONJ
ijpds-4398	148	3	precision	precision	NOUN
ijpds-4398	148	4	:	:	PUNCT
ijpds-4398	148	5	the	the	DET
ijpds-4398	148	6	accuracy	accuracy	NOUN
ijpds-4398	148	7	study	study	NOUN
ijpds-4398	148	8	was	be	AUX
ijpds-4398	148	9	carried	carry	VERB
ijpds-4398	148	10	out	out	ADP
ijpds-4398	148	11	at	at	ADP
ijpds-4398	148	12	3	3	NUM
ijpds-4398	148	13	levels	level	NOUN
ijpds-4398	148	14	;	;	PUNCT
ijpds-4398	148	15	and	and	CCONJ
ijpds-4398	148	16	the	the	DET
ijpds-4398	148	17	results	result	NOUN
ijpds-4398	148	18	of	of	ADP
ijpds-4398	148	19	accuracy	accuracy	NOUN
ijpds-4398	148	20	are	be	AUX
ijpds-4398	148	21	summarised	summarise	VERB
ijpds-4398	148	22	in	in	ADP
ijpds-4398	148	23	(	(	PUNCT
ijpds-4398	148	24	table	table	NOUN
ijpds-4398	148	25	5	5	NUM
ijpds-4398	148	26	)	)	PUNCT
ijpds-4398	148	27	,	,	PUNCT
ijpds-4398	148	28	the	the	DET
ijpds-4398	148	29	obtained	obtain	VERB
ijpds-4398	148	30	results	result	NOUN
ijpds-4398	148	31	were	be	AUX
ijpds-4398	148	32	within	within	ADP
ijpds-4398	148	33	acceptable	acceptable	ADJ
ijpds-4398	148	34	limit	limit	NOUN
ijpds-4398	148	35	;	;	PUNCT
ijpds-4398	148	36	and	and	CCONJ
ijpds-4398	148	37	methods	method	NOUN
ijpds-4398	148	38	accuracy	accuracy	NOUN
ijpds-4398	148	39	was	be	AUX
ijpds-4398	148	40	justified	justify	VERB
ijpds-4398	148	41	by	by	ADP
ijpds-4398	148	42	calculating	calculate	VERB
ijpds-4398	148	43	%	%	NOUN
ijpds-4398	148	44	drug	drug	NOUN
ijpds-4398	148	45	content	content	NOUN
ijpds-4398	148	46	.	.	PUNCT
ijpds-4398	149	1	the	the	DET
ijpds-4398	149	2	precision	precision	NOUN
ijpds-4398	149	3	study	study	NOUN
ijpds-4398	149	4	was	be	AUX
ijpds-4398	149	5	carried	carry	VERB
ijpds-4398	149	6	out	out	ADP
ijpds-4398	149	7	by	by	ADP
ijpds-4398	149	8	performing	perform	VERB
ijpds-4398	149	9	assay	assay	NOUN
ijpds-4398	149	10	of	of	ADP
ijpds-4398	149	11	solutions	solution	NOUN
ijpds-4398	149	12	;	;	PUNCT
ijpds-4398	149	13	further	far	ADV
ijpds-4398	149	14	the	the	DET
ijpds-4398	149	15	reproducibility	reproducibility	NOUN
ijpds-4398	149	16	in	in	ADP
ijpds-4398	149	17	result	result	NOUN
ijpds-4398	149	18	was	be	AUX
ijpds-4398	149	19	studied	study	VERB
ijpds-4398	149	20	by	by	ADP
ijpds-4398	149	21	interday	interday	NOUN
ijpds-4398	149	22	and	and	CCONJ
ijpds-4398	149	23	intraday	intraday	NOUN
ijpds-4398	149	24	precision	precision	NOUN
ijpds-4398	149	25	.	.	PUNCT
ijpds-4398	150	1	the	the	DET
ijpds-4398	150	2	values	value	NOUN
ijpds-4398	150	3	obtained	obtain	VERB
ijpds-4398	150	4	sd	sd	ADP
ijpds-4398	150	5	and	and	CCONJ
ijpds-4398	150	6	%	%	NOUN
ijpds-4398	150	7	rsd	rsd	PROPN
ijpds-4398	150	8	was	be	AUX
ijpds-4398	150	9	shown	show	VERB
ijpds-4398	150	10	methods	method	NOUN
ijpds-4398	150	11	precision	precision	NOUN
ijpds-4398	150	12	and	and	CCONJ
ijpds-4398	150	13	are	be	AUX
ijpds-4398	150	14	summarised	summarise	VERB
ijpds-4398	150	15	in	in	ADP
ijpds-4398	150	16	(	(	PUNCT
ijpds-4398	150	17	table	table	NOUN
ijpds-4398	150	18	5	5	NUM
ijpds-4398	150	19	)	)	PUNCT
ijpds-4398	150	20	.	.	PUNCT
ijpds-4398	151	1	d	d	X
ijpds-4398	151	2	kolekar	kolekar	PROPN
ijpds-4398	151	3	et	et	PROPN
ijpds-4398	151	4	al	al	PROPN
ijpds-4398	151	5	.	.	PROPN
ijpds-4398	151	6	chemometric	chemometric	PROPN
ijpds-4398	151	7	assisted	assist	VERB
ijpds-4398	151	8	qbd	qbd	NOUN
ijpds-4398	151	9	method	method	NOUN
ijpds-4398	151	10	for	for	ADP
ijpds-4398	151	11	estimation	estimation	NOUN
ijpds-4398	151	12	of	of	ADP
ijpds-4398	151	13	bilastine	bilastine	NOUN
ijpds-4398	151	14	and	and	CCONJ
ijpds-4398	151	15	montelukast	montelukast	NOUN
ijpds-4398	151	16	sodium	sodium	NOUN
ijpds-4398	151	17	vol	vol	NOUN
ijpds-4398	151	18	3	3	NUM
ijpds-4398	151	19	|	|	NOUN
ijpds-4398	151	20	issue	issue	VERB
ijpds-4398	151	21	1	1	NUM
ijpds-4398	152	1	|	|	ADV
ijpds-4398	152	2	jan	jan	PROPN
ijpds-4398	152	3	–	–	PUNCT
ijpds-4398	152	4	mar	mar	PROPN
ijpds-4398	152	5	2024	2024	NUM
ijpds-4398	153	1	indian	indian	PROPN
ijpds-4398	153	2	j	j	PROPN
ijpds-4398	153	3	pharm	pharm	PROPN
ijpds-4398	153	4	drug	drug	PROPN
ijpds-4398	153	5	studies	study	NOUN
ijpds-4398	153	6	|	|	ADV
ijpds-4398	153	7	20	20	NUM
ijpds-4398	153	8	limit	limit	NOUN
ijpds-4398	153	9	of	of	ADP
ijpds-4398	153	10	detection	detection	NOUN
ijpds-4398	153	11	(	(	PUNCT
ijpds-4398	153	12	lod	lod	PROPN
ijpds-4398	153	13	)	)	PUNCT
ijpds-4398	153	14	and	and	CCONJ
ijpds-4398	153	15	limit	limit	NOUN
ijpds-4398	153	16	of	of	ADP
ijpds-4398	153	17	quantitation	quantitation	NOUN
ijpds-4398	153	18	(	(	PUNCT
ijpds-4398	153	19	loq	loq	PROPN
ijpds-4398	153	20	):	):	PUNCT
ijpds-4398	153	21	the	the	DET
ijpds-4398	153	22	lod	lod	PROPN
ijpds-4398	153	23	and	and	CCONJ
ijpds-4398	153	24	loq	loq	PROPN
ijpds-4398	153	25	of	of	ADP
ijpds-4398	153	26	bse	bse	PROPN
ijpds-4398	153	27	and	and	CCONJ
ijpds-4398	153	28	mks	mks	PROPN
ijpds-4398	153	29	by	by	ADP
ijpds-4398	153	30	the	the	DET
ijpds-4398	153	31	proposed	propose	VERB
ijpds-4398	153	32	method	method	NOUN
ijpds-4398	153	33	were	be	AUX
ijpds-4398	153	34	calculated	calculate	VERB
ijpds-4398	153	35	and	and	CCONJ
ijpds-4398	153	36	shown	show	VERB
ijpds-4398	153	37	in	in	ADP
ijpds-4398	153	38	(	(	PUNCT
ijpds-4398	153	39	table	table	NOUN
ijpds-4398	153	40	6	6	NUM
ijpds-4398	153	41	)	)	PUNCT
ijpds-4398	153	42	.	.	PUNCT
ijpds-4398	154	1	robustness	robustness	NOUN
ijpds-4398	154	2	and	and	CCONJ
ijpds-4398	154	3	ruggedness	ruggedness	NOUN
ijpds-4398	154	4	:	:	PUNCT
ijpds-4398	154	5	robustness	robustness	NOUN
ijpds-4398	154	6	was	be	AUX
ijpds-4398	154	7	studied	study	VERB
ijpds-4398	154	8	and	and	CCONJ
ijpds-4398	154	9	capacity	capacity	NOUN
ijpds-4398	154	10	of	of	ADP
ijpds-4398	154	11	analytical	analytical	ADJ
ijpds-4398	154	12	procedure	procedure	NOUN
ijpds-4398	154	13	to	to	PART
ijpds-4398	154	14	measure	measure	VERB
ijpds-4398	154	15	analyte	analyte	NOUN
ijpds-4398	154	16	was	be	AUX
ijpds-4398	154	17	remain	remain	VERB
ijpds-4398	154	18	unaffected	unaffected	ADJ
ijpds-4398	154	19	by	by	ADP
ijpds-4398	154	20	small	small	ADJ
ijpds-4398	154	21	but	but	CCONJ
ijpds-4398	154	22	deliberate	deliberate	ADJ
ijpds-4398	154	23	variations	variation	NOUN
ijpds-4398	154	24	in	in	ADP
ijpds-4398	154	25	method	method	NOUN
ijpds-4398	154	26	parameter	parameter	NOUN
ijpds-4398	154	27	.	.	PUNCT
ijpds-4398	155	1	the	the	DET
ijpds-4398	155	2	analytical	analytical	ADJ
ijpds-4398	155	3	method	method	NOUN
ijpds-4398	155	4	was	be	AUX
ijpds-4398	155	5	found	find	VERB
ijpds-4398	155	6	rugged	rugged	ADJ
ijpds-4398	155	7	during	during	ADP
ijpds-4398	155	8	development	development	NOUN
ijpds-4398	155	9	;	;	PUNCT
ijpds-4398	155	10	similarly	similarly	ADV
ijpds-4398	155	11	the	the	DET
ijpds-4398	155	12	result	result	NOUN
ijpds-4398	155	13	was	be	AUX
ijpds-4398	155	14	produced	produce	VERB
ijpds-4398	155	15	shown	show	VERB
ijpds-4398	155	16	in	in	ADP
ijpds-4398	155	17	(	(	PUNCT
ijpds-4398	155	18	table	table	NOUN
ijpds-4398	155	19	6	6	NUM
ijpds-4398	155	20	)	)	PUNCT
ijpds-4398	155	21	by	by	ADP
ijpds-4398	155	22	performing	perform	VERB
ijpds-4398	155	23	the	the	DET
ijpds-4398	155	24	analysis	analysis	NOUN
ijpds-4398	155	25	by	by	ADP
ijpds-4398	155	26	different	different	ADJ
ijpds-4398	155	27	analyst	analyst	NOUN
ijpds-4398	155	28	.	.	PUNCT
ijpds-4398	156	1	figure	figure	VERB
ijpds-4398	156	2	5	5	NUM
ijpds-4398	156	3	:	:	PUNCT
ijpds-4398	156	4	overlaid	overlay	VERB
ijpds-4398	156	5	spectra	spectra	NOUN
ijpds-4398	156	6	of	of	ADP
ijpds-4398	156	7	bilastine	bilastine	PROPN
ijpds-4398	156	8	obtained	obtain	VERB
ijpds-4398	156	9	in	in	ADP
ijpds-4398	156	10	linearity	linearity	NOUN
ijpds-4398	156	11	study	study	NOUN
ijpds-4398	156	12	figure	figure	NOUN
ijpds-4398	156	13	6	6	NUM
ijpds-4398	156	14	:	:	PUNCT
ijpds-4398	156	15	overlaid	overlay	VERB
ijpds-4398	156	16	spectra	spectra	NOUN
ijpds-4398	156	17	of	of	ADP
ijpds-4398	156	18	montelukast	montelukast	NOUN
ijpds-4398	156	19	obtained	obtain	VERB
ijpds-4398	156	20	in	in	ADP
ijpds-4398	156	21	linearity	linearity	NOUN
ijpds-4398	156	22	study	study	NOUN
ijpds-4398	156	23	fig	fig	NOUN
ijpds-4398	156	24	no	no	DET
ijpds-4398	156	25	7	7	NUM
ijpds-4398	156	26	:	:	PUNCT
ijpds-4398	156	27	calibration	calibration	NOUN
ijpds-4398	156	28	curve	curve	NOUN
ijpds-4398	156	29	of	of	ADP
ijpds-4398	156	30	bse	bse	PROPN
ijpds-4398	156	31	and	and	CCONJ
ijpds-4398	156	32	mks	mks	PROPN
ijpds-4398	156	33	table	table	NOUN
ijpds-4398	156	34	3	3	NUM
ijpds-4398	156	35	:	:	PUNCT
ijpds-4398	156	36	parameters	parameter	NOUN
ijpds-4398	156	37	of	of	ADP
ijpds-4398	156	38	regression	regression	NOUN
ijpds-4398	156	39	equation	equation	NOUN
ijpds-4398	156	40	obtained	obtain	VERB
ijpds-4398	156	41	in	in	ADP
ijpds-4398	156	42	microsoft	microsoft	PROPN
ijpds-4398	156	43	excel	excel	PROPN
ijpds-4398	156	44	parameters	parameter	NOUN
ijpds-4398	156	45	bse	bse	PROPN
ijpds-4398	156	46	mks	mks	PROPN
ijpds-4398	156	47	detection	detection	PROPN
ijpds-4398	156	48	wavelength	wavelength	VERB
ijpds-4398	156	49	274.5	274.5	NUM
ijpds-4398	156	50	351.5	351.5	NUM
ijpds-4398	156	51	beer	beer	NOUN
ijpds-4398	156	52	’s	’s	PART
ijpds-4398	156	53	law	law	NOUN
ijpds-4398	156	54	limit	limit	NOUN
ijpds-4398	156	55	(	(	PUNCT
ijpds-4398	156	56	μg	μg	NOUN
ijpds-4398	156	57	/	/	SYM
ijpds-4398	156	58	ml	ml	NOUN
ijpds-4398	156	59	)	)	PUNCT
ijpds-4398	156	60	1–32	1–32	PROPN
ijpds-4398	156	61	μg	μg	PROPN
ijpds-4398	156	62	/	/	SYM
ijpds-4398	156	63	ml	ml	ADP
ijpds-4398	156	64	1–20	1–20	PROPN
ijpds-4398	156	65	μg	μg	PROPN
ijpds-4398	156	66	/	/	SYM
ijpds-4398	156	67	ml	ml	NOUN
ijpds-4398	156	68	correlation	correlation	NOUN
ijpds-4398	156	69	coefficient	coefficient	NOUN
ijpds-4398	156	70	(	(	PUNCT
ijpds-4398	156	71	r2	r2	PROPN
ijpds-4398	156	72	)	)	PUNCT
ijpds-4398	156	73	0.9967	0.9967	NUM
ijpds-4398	156	74	0.9998	0.9998	NUM
ijpds-4398	156	75	regression	regression	NOUN
ijpds-4398	156	76	equation	equation	NOUN
ijpds-4398	156	77	(	(	PUNCT
ijpds-4398	156	78	y	y	NOUN
ijpds-4398	156	79	=	=	SYM
ijpds-4398	156	80	mx	mx	PROPN
ijpds-4398	157	1	+	+	CCONJ
ijpds-4398	157	2	c	c	X
ijpds-4398	157	3	)	)	PUNCT
ijpds-4398	157	4	y	y	NOUN
ijpds-4398	157	5	=	=	PUNCT
ijpds-4398	157	6	0.0203x	0.0203x	PROPN
ijpds-4398	157	7	0.0037	0.0037	NUM
ijpds-4398	157	8	y	y	NOUN
ijpds-4398	157	9	=	=	PUNCT
ijpds-4398	157	10	0.0302x	0.0302x	PROPN
ijpds-4398	157	11	0.0013	0.0013	NUM
ijpds-4398	157	12	fig	fig	NOUN
ijpds-4398	158	1	no	no	DET
ijpds-4398	158	2	8	8	NOUN
ijpds-4398	158	3	:	:	PUNCT
ijpds-4398	158	4	spectra	spectra	NOUN
ijpds-4398	158	5	of	of	ADP
ijpds-4398	158	6	formulation	formulation	NOUN
ijpds-4398	158	7	obtained	obtain	VERB
ijpds-4398	158	8	in	in	ADP
ijpds-4398	158	9	the	the	DET
ijpds-4398	158	10	assay	assay	NOUN
ijpds-4398	158	11	table	table	NOUN
ijpds-4398	158	12	4	4	NUM
ijpds-4398	158	13	:	:	PUNCT
ijpds-4398	158	14	results	result	NOUN
ijpds-4398	158	15	of	of	ADP
ijpds-4398	158	16	assay	assay	NOUN
ijpds-4398	158	17	of	of	ADP
ijpds-4398	158	18	formulation	formulation	NOUN
ijpds-4398	158	19	by	by	ADP
ijpds-4398	158	20	proposed	propose	VERB
ijpds-4398	158	21	method	method	NOUN
ijpds-4398	158	22	name	name	NOUN
ijpds-4398	158	23	of	of	ADP
ijpds-4398	158	24	the	the	DET
ijpds-4398	158	25	formulation	formulation	NOUN
ijpds-4398	158	26	bilafav	bilafav	NOUN
ijpds-4398	158	27	m	m	PROPN
ijpds-4398	158	28	(	(	PUNCT
ijpds-4398	158	29	bilastine	bilastine	VERB
ijpds-4398	158	30	20	20	NUM
ijpds-4398	158	31	mg	mg	NOUN
ijpds-4398	158	32	,	,	PUNCT
ijpds-4398	158	33	montelukast	montelukast	NOUN
ijpds-4398	158	34	sodium	sodium	NOUN
ijpds-4398	158	35	10	10	NUM
ijpds-4398	158	36	mg	mg	NOUN
ijpds-4398	158	37	)	)	PUNCT
ijpds-4398	158	38	b	b	NOUN
ijpds-4398	159	1	no	no	DET
ijpds-4398	159	2	-23s2gtb843	-23s2gtb843	PROPN
ijpds-4398	159	3	,	,	PUNCT
ijpds-4398	159	4	mfg	mfg	ADJ
ijpds-4398	159	5	datejul	datejul	NOUN
ijpds-4398	159	6	2023	2023	NUM
ijpds-4398	159	7	,	,	PUNCT
ijpds-4398	159	8	exp	exp	NOUN
ijpds-4398	159	9	date	date	NOUN
ijpds-4398	159	10	–	–	PUNCT
ijpds-4398	159	11	jun	jun	PROPN
ijpds-4398	159	12	2025	2025	NUM
ijpds-4398	159	13	formulation	formulation	NOUN
ijpds-4398	159	14	drug	drug	NOUN
ijpds-4398	159	15	label	label	NOUN
ijpds-4398	159	16	claim	claim	NOUN
ijpds-4398	159	17	(	(	PUNCT
ijpds-4398	159	18	mg	mg	NOUN
ijpds-4398	159	19	/	/	SYM
ijpds-4398	159	20	tablet	tablet	NOUN
ijpds-4398	159	21	;	;	PUNCT
ijpds-4398	159	22	n=6	n=6	X
ijpds-4398	159	23	)	)	PUNCT
ijpds-4398	159	24	amount	amount	NOUN
ijpds-4398	159	25	found	find	VERB
ijpds-4398	159	26	/	/	SYM
ijpds-4398	159	27	mg	mg	PROPN
ijpds-4398	159	28	drug	drug	NOUN
ijpds-4398	159	29	content	content	NOUN
ijpds-4398	159	30	%	%	NOUN
ijpds-4398	159	31	std	std	NOUN
ijpds-4398	159	32	deviation	deviation	NOUN
ijpds-4398	159	33	%	%	NOUN
ijpds-4398	159	34	rsd	rsd	PROPN
ijpds-4398	159	35	method	method	NOUN
ijpds-4398	159	36	bse	bse	PROPN
ijpds-4398	159	37	20	20	NUM
ijpds-4398	159	38	19.618	19.618	NUM
ijpds-4398	159	39	98.092	98.092	NUM
ijpds-4398	159	40	0.15702	0.15702	NUM
ijpds-4398	159	41	0.16092	0.16092	NUM
ijpds-4398	159	42	mks	mks	NOUN
ijpds-4398	159	43	10	10	NUM
ijpds-4398	159	44	10.362	10.362	NUM
ijpds-4398	159	45	103.62	103.62	NUM
ijpds-4398	159	46	0.21932	0.21932	NUM
ijpds-4398	159	47	0.24942	0.24942	NUM
ijpds-4398	159	48	table	table	NOUN
ijpds-4398	159	49	no	no	DET
ijpds-4398	159	50	5	5	NUM
ijpds-4398	159	51	:	:	PUNCT
ijpds-4398	159	52	results	result	NOUN
ijpds-4398	159	53	of	of	ADP
ijpds-4398	159	54	accuracy	accuracy	NOUN
ijpds-4398	159	55	and	and	CCONJ
ijpds-4398	159	56	precision	precision	NOUN
ijpds-4398	159	57	parameter	parameter	NOUN
ijpds-4398	159	58	level	level	NOUN
ijpds-4398	159	59	of	of	ADP
ijpds-4398	159	60	study	study	NOUN
ijpds-4398	159	61	drug	drug	NOUN
ijpds-4398	159	62	name	name	PROPN
ijpds-4398	159	63	s.d	s.d	PROPN
ijpds-4398	159	64	.	.	PROPN
ijpds-4398	159	65	%	%	PROPN
ijpds-4398	159	66	rsd	rsd	PROPN
ijpds-4398	159	67	precision	precision	PROPN
ijpds-4398	159	68	intraday	intraday	PROPN
ijpds-4398	159	69	precision	precision	NOUN
ijpds-4398	159	70	bse	bse	NOUN
ijpds-4398	159	71	0.19025	0.19025	NUM
ijpds-4398	159	72	3.9635	3.9635	NUM
ijpds-4398	159	73	mks	mks	PROPN
ijpds-4398	159	74	0.28281	0.28281	NUM
ijpds-4398	159	75	0.2828	0.2828	NUM
ijpds-4398	159	76	inter	inter	ADJ
ijpds-4398	159	77	day	day	NOUN
ijpds-4398	159	78	precision	precision	NOUN
ijpds-4398	159	79	bse	bse	NOUN
ijpds-4398	159	80	0.57732	0.57732	NUM
ijpds-4398	159	81	0.83165	0.83165	NUM
ijpds-4398	159	82	mks	mks	NOUN
ijpds-4398	159	83	0.54582	0.54582	NUM
ijpds-4398	159	84	0.64584	0.64584	NUM
ijpds-4398	159	85	accuracy	accuracy	NOUN
ijpds-4398	159	86	study	study	NOUN
ijpds-4398	159	87	of	of	ADP
ijpds-4398	159	88	bse	bse	PROPN
ijpds-4398	159	89	and	and	CCONJ
ijpds-4398	159	90	mks	mks	PROPN
ijpds-4398	159	91	80	80	NUM
ijpds-4398	159	92	%	%	NOUN
ijpds-4398	159	93	bse	bse	NOUN
ijpds-4398	159	94	0.25236	0.25236	NUM
ijpds-4398	159	95	0.21612	0.21612	NUM
ijpds-4398	159	96	100	100	NUM
ijpds-4398	159	97	%	%	NOUN
ijpds-4398	159	98	0.28842	0.28842	NUM
ijpds-4398	159	99	0.24982	0.24982	NUM
ijpds-4398	159	100	120	120	NUM
ijpds-4398	159	101	%	%	NOUN
ijpds-4398	160	1	0.52218	0.52218	NUM
ijpds-4398	160	2	0.44192	0.44192	NUM
ijpds-4398	160	3	80	80	NUM
ijpds-4398	160	4	%	%	NOUN
ijpds-4398	160	5	mks	mks	NOUN
ijpds-4398	160	6	0.25123	0.25123	NUM
ijpds-4398	160	7	0.34451	0.34451	NUM
ijpds-4398	161	1	d	d	NOUN
ijpds-4398	161	2	kolekar	kolekar	PROPN
ijpds-4398	161	3	et	et	PROPN
ijpds-4398	161	4	al	al	PROPN
ijpds-4398	161	5	.	.	PROPN
ijpds-4398	162	1	chemometric	chemometric	PROPN
ijpds-4398	162	2	assisted	assist	VERB
ijpds-4398	162	3	qbd	qbd	NOUN
ijpds-4398	162	4	method	method	NOUN
ijpds-4398	162	5	for	for	ADP
ijpds-4398	162	6	estimation	estimation	NOUN
ijpds-4398	162	7	of	of	ADP
ijpds-4398	162	8	bilastine	bilastine	NOUN
ijpds-4398	162	9	and	and	CCONJ
ijpds-4398	162	10	montelukast	montelukast	NOUN
ijpds-4398	162	11	sodium	sodium	NOUN
ijpds-4398	162	12	vol	vol	NOUN
ijpds-4398	162	13	3	3	NUM
ijpds-4398	162	14	|	|	NOUN
ijpds-4398	162	15	issue	issue	VERB
ijpds-4398	162	16	1	1	NUM
ijpds-4398	163	1	|	|	ADV
ijpds-4398	163	2	jan	jan	PROPN
ijpds-4398	163	3	–	–	PUNCT
ijpds-4398	163	4	mar	mar	PROPN
ijpds-4398	163	5	2024	2024	NUM
ijpds-4398	164	1	indian	indian	PROPN
ijpds-4398	164	2	j	j	PROPN
ijpds-4398	164	3	pharm	pharm	PROPN
ijpds-4398	164	4	drug	drug	PROPN
ijpds-4398	164	5	studies	study	NOUN
ijpds-4398	164	6	|	|	ADV
ijpds-4398	164	7	21	21	NUM
ijpds-4398	164	8	100	100	NUM
ijpds-4398	164	9	%	%	NOUN
ijpds-4398	164	10	0.68602	0.68602	NUM
ijpds-4398	164	11	0.88492	0.88492	NUM
ijpds-4398	164	12	120	120	NUM
ijpds-4398	164	13	%	%	NOUN
ijpds-4398	164	14	1.25152	1.25152	NUM
ijpds-4398	164	15	1.81023	1.81023	NUM
ijpds-4398	164	16	table	table	NOUN
ijpds-4398	164	17	no.6	no.6	PROPN
ijpds-4398	164	18	:	:	PUNCT
ijpds-4398	164	19	results	result	NOUN
ijpds-4398	164	20	of	of	ADP
ijpds-4398	164	21	lod	lod	PROPN
ijpds-4398	164	22	and	and	CCONJ
ijpds-4398	164	23	loq	loq	PROPN
ijpds-4398	164	24	,	,	PUNCT
ijpds-4398	164	25	robustness	robustness	NOUN
ijpds-4398	164	26	parameters	parameter	NOUN
ijpds-4398	164	27	bse	bse	PROPN
ijpds-4398	164	28	mks	mks	PROPN
ijpds-4398	164	29	lod	lod	PROPN
ijpds-4398	164	30	μg	μg	PROPN
ijpds-4398	164	31	/	/	SYM
ijpds-4398	164	32	ml	ml	VERB
ijpds-4398	164	33	0.7253	0.7253	NUM
ijpds-4398	164	34	0.6726	0.6726	NUM
ijpds-4398	164	35	loq	loq	PROPN
ijpds-4398	164	36	μg	μg	PROPN
ijpds-4398	164	37	/	/	SYM
ijpds-4398	164	38	ml	ml	VERB
ijpds-4398	164	39	1.1761	1.1761	NUM
ijpds-4398	164	40	0.8458	0.8458	NUM
ijpds-4398	164	41	robustness	robustness	NOUN
ijpds-4398	164	42	(	(	PUNCT
ijpds-4398	164	43	conc	conc	X
ijpds-4398	164	44	20	20	NUM
ijpds-4398	164	45	bse	bse	NOUN
ijpds-4398	164	46	and	and	CCONJ
ijpds-4398	164	47	16	16	NUM
ijpds-4398	164	48	μg	μg	PROPN
ijpds-4398	164	49	/	/	SYM
ijpds-4398	164	50	ml	ml	X
ijpds-4398	164	51	mks	mks	PROPN
ijpds-4398	164	52	)	)	PUNCT
ijpds-4398	164	53	0.3724	0.3724	NUM
ijpds-4398	164	54	-to0.3973	-to0.3973	NOUN
ijpds-4398	164	55	(	(	PUNCT
ijpds-4398	164	56	±	±	NOUN
ijpds-4398	164	57	2	2	NUM
ijpds-4398	164	58	nm	nm	NOUN
ijpds-4398	164	59	)	)	PUNCT
ijpds-4398	164	60	0.5308	0.5308	NUM
ijpds-4398	164	61	-to0.5229	-to0.5229	PROPN
ijpds-4398	165	1	(	(	PUNCT
ijpds-4398	165	2	±	±	NOUN
ijpds-4398	165	3	2	2	NUM
ijpds-4398	165	4	nm	nm	NOUN
ijpds-4398	165	5	)	)	PUNCT
ijpds-4398	165	6	ruggedness	ruggedness	NOUN
ijpds-4398	165	7	analyst	analyst	NOUN
ijpds-4398	165	8	1	1	NUM
ijpds-4398	165	9	sd	sd	ADP
ijpds-4398	165	10	±	±	NUM
ijpds-4398	165	11	0.20681	0.20681	NUM
ijpds-4398	165	12	rsd	rsd	NOUN
ijpds-4398	165	13	±	±	NUM
ijpds-4398	165	14	3.53719	3.53719	NUM
ijpds-4398	165	15	sd	sd	ADP
ijpds-4398	165	16	±	±	NUM
ijpds-4398	165	17	0.64246	0.64246	NUM
ijpds-4398	165	18	rsd	rsd	PROPN
ijpds-4398	165	19	±	±	NUM
ijpds-4398	165	20	2.9893	2.9893	NUM
ijpds-4398	165	21	analyst	analyst	NOUN
ijpds-4398	165	22	2	2	NUM
ijpds-4398	165	23	sd	sd	ADP
ijpds-4398	165	24	±	±	NUM
ijpds-4398	165	25	0.20167	0.20167	NUM
ijpds-4398	165	26	rsd	rsd	PROPN
ijpds-4398	165	27	±	±	NUM
ijpds-4398	165	28	5.16971	5.16971	NUM
ijpds-4398	165	29	sd	sd	ADP
ijpds-4398	165	30	±	±	NUM
ijpds-4398	165	31	0.062412	0.062412	NUM
ijpds-4398	165	32	rsd	rsd	PROPN
ijpds-4398	165	33	±	±	NUM
ijpds-4398	165	34	2.55771	2.55771	NUM
ijpds-4398	165	35	conclusion	conclusion	NOUN
ijpds-4398	165	36	both	both	CCONJ
ijpds-4398	165	37	the	the	DET
ijpds-4398	165	38	drugs	drug	NOUN
ijpds-4398	165	39	were	be	AUX
ijpds-4398	165	40	estimated	estimate	VERB
ijpds-4398	165	41	from	from	ADP
ijpds-4398	165	42	their	their	PRON
ijpds-4398	165	43	combined	combine	VERB
ijpds-4398	165	44	formulation	formulation	NOUN
ijpds-4398	165	45	by	by	ADP
ijpds-4398	165	46	simultaneous	simultaneous	ADJ
ijpds-4398	165	47	equation	equation	NOUN
ijpds-4398	165	48	method	method	NOUN
ijpds-4398	165	49	.	.	PUNCT
ijpds-4398	166	1	results	result	NOUN
ijpds-4398	166	2	were	be	AUX
ijpds-4398	166	3	found	find	VERB
ijpds-4398	166	4	within	within	ADP
ijpds-4398	166	5	acceptable	acceptable	ADJ
ijpds-4398	166	6	limits	limit	NOUN
ijpds-4398	166	7	,	,	PUNCT
ijpds-4398	166	8	statistical	statistical	ADJ
ijpds-4398	166	9	data	datum	NOUN
ijpds-4398	166	10	obtained	obtain	VERB
ijpds-4398	166	11	were	be	AUX
ijpds-4398	166	12	shown	show	VERB
ijpds-4398	166	13	rigidity	rigidity	NOUN
ijpds-4398	166	14	of	of	ADP
ijpds-4398	166	15	the	the	DET
ijpds-4398	166	16	method	method	NOUN
ijpds-4398	166	17	.	.	PUNCT
ijpds-4398	167	1	the	the	DET
ijpds-4398	167	2	validated	validate	VERB
ijpds-4398	167	3	method	method	NOUN
ijpds-4398	167	4	was	be	AUX
ijpds-4398	167	5	employed	employ	VERB
ijpds-4398	167	6	50	50	NUM
ijpds-4398	167	7	%	%	NOUN
ijpds-4398	167	8	alcohol	alcohol	NOUN
ijpds-4398	167	9	as	as	SCONJ
ijpds-4398	167	10	solvent	solvent	NOUN
ijpds-4398	167	11	thus	thus	ADV
ijpds-4398	167	12	become	become	VERB
ijpds-4398	167	13	economical	economical	ADJ
ijpds-4398	167	14	.	.	PUNCT
ijpds-4398	168	1	the	the	DET
ijpds-4398	168	2	proposed	propose	VERB
ijpds-4398	168	3	method	method	NOUN
ijpds-4398	168	4	is	be	AUX
ijpds-4398	168	5	precise	precise	ADJ
ijpds-4398	168	6	,	,	PUNCT
ijpds-4398	168	7	accurate	accurate	ADJ
ijpds-4398	168	8	,	,	PUNCT
ijpds-4398	168	9	robust	robust	ADJ
ijpds-4398	168	10	and	and	CCONJ
ijpds-4398	168	11	reproducible	reproducible	ADJ
ijpds-4398	168	12	hence	hence	ADV
ijpds-4398	168	13	can	can	AUX
ijpds-4398	168	14	be	be	AUX
ijpds-4398	168	15	routinely	routinely	ADV
ijpds-4398	168	16	used	use	VERB
ijpds-4398	168	17	for	for	ADP
ijpds-4398	168	18	simultaneous	simultaneous	ADJ
ijpds-4398	168	19	estimation	estimation	NOUN
ijpds-4398	168	20	of	of	ADP
ijpds-4398	168	21	bilastine	bilastine	NOUN
ijpds-4398	168	22	and	and	CCONJ
ijpds-4398	168	23	montelukast	montelukast	NOUN
ijpds-4398	168	24	sodium	sodium	NOUN
ijpds-4398	168	25	from	from	ADP
ijpds-4398	168	26	combined	combine	VERB
ijpds-4398	168	27	dosage	dosage	NOUN
ijpds-4398	168	28	form	form	NOUN
ijpds-4398	168	29	acknowledgement	acknowledgement	NOUN
ijpds-4398	168	30	authors	author	NOUN
ijpds-4398	168	31	are	be	AUX
ijpds-4398	168	32	thankful	thankful	ADJ
ijpds-4398	168	33	to	to	ADP
ijpds-4398	168	34	glenmark	glenmark	ADJ
ijpds-4398	168	35	pharmaceuticals	pharmaceutical	NOUN
ijpds-4398	168	36	,	,	PUNCT
ijpds-4398	168	37	nashik	nashik	PROPN
ijpds-4398	168	38	,	,	PUNCT
ijpds-4398	168	39	maharashtra	maharashtra	PROPN
ijpds-4398	168	40	.	.	PUNCT
ijpds-4398	168	41	india	india	PROPN
ijpds-4398	168	42	for	for	ADP
ijpds-4398	168	43	providing	provide	VERB
ijpds-4398	168	44	drugs	drug	NOUN
ijpds-4398	168	45	as	as	ADP
ijpds-4398	168	46	gift	gift	NOUN
ijpds-4398	168	47	sample	sample	NOUN
ijpds-4398	168	48	and	and	CCONJ
ijpds-4398	168	49	management	management	NOUN
ijpds-4398	168	50	,	,	PUNCT
ijpds-4398	168	51	principal	principal	NOUN
ijpds-4398	168	52	of	of	ADP
ijpds-4398	168	53	svpm	svpm	NOUN
ijpds-4398	168	54	’s	’s	PART
ijpds-4398	168	55	college	college	NOUN
ijpds-4398	168	56	of	of	ADP
ijpds-4398	168	57	pharmacy	pharmacy	NOUN
ijpds-4398	168	58	malegaon	malegaon	PROPN
ijpds-4398	168	59	(	(	PUNCT
ijpds-4398	168	60	bkii),baramati	bkii),baramati	NOUN
ijpds-4398	168	61	dist	dist	NOUN
ijpds-4398	168	62	.	.	PUNCT
ijpds-4398	169	1	pune	pune	PROPN
ijpds-4398	169	2	,	,	PUNCT
ijpds-4398	169	3	maharashtra	maharashtra	PROPN
ijpds-4398	169	4	,	,	PUNCT
ijpds-4398	169	5	india	india	PROPN
ijpds-4398	169	6	for	for	ADP
ijpds-4398	169	7	providing	provide	VERB
ijpds-4398	169	8	necessary	necessary	ADJ
ijpds-4398	169	9	facilities	facility	NOUN
ijpds-4398	169	10	,	,	PUNCT
ijpds-4398	169	11	chemicals	chemical	NOUN
ijpds-4398	169	12	,	,	PUNCT
ijpds-4398	169	13	instruments	instrument	NOUN
ijpds-4398	169	14	etc	etc	X
ijpds-4398	169	15	.	.	X
ijpds-4398	169	16	for	for	ADP
ijpds-4398	169	17	research	research	NOUN
ijpds-4398	169	18	.	.	PUNCT
ijpds-4398	170	1	references	reference	NOUN
ijpds-4398	170	2	1	1	NUM
ijpds-4398	170	3	.	.	PUNCT
ijpds-4398	171	1	the	the	DET
ijpds-4398	171	2	merck	merck	PROPN
ijpds-4398	171	3	index	index	PROPN
ijpds-4398	171	4	.	.	PUNCT
ijpds-4398	172	1	an	an	DET
ijpds-4398	172	2	encyclopaedia	encyclopaedia	NOUN
ijpds-4398	172	3	of	of	ADP
ijpds-4398	172	4	chemicals	chemical	NOUN
ijpds-4398	172	5	,	,	PUNCT
ijpds-4398	172	6	drugs	drug	NOUN
ijpds-4398	172	7	and	and	CCONJ
ijpds-4398	172	8	biological	biological	ADJ
ijpds-4398	172	9	.	.	PUNCT
ijpds-4398	173	1	15th	15th	ADJ
ijpds-4398	173	2	ed	ed	NOUN
ijpds-4398	173	3	.	.	PUNCT
ijpds-4398	174	1	the	the	DET
ijpds-4398	174	2	royal	royal	ADJ
ijpds-4398	174	3	society	society	NOUN
ijpds-4398	174	4	of	of	ADP
ijpds-4398	174	5	chemistry	chemistry	PROPN
ijpds-4398	174	6	cambridge	cambridge	PROPN
ijpds-4398	174	7	uk	uk	PROPN
ijpds-4398	174	8	.	.	PROPN
ijpds-4398	174	9	2013	2013	NUM
ijpds-4398	174	10	.	.	PUNCT
ijpds-4398	175	1	p.	p.	NOUN
ijpds-4398	175	2	214	214	NUM
ijpds-4398	175	3	,	,	PUNCT
ijpds-4398	175	4	1164	1164	NUM
ijpds-4398	175	5	.	.	PUNCT
ijpds-4398	176	1	2	2	X
ijpds-4398	176	2	.	.	X
ijpds-4398	176	3	alison	alison	PROPN
ijpds-4398	176	4	brayfield	brayfield	PROPN
ijpds-4398	176	5	.	.	PUNCT
ijpds-4398	177	1	martindale	martindale	PROPN
ijpds-4398	177	2	(	(	PUNCT
ijpds-4398	177	3	the	the	DET
ijpds-4398	177	4	complete	complete	ADJ
ijpds-4398	177	5	drug	drug	NOUN
ijpds-4398	177	6	reference	reference	NOUN
ijpds-4398	177	7	)	)	PUNCT
ijpds-4398	177	8	.	.	PUNCT
ijpds-4398	178	1	39th	39th	ADJ
ijpds-4398	178	2	ed	ed	NOUN
ijpds-4398	178	3	.	.	PUNCT
ijpds-4398	178	4	pharmaceutical	pharmaceutical	PROPN
ijpds-4398	178	5	press	press	PROPN
ijpds-4398	178	6	london	london	PROPN
ijpds-4398	178	7	uk	uk	PROPN
ijpds-4398	178	8	.	.	PROPN
ijpds-4398	178	9	2017(a	2017(a	NUM
ijpds-4398	178	10	):	):	PUNCT
ijpds-4398	178	11	617	617	NUM
ijpds-4398	178	12	-	-	SYM
ijpds-4398	178	13	1214	1214	NUM
ijpds-4398	178	14	.	.	PUNCT
ijpds-4398	179	1	3	3	X
ijpds-4398	179	2	.	.	X
ijpds-4398	179	3	t	t	PROPN
ijpds-4398	179	4	anju	anju	PROPN
ijpds-4398	179	5	,	,	PUNCT
ijpds-4398	179	6	sk	sk	VERB
ijpds-4398	179	7	hakeema	hakeema	X
ijpds-4398	179	8	,	,	PUNCT
ijpds-4398	179	9	g	g	PROPN
ijpds-4398	179	10	divya	divya	PROPN
ijpds-4398	179	11	jyothi	jyothi	PROPN
ijpds-4398	179	12	,	,	PUNCT
ijpds-4398	179	13	et	et	PROPN
ijpds-4398	179	14	al	al	PROPN
ijpds-4398	179	15	.	.	PROPN
ijpds-4398	180	1	quantitative	quantitative	ADJ
ijpds-4398	180	2	determination	determination	NOUN
ijpds-4398	180	3	and	and	CCONJ
ijpds-4398	180	4	validation	validation	NOUN
ijpds-4398	180	5	of	of	ADP
ijpds-4398	180	6	bilastine	bilastine	NOUN
ijpds-4398	180	7	in	in	ADP
ijpds-4398	180	8	bulk	bulk	NOUN
ijpds-4398	180	9	and	and	CCONJ
ijpds-4398	180	10	pharmaceutical	pharmaceutical	ADJ
ijpds-4398	180	11	dosage	dosage	NOUN
ijpds-4398	180	12	form	form	NOUN
ijpds-4398	180	13	by	by	ADP
ijpds-4398	180	14	using	use	VERB
ijpds-4398	180	15	uv	uv	NOUN
ijpds-4398	180	16	-	-	PUNCT
ijpds-4398	180	17	spectroscopy	spectroscopy	NOUN
ijpds-4398	180	18	.	.	PUNCT
ijpds-4398	181	1	inter	inter	PROPN
ijpds-4398	181	2	j	j	PROPN
ijpds-4398	181	3	pharm	pharm	PROPN
ijpds-4398	181	4	and	and	CCONJ
ijpds-4398	181	5	pharma	pharma	PROPN
ijpds-4398	181	6	res	re	NOUN
ijpds-4398	181	7	.	.	PUNCT
ijpds-4398	182	1	2022;23(2):136	2022;23(2):136	NUM
ijpds-4398	182	2	-	-	PUNCT
ijpds-4398	182	3	146	146	NUM
ijpds-4398	182	4	.	.	NOUN
ijpds-4398	183	1	4	4	NUM
ijpds-4398	183	2	.	.	PUNCT
ijpds-4398	183	3	kuldip	kuldip	PROPN
ijpds-4398	183	4	makawana	makawana	PROPN
ijpds-4398	183	5	,	,	PUNCT
ijpds-4398	183	6	divya	divya	PROPN
ijpds-4398	183	7	patel	patel	PROPN
ijpds-4398	183	8	,	,	PUNCT
ijpds-4398	183	9	dhruv	dhruv	PROPN
ijpds-4398	183	10	thakor	thakor	PROPN
ijpds-4398	183	11	,	,	PUNCT
ijpds-4398	184	1	et	et	PROPN
ijpds-4398	184	2	al	al	PROPN
ijpds-4398	184	3	.	.	PUNCT
ijpds-4398	185	1	uv	uv	PROPN
ijpds-4398	185	2	spectrophotometric	spectrophotometric	VERB
ijpds-4398	185	3	method	method	NOUN
ijpds-4398	185	4	development	development	NOUN
ijpds-4398	185	5	and	and	CCONJ
ijpds-4398	185	6	validation	validation	NOUN
ijpds-4398	185	7	for	for	ADP
ijpds-4398	185	8	the	the	DET
ijpds-4398	185	9	estimation	estimation	NOUN
ijpds-4398	185	10	of	of	ADP
ijpds-4398	185	11	bilastine	bilastine	NOUN
ijpds-4398	185	12	in	in	ADP
ijpds-4398	185	13	pharmaceutical	pharmaceutical	ADJ
ijpds-4398	185	14	dosage	dosage	NOUN
ijpds-4398	185	15	form	form	NOUN
ijpds-4398	185	16	.	.	PUNCT
ijpds-4398	186	1	inter	inter	PROPN
ijpds-4398	186	2	j	j	PROPN
ijpds-4398	186	3	res	re	VERB
ijpds-4398	186	4	pub	pub	NOUN
ijpds-4398	186	5	and	and	CCONJ
ijpds-4398	186	6	rev	rev	VERB
ijpds-4398	186	7	.	.	PROPN
ijpds-4398	186	8	2022;3(3):1286	2022;3(3):1286	NUM
ijpds-4398	186	9	-	-	SYM
ijpds-4398	186	10	1295	1295	NUM
ijpds-4398	186	11	.	.	PUNCT
ijpds-4398	187	1	5	5	NUM
ijpds-4398	187	2	.	.	X
ijpds-4398	187	3	os	os	PROPN
ijpds-4398	187	4	supe	supe	PROPN
ijpds-4398	187	5	,	,	PUNCT
ijpds-4398	187	6	mm	mm	PROPN
ijpds-4398	187	7	maste	maste	NOUN
ijpds-4398	187	8	,	,	PUNCT
ijpds-4398	187	9	ss	ss	PROPN
ijpds-4398	187	10	suryawanshi	suryawanshi	NOUN
ijpds-4398	187	11	,	,	PUNCT
ijpds-4398	187	12	et	et	PROPN
ijpds-4398	187	13	al	al	PROPN
ijpds-4398	187	14	.	.	PUNCT
ijpds-4398	187	15	development	development	NOUN
ijpds-4398	187	16	and	and	CCONJ
ijpds-4398	187	17	standardization	standardization	NOUN
ijpds-4398	187	18	of	of	ADP
ijpds-4398	187	19	stability	stability	NOUN
ijpds-4398	187	20	indicating	indicate	VERB
ijpds-4398	187	21	uv	uv	NOUN
ijpds-4398	187	22	spectrophotometric	spectrophotometric	ADJ
ijpds-4398	187	23	method	method	NOUN
ijpds-4398	187	24	for	for	ADP
ijpds-4398	187	25	assessment	assessment	NOUN
ijpds-4398	187	26	of	of	ADP
ijpds-4398	187	27	bilastine	bilastine	NOUN
ijpds-4398	187	28	in	in	ADP
ijpds-4398	187	29	bulk	bulk	NOUN
ijpds-4398	187	30	and	and	CCONJ
ijpds-4398	187	31	pharmaceutical	pharmaceutical	ADJ
ijpds-4398	187	32	dosage	dosage	NOUN
ijpds-4398	187	33	formulation	formulation	NOUN
ijpds-4398	187	34	.	.	PUNCT
ijpds-4398	188	1	inter	inter	PROPN
ijpds-4398	188	2	j	j	PROPN
ijpds-4398	188	3	pharma	pharma	PROPN
ijpds-4398	188	4	sci	sci	PROPN
ijpds-4398	188	5	and	and	CCONJ
ijpds-4398	188	6	res	re	NOUN
ijpds-4398	188	7	.	.	PUNCT
ijpds-4398	189	1	2021;13(2):962968	2021;13(2):962968	NUM
ijpds-4398	189	2	.	.	PUNCT
ijpds-4398	190	1	6	6	NUM
ijpds-4398	190	2	.	.	X
ijpds-4398	190	3	andressa	andressa	PROPN
ijpds-4398	190	4	tassinari	tassinari	PROPN
ijpds-4398	190	5	dasilva	dasilva	PROPN
ijpds-4398	190	6	,	,	PUNCT
ijpds-4398	190	7	gabriela	gabriela	PROPN
ijpds-4398	190	8	rossi	rossi	PROPN
ijpds-4398	190	9	brabo	brabo	PROPN
ijpds-4398	190	10	,	,	PUNCT
ijpds-4398	190	11	isadora	isadora	PROPN
ijpds-4398	190	12	dias	dias	PROPN
ijpds-4398	190	13	marques	marques	PROPN
ijpds-4398	190	14	,	,	PUNCT
ijpds-4398	190	15	et	et	PROPN
ijpds-4398	190	16	al	al	PROPN
ijpds-4398	190	17	.	.	PUNCT
ijpds-4398	191	1	uv	uv	PROPN
ijpds-4398	191	2	spectrophotometric	spectrophotometric	ADJ
ijpds-4398	191	3	method	method	NOUN
ijpds-4398	191	4	for	for	ADP
ijpds-4398	191	5	quantitative	quantitative	ADJ
ijpds-4398	191	6	determination	determination	NOUN
ijpds-4398	191	7	of	of	ADP
ijpds-4398	191	8	bilastine	bilastine	NOUN
ijpds-4398	191	9	using	use	VERB
ijpds-4398	191	10	experimental	experimental	ADJ
ijpds-4398	191	11	design	design	NOUN
ijpds-4398	191	12	for	for	ADP
ijpds-4398	191	13	robustness	robustness	NOUN
ijpds-4398	191	14	.	.	PUNCT
ijpds-4398	192	1	drug	drug	NOUN
ijpds-4398	192	2	analytical	analytical	ADJ
ijpds-4398	192	3	research	research	NOUN
ijpds-4398	192	4	.	.	PUNCT
ijpds-4398	193	1	2017;1(2):38	2017;1(2):38	NUM
ijpds-4398	193	2	-	-	SYM
ijpds-4398	193	3	43	43	NUM
ijpds-4398	193	4	.	.	PUNCT
ijpds-4398	194	1	7	7	X
ijpds-4398	194	2	.	.	X
ijpds-4398	194	3	r	r	PROPN
ijpds-4398	194	4	mohan	mohan	PROPN
ijpds-4398	194	5	raj	raj	PROPN
ijpds-4398	194	6	,	,	PUNCT
ijpds-4398	194	7	ask	ask	NOUN
ijpds-4398	194	8	sankar	sankar	NOUN
ijpds-4398	194	9	,	,	PUNCT
ijpds-4398	194	10	t	t	PROPN
ijpds-4398	194	11	vetrichelvan	vetrichelvan	PROPN
ijpds-4398	194	12	.	.	PUNCT
ijpds-4398	195	1	analytical	analytical	ADJ
ijpds-4398	195	2	method	method	NOUN
ijpds-4398	195	3	development	development	NOUN
ijpds-4398	195	4	and	and	CCONJ
ijpds-4398	195	5	validation	validation	NOUN
ijpds-4398	195	6	for	for	ADP
ijpds-4398	195	7	simultaneous	simultaneous	ADJ
ijpds-4398	195	8	estimation	estimation	NOUN
ijpds-4398	195	9	of	of	ADP
ijpds-4398	195	10	bilastine	bilastine	NOUN
ijpds-4398	195	11	and	and	CCONJ
ijpds-4398	195	12	montelukast	montelukast	NOUN
ijpds-4398	195	13	sodium	sodium	NOUN
ijpds-4398	195	14	by	by	ADP
ijpds-4398	195	15	uv	uv	NOUN
ijpds-4398	195	16	spectrophotometry	spectrophotometry	NOUN
ijpds-4398	195	17	.	.	PUNCT
ijpds-4398	196	1	world	world	PROPN
ijpds-4398	196	2	j	j	PROPN
ijpds-4398	196	3	pharm	pharm	PROPN
ijpds-4398	196	4	pharma	pharma	PROPN
ijpds-4398	196	5	sci	sci	PROPN
ijpds-4398	196	6	.	.	PUNCT
ijpds-4398	197	1	2010;10(1):680	2010;10(1):680	NUM
ijpds-4398	197	2	-	-	NUM
ijpds-4398	197	3	687	687	NUM
ijpds-4398	197	4	.	.	PUNCT
ijpds-4398	198	1	8	8	NUM
ijpds-4398	198	2	.	.	PUNCT
ijpds-4398	198	3	riya	riya	PROPN
ijpds-4398	198	4	mistry	mistry	PROPN
ijpds-4398	198	5	,	,	PUNCT
ijpds-4398	198	6	rajashree	rajashree	PROPN
ijpds-4398	198	7	mashru	mashru	NOUN
ijpds-4398	198	8	.	.	PUNCT
ijpds-4398	199	1	analytical	analytical	ADJ
ijpds-4398	199	2	method	method	NOUN
ijpds-4398	199	3	development	development	NOUN
ijpds-4398	199	4	and	and	CCONJ
ijpds-4398	199	5	validation	validation	NOUN
ijpds-4398	199	6	for	for	ADP
ijpds-4398	199	7	simultaneous	simultaneous	ADJ
ijpds-4398	199	8	estimation	estimation	NOUN
ijpds-4398	199	9	of	of	ADP
ijpds-4398	199	10	bilastine	bilastine	NOUN
ijpds-4398	199	11	and	and	CCONJ
ijpds-4398	199	12	montelukast	montelukast	NOUN
ijpds-4398	199	13	sodium	sodium	NOUN
ijpds-4398	199	14	in	in	ADP
ijpds-4398	199	15	their	their	PRON
ijpds-4398	199	16	combined	combine	VERB
ijpds-4398	199	17	dosage	dosage	NOUN
ijpds-4398	199	18	form	form	NOUN
ijpds-4398	199	19	by	by	ADP
ijpds-4398	199	20	derivative	derivative	ADJ
ijpds-4398	199	21	uv	uv	NOUN
ijpds-4398	199	22	-	-	PUNCT
ijpds-4398	199	23	spectroscopy	spectroscopy	NOUN
ijpds-4398	199	24	and	and	CCONJ
ijpds-4398	199	25	rphplc	rphplc	NOUN
ijpds-4398	199	26	method	method	NOUN
ijpds-4398	199	27	.	.	PUNCT
ijpds-4398	200	1	inter	inter	PROPN
ijpds-4398	200	2	j	j	PROPN
ijpds-4398	200	3	pharma	pharma	PROPN
ijpds-4398	200	4	res	re	VERB
ijpds-4398	200	5	health	health	PROPN
ijpds-4398	200	6	sci	sci	PROPN
ijpds-4398	200	7	,	,	PUNCT
ijpds-4398	200	8	2021;9(3):3313	2021;9(3):3313	PROPN
ijpds-4398	200	9	-	-	SYM
ijpds-4398	200	10	3318	3318	NUM
ijpds-4398	200	11	.	.	PUNCT
ijpds-4398	201	1	9	9	X
ijpds-4398	201	2	.	.	X
ijpds-4398	201	3	syed	syed	PROPN
ijpds-4398	201	4	nizamuddin	nizamuddin	PROPN
ijpds-4398	201	5	,	,	PUNCT
ijpds-4398	201	6	s	s	VERB
ijpds-4398	201	7	appala	appala	PROPN
ijpds-4398	201	8	raju	raju	PROPN
ijpds-4398	201	9	.	.	PUNCT
ijpds-4398	202	1	development	development	NOUN
ijpds-4398	202	2	and	and	CCONJ
ijpds-4398	202	3	validation	validation	NOUN
ijpds-4398	202	4	rp	rp	NOUN
ijpds-4398	202	5	-	-	PUNCT
ijpds-4398	202	6	hplc	hplc	NOUN
ijpds-4398	202	7	method	method	NOUN
ijpds-4398	202	8	for	for	ADP
ijpds-4398	202	9	simultaneous	simultaneous	ADJ
ijpds-4398	202	10	estimation	estimation	NOUN
ijpds-4398	202	11	of	of	ADP
ijpds-4398	202	12	bilastine	bilastine	NOUN
ijpds-4398	202	13	and	and	CCONJ
ijpds-4398	202	14	montelukast	montelukast	NOUN
ijpds-4398	202	15	in	in	ADP
ijpds-4398	202	16	bulk	bulk	NOUN
ijpds-4398	202	17	and	and	CCONJ
ijpds-4398	202	18	pharmaceutical	pharmaceutical	NOUN
ijpds-4398	202	19	dosage	dosage	NOUN
ijpds-4398	202	20	.	.	PUNCT
ijpds-4398	203	1	asian	asian	PROPN
ijpds-4398	203	2	pacific	pacific	PROPN
ijpds-4398	203	3	j	j	PROPN
ijpds-4398	203	4	health	health	PROPN
ijpds-4398	203	5	sci.2022;9(3):242	sci.2022;9(3):242	PROPN
ijpds-4398	203	6	-	-	PUNCT
ijpds-4398	203	7	247	247	NUM
ijpds-4398	203	8	.	.	PUNCT
ijpds-4398	203	9	10	10	NUM
ijpds-4398	203	10	.	.	PUNCT
ijpds-4398	204	1	narmada	narmada	PROPN
ijpds-4398	204	2	vallakeerthi	vallakeerthi	PROPN
ijpds-4398	204	3	,	,	PUNCT
ijpds-4398	204	4	rachala	rachala	PROPN
ijpds-4398	204	5	swetha	swetha	PROPN
ijpds-4398	204	6	,	,	PUNCT
ijpds-4398	204	7	t	t	PROPN
ijpds-4398	204	8	tejaswi	tejaswi	PROPN
ijpds-4398	204	9	,	,	PUNCT
ijpds-4398	204	10	et	et	PROPN
ijpds-4398	204	11	al	al	PROPN
ijpds-4398	204	12	.	.	PROPN
ijpds-4398	204	13	development	development	PROPN
ijpds-4398	204	14	and	and	CCONJ
ijpds-4398	204	15	validation	validation	NOUN
ijpds-4398	204	16	of	of	ADP
ijpds-4398	204	17	rp	rp	NOUN
ijpds-4398	204	18	hplc	hplc	NOUN
ijpds-4398	204	19	method	method	NOUN
ijpds-4398	204	20	for	for	ADP
ijpds-4398	204	21	the	the	DET
ijpds-4398	204	22	simultaneous	simultaneous	ADJ
ijpds-4398	204	23	estimation	estimation	NOUN
ijpds-4398	204	24	of	of	ADP
ijpds-4398	204	25	bilastine	bilastine	NOUN
ijpds-4398	204	26	and	and	CCONJ
ijpds-4398	204	27	montelukast	montelukast	NOUN
ijpds-4398	204	28	in	in	ADP
ijpds-4398	204	29	tablet	tablet	ADJ
ijpds-4398	204	30	dosage	dosage	NOUN
ijpds-4398	204	31	form	form	NOUN
ijpds-4398	204	32	.	.	PUNCT
ijpds-4398	205	1	chem	chem	NOUN
ijpds-4398	205	2	sci	sci	PROPN
ijpds-4398	205	3	inter	inter	PROPN
ijpds-4398	205	4	j.	j.	PROPN
ijpds-4398	205	5	2023;32(3):52	2023;32(3):52	PROPN
ijpds-4398	205	6	-	-	PUNCT
ijpds-4398	205	7	61	61	NUM
ijpds-4398	205	8	.	.	PUNCT
ijpds-4398	205	9	11	11	NUM
ijpds-4398	205	10	.	.	PUNCT
ijpds-4398	206	1	bagul	bagul	PROPN
ijpds-4398	206	2	rashmi	rashmi	PROPN
ijpds-4398	206	3	arun	arun	PROPN
ijpds-4398	206	4	,	,	PUNCT
ijpds-4398	206	5	gosavi	gosavi	PROPN
ijpds-4398	206	6	seema	seema	PROPN
ijpds-4398	206	7	.	.	PUNCT
ijpds-4398	207	1	a	a	DET
ijpds-4398	207	2	research	research	NOUN
ijpds-4398	207	3	article	article	NOUN
ijpds-4398	207	4	on	on	ADP
ijpds-4398	207	5	analytical	analytical	ADJ
ijpds-4398	207	6	method	method	NOUN
ijpds-4398	207	7	development	development	NOUN
ijpds-4398	207	8	and	and	CCONJ
ijpds-4398	207	9	validation	validation	NOUN
ijpds-4398	207	10	of	of	ADP
ijpds-4398	207	11	antihistamine	antihistamine	PROPN
ijpds-4398	207	12	drugs	drug	NOUN
ijpds-4398	207	13	bilastine	bilastine	VERB
ijpds-4398	207	14	and	and	CCONJ
ijpds-4398	207	15	montelukast	montelukast	NOUN
ijpds-4398	207	16	sodium	sodium	NOUN
ijpds-4398	207	17	by	by	ADP
ijpds-4398	207	18	rp	rp	NOUN
ijpds-4398	207	19	-	-	PUNCT
ijpds-4398	207	20	hplc	hplc	NOUN
ijpds-4398	207	21	and	and	CCONJ
ijpds-4398	207	22	uv	uv	NOUN
ijpds-4398	207	23	spectrophotometric	spectrophotometric	ADJ
ijpds-4398	207	24	method	method	NOUN
ijpds-4398	207	25	.	.	PUNCT
ijpds-4398	208	1	inter	inter	PROPN
ijpds-4398	208	2	j	j	PROPN
ijpds-4398	208	3	pharma	pharma	PROPN
ijpds-4398	208	4	res	re	NOUN
ijpds-4398	208	5	applications	application	NOUN
ijpds-4398	208	6	.	.	PUNCT
ijpds-4398	209	1	2022;7(6):539	2022;7(6):539	X
ijpds-4398	209	2	-	-	SYM
ijpds-4398	209	3	550	550	NUM
ijpds-4398	209	4	.	.	PUNCT
ijpds-4398	210	1	12	12	NUM
ijpds-4398	210	2	.	.	PUNCT
ijpds-4398	211	1	swati	swati	PROPN
ijpds-4398	211	2	m	m	PROPN
ijpds-4398	211	3	andhale	andhale	PROPN
ijpds-4398	211	4	a	a	PRON
ijpds-4398	211	5	,	,	PUNCT
ijpds-4398	211	6	anna	anna	PROPN
ijpds-4398	211	7	pratima	pratima	PROPN
ijpds-4398	211	8	g	g	PROPN
ijpds-4398	211	9	nikalje	nikalje	PROPN
ijpds-4398	211	10	b.	b.	PROPN
ijpds-4398	211	11	simultaneous	simultaneous	ADJ
ijpds-4398	211	12	estimation	estimation	NOUN
ijpds-4398	211	13	of	of	ADP
ijpds-4398	211	14	bilastine	bilastine	NOUN
ijpds-4398	211	15	and	and	CCONJ
ijpds-4398	211	16	montelukast	montelukast	NOUN
ijpds-4398	211	17	in	in	ADP
ijpds-4398	211	18	bulk	bulk	NOUN
ijpds-4398	211	19	by	by	ADP
ijpds-4398	211	20	rp	rp	NOUN
ijpds-4398	211	21	-	-	PUNCT
ijpds-4398	211	22	hplc	hplc	NOUN
ijpds-4398	211	23	and	and	CCONJ
ijpds-4398	211	24	assessment	assessment	NOUN
ijpds-4398	211	25	of	of	ADP
ijpds-4398	211	26	its	its	PRON
ijpds-4398	211	27	applicability	applicability	NOUN
ijpds-4398	211	28	in	in	ADP
ijpds-4398	211	29	marketed	market	VERB
ijpds-4398	211	30	tablet	tablet	NOUN
ijpds-4398	211	31	dosage	dosage	NOUN
ijpds-4398	211	32	form	form	NOUN
ijpds-4398	211	33	.	.	PUNCT
ijpds-4398	212	1	j	j	PROPN
ijpds-4398	212	2	pharma	pharma	PROPN
ijpds-4398	212	3	res	re	VERB
ijpds-4398	212	4	inter	inter	ADJ
ijpds-4398	212	5	.	.	PUNCT
ijpds-4398	213	1	2022;34(3b):8	2022;34(3b):8	NUM
ijpds-4398	213	2	-	-	SYM
ijpds-4398	213	3	25	25	NUM
ijpds-4398	213	4	.	.	NOUN
ijpds-4398	213	5	13	13	NUM
ijpds-4398	213	6	.	.	PUNCT
ijpds-4398	214	1	aejaz	aejaz	PROPN
ijpds-4398	214	2	ahmed	ahmed	PROPN
ijpds-4398	214	3	,	,	PUNCT
ijpds-4398	214	4	et	et	PROPN
ijpds-4398	214	5	al	al	PROPN
ijpds-4398	214	6	.	.	PUNCT
ijpds-4398	214	7	development	development	NOUN
ijpds-4398	214	8	of	of	ADP
ijpds-4398	214	9	rp	rp	NOUN
ijpds-4398	214	10	-	-	PUNCT
ijpds-4398	214	11	hplc	hplc	NOUN
ijpds-4398	214	12	method	method	NOUN
ijpds-4398	214	13	for	for	ADP
ijpds-4398	214	14	simultaneous	simultaneous	ADJ
ijpds-4398	214	15	determination	determination	NOUN
ijpds-4398	214	16	of	of	ADP
ijpds-4398	214	17	bilastine	bilastine	NOUN
ijpds-4398	214	18	and	and	CCONJ
ijpds-4398	214	19	montelukast	montelukast	NOUN
ijpds-4398	214	20	by	by	ADP
ijpds-4398	214	21	qbd	qbd	NOUN
ijpds-4398	214	22	approach	approach	NOUN
ijpds-4398	214	23	and	and	CCONJ
ijpds-4398	214	24	its	its	PRON
ijpds-4398	214	25	validation	validation	NOUN
ijpds-4398	214	26	.	.	PUNCT
ijpds-4398	215	1	inter	inter	PROPN
ijpds-4398	215	2	j	j	PROPN
ijpds-4398	215	3	life	life	NOUN
ijpds-4398	215	4	sci	sci	PROPN
ijpds-4398	215	5	pharma	pharma	PROPN
ijpds-4398	215	6	res	re	NOUN
ijpds-4398	215	7	.	.	PUNCT
ijpds-4398	216	1	2023;13(5):199	2023;13(5):199	NUM
ijpds-4398	216	2	-	-	SYM
ijpds-4398	216	3	220	220	NUM
ijpds-4398	216	4	.	.	PUNCT
ijpds-4398	216	5	14	14	NUM
ijpds-4398	216	6	.	.	PUNCT
ijpds-4398	217	1	chandra	chandra	PROPN
ijpds-4398	217	2	umesh	umesh	PROPN
ijpds-4398	217	3	,	,	PUNCT
ijpds-4398	217	4	kumar	kumar	PROPN
ijpds-4398	217	5	manish	manish	PROPN
ijpds-4398	217	6	,	,	PUNCT
ijpds-4398	217	7	sharma	sharma	PROPN
ijpds-4398	217	8	shrestha	shrestha	PROPN
ijpds-4398	217	9	,	,	PUNCT
ijpds-4398	217	10	et	et	PROPN
ijpds-4398	217	11	al	al	PROPN
ijpds-4398	217	12	.	.	PUNCT
ijpds-4398	218	1	new	new	ADJ
ijpds-4398	218	2	rp	rp	NOUN
ijpds-4398	218	3	-	-	PUNCT
ijpds-4398	218	4	hplc	hplc	NOUN
ijpds-4398	218	5	assay	assay	NOUN
ijpds-4398	218	6	method	method	NOUN
ijpds-4398	218	7	development	development	NOUN
ijpds-4398	218	8	and	and	CCONJ
ijpds-4398	218	9	validation	validation	NOUN
ijpds-4398	218	10	for	for	ADP
ijpds-4398	218	11	simultaneous	simultaneous	ADJ
ijpds-4398	218	12	quantitation	quantitation	NOUN
ijpds-4398	218	13	of	of	ADP
ijpds-4398	218	14	bilastine	bilastine	NOUN
ijpds-4398	218	15	and	and	CCONJ
ijpds-4398	218	16	montelukast	montelukast	NOUN
ijpds-4398	218	17	in	in	ADP
ijpds-4398	218	18	bulk	bulk	NOUN
ijpds-4398	218	19	and	and	CCONJ
ijpds-4398	218	20	tablet	tablet	ADJ
ijpds-4398	218	21	dosage	dosage	NOUN
ijpds-4398	218	22	form	form	NOUN
ijpds-4398	218	23	.	.	PUNCT
ijpds-4398	219	1	inter	inter	PROPN
ijpds-4398	219	2	j	j	PROPN
ijpds-4398	219	3	curr	curr	PROPN
ijpds-4398	219	4	res	res	PROPN
ijpds-4398	219	5	rev	rev	PROPN
ijpds-4398	219	6	.	.	PROPN
ijpds-4398	220	1	2021;13(10	2021;13(10	NUM
ijpds-4398	220	2	):	):	PUNCT
ijpds-4398	220	3	179	179	NUM
ijpds-4398	220	4	-	-	SYM
ijpds-4398	220	5	188	188	NUM
ijpds-4398	220	6	.	.	PUNCT
ijpds-4398	221	1	15	15	NUM
ijpds-4398	221	2	.	.	PUNCT
ijpds-4398	222	1	peethala	peethala	PROPN
ijpds-4398	222	2	prathyusha	prathyusha	PROPN
ijpds-4398	222	3	,	,	PUNCT
ijpds-4398	222	4	raja	raja	PROPN
ijpds-4398	222	5	sundararajan	sundararajan	PROPN
ijpds-4398	222	6	,	,	PUNCT
ijpds-4398	222	7	palyam	palyam	NOUN
ijpds-4398	222	8	bhanu	bhanu	PROPN
ijpds-4398	222	9	,	,	PUNCT
ijpds-4398	222	10	et	et	PROPN
ijpds-4398	222	11	al	al	PROPN
ijpds-4398	222	12	.	.	PUNCT
ijpds-4398	223	1	a	a	DET
ijpds-4398	223	2	new	new	ADJ
ijpds-4398	223	3	stability	stability	NOUN
ijpds-4398	223	4	indicating	indicate	VERB
ijpds-4398	223	5	rp	rp	NOUN
ijpds-4398	223	6	-	-	PUNCT
ijpds-4398	223	7	hplc	hplc	NOUN
ijpds-4398	223	8	method	method	NOUN
ijpds-4398	223	9	for	for	ADP
ijpds-4398	223	10	determination	determination	NOUN
ijpds-4398	223	11	of	of	ADP
ijpds-4398	223	12	bilastine	bilastine	NOUN
ijpds-4398	223	13	in	in	ADP
ijpds-4398	223	14	bulk	bulk	ADJ
ijpds-4398	223	15	and	and	CCONJ
ijpds-4398	223	16	pharmaceutical	pharmaceutical	NOUN
ijpds-4398	223	17	formulation	formulation	NOUN
ijpds-4398	223	18	.	.	PUNCT
ijpds-4398	224	1	res	re	NOUN
ijpds-4398	224	2	j	j	PROPN
ijpds-4398	224	3	pharm	pharm	PROPN
ijpds-4398	224	4	tech	tech	NOUN
ijpds-4398	224	5	.	.	PUNCT
ijpds-4398	225	1	2020;13(6):2849	2020;13(6):2849	NUM
ijpds-4398	225	2	-	-	SYM
ijpds-4398	225	3	2853	2853	NUM
ijpds-4398	225	4	.	.	PUNCT
ijpds-4398	226	1	16	16	NUM
ijpds-4398	226	2	.	.	PUNCT
ijpds-4398	227	1	paulo	paulo	PROPN
ijpds-4398	227	2	roberto	roberto	PROPN
ijpds-4398	227	3	rodrigues	rodrigues	PROPN
ijpds-4398	227	4	martini	martini	PROPN
ijpds-4398	227	5	,	,	PUNCT
ijpds-4398	227	6	et	et	PROPN
ijpds-4398	227	7	al	al	PROPN
ijpds-4398	227	8	.	.	PROPN
ijpds-4398	227	9	bilastine	bilastine	PROPN
ijpds-4398	227	10	:	:	PUNCT
ijpds-4398	227	11	stabilityindicating	stabilityindicate	VERB
ijpds-4398	227	12	a	a	DET
ijpds-4398	227	13	method	method	NOUN
ijpds-4398	227	14	using	use	VERB
ijpds-4398	227	15	environmentally	environmentally	ADV
ijpds-4398	227	16	friendly	friendly	ADJ
ijpds-4398	227	17	by	by	ADP
ijpds-4398	227	18	reversedphase	reversedphase	NOUN
ijpds-4398	227	19	high	high	ADJ
ijpds-4398	227	20	-	-	PUNCT
ijpds-4398	227	21	performance	performance	NOUN
ijpds-4398	227	22	liquid	liquid	ADJ
ijpds-4398	227	23	chromatography	chromatography	NOUN
ijpds-4398	227	24	(	(	PUNCT
ijpds-4398	227	25	rp	rp	NOUN
ijpds-4398	227	26	-	-	PUNCT
ijpds-4398	227	27	hplc	hplc	NOUN
ijpds-4398	227	28	)	)	PUNCT
ijpds-4398	227	29	.	.	PUNCT
ijpds-4398	228	1	drug	drug	NOUN
ijpds-4398	228	2	analytical	analytical	ADJ
ijpds-4398	228	3	res	re	NOUN
ijpds-4398	228	4	.	.	PUNCT
ijpds-4398	229	1	2022;6(n1):13	2022;6(n1):13	NUM
ijpds-4398	229	2	-	-	SYM
ijpds-4398	229	3	20	20	NUM
ijpds-4398	229	4	.	.	PUNCT
ijpds-4398	230	1	d	d	NOUN
ijpds-4398	230	2	kolekar	kolekar	PROPN
ijpds-4398	230	3	et	et	PROPN
ijpds-4398	230	4	al	al	PROPN
ijpds-4398	230	5	.	.	PROPN
ijpds-4398	231	1	chemometric	chemometric	PROPN
ijpds-4398	232	1	assisted	assist	VERB
ijpds-4398	233	1	qbd	qbd	NOUN
ijpds-4398	233	2	method	method	NOUN
ijpds-4398	233	3	for	for	ADP
ijpds-4398	233	4	estimation	estimation	NOUN
ijpds-4398	233	5	of	of	ADP
ijpds-4398	233	6	bilastine	bilastine	NOUN
ijpds-4398	233	7	and	and	CCONJ
ijpds-4398	233	8	montelukast	montelukast	NOUN
ijpds-4398	233	9	sodium	sodium	NOUN
ijpds-4398	233	10	vol	vol	NOUN
ijpds-4398	233	11	3	3	NUM
ijpds-4398	233	12	|	|	NOUN
ijpds-4398	233	13	issue	issue	VERB
ijpds-4398	233	14	1	1	NUM
ijpds-4398	234	1	|	|	ADV
ijpds-4398	234	2	jan	jan	PROPN
ijpds-4398	234	3	–	–	PUNCT
ijpds-4398	234	4	mar	mar	PROPN
ijpds-4398	234	5	2024	2024	NUM
ijpds-4398	235	1	indian	indian	PROPN
ijpds-4398	235	2	j	j	PROPN
ijpds-4398	235	3	pharm	pharm	PROPN
ijpds-4398	235	4	drug	drug	PROPN
ijpds-4398	235	5	studies	study	NOUN
ijpds-4398	235	6	|	|	ADV
ijpds-4398	235	7	22	22	NUM
ijpds-4398	235	8	17	17	NUM
ijpds-4398	235	9	.	.	PUNCT
ijpds-4398	236	1	chetan	chetan	PROPN
ijpds-4398	236	2	vilasrao	vilasrao	PROPN
ijpds-4398	236	3	patil	patil	PROPN
ijpds-4398	236	4	,	,	PUNCT
ijpds-4398	236	5	shabnam	shabnam	PROPN
ijpds-4398	236	6	khan	khan	PROPN
ijpds-4398	236	7	,	,	PUNCT
ijpds-4398	236	8	ramakant	ramakant	PROPN
ijpds-4398	236	9	sharma	sharma	PROPN
ijpds-4398	236	10	,	,	PUNCT
ijpds-4398	236	11	et	et	PROPN
ijpds-4398	236	12	al	al	PROPN
ijpds-4398	236	13	.	.	PROPN
ijpds-4398	236	14	stability	stability	PROPN
ijpds-4398	236	15	indicating	indicate	VERB
ijpds-4398	236	16	rp	rp	NOUN
ijpds-4398	236	17	-	-	PUNCT
ijpds-4398	236	18	hplc	hplc	NOUN
ijpds-4398	236	19	method	method	NOUN
ijpds-4398	236	20	development	development	NOUN
ijpds-4398	236	21	and	and	CCONJ
ijpds-4398	236	22	validation	validation	NOUN
ijpds-4398	236	23	for	for	ADP
ijpds-4398	236	24	simultaneous	simultaneous	ADJ
ijpds-4398	236	25	estimation	estimation	NOUN
ijpds-4398	236	26	of	of	ADP
ijpds-4398	236	27	bilastine	bilastine	NOUN
ijpds-4398	236	28	and	and	CCONJ
ijpds-4398	236	29	montelukast	montelukast	NOUN
ijpds-4398	236	30	in	in	ADP
ijpds-4398	236	31	bulk	bulk	NOUN
ijpds-4398	236	32	and	and	CCONJ
ijpds-4398	236	33	tablet	tablet	ADJ
ijpds-4398	236	34	dosage	dosage	NOUN
ijpds-4398	236	35	form	form	NOUN
ijpds-4398	236	36	.	.	PUNCT
ijpds-4398	237	1	inter	inter	PROPN
ijpds-4398	237	2	j	j	PROPN
ijpds-4398	237	3	pharma	pharma	PROPN
ijpds-4398	237	4	sci	sci	PROPN
ijpds-4398	237	5	med	med	PROPN
ijpds-4398	237	6	.	.	PUNCT
ijpds-4398	238	1	2023;8(3):132149	2023;8(3):132149	X
ijpds-4398	238	2	.	.	PROPN
ijpds-4398	238	3	18	18	NUM
ijpds-4398	238	4	.	.	PUNCT
ijpds-4398	238	5	aya	aya	PROPN
ijpds-4398	238	6	roshdy	roshdy	PROPN
ijpds-4398	238	7	,	,	PUNCT
ijpds-4398	238	8	randa	randa	PROPN
ijpds-4398	238	9	abdel	abdel	PROPN
ijpds-4398	238	10	salam	salam	PROPN
ijpds-4398	238	11	,	,	PUNCT
ijpds-4398	238	12	ghada	ghada	PROPN
ijpds-4398	238	13	hadad	hadad	PROPN
ijpds-4398	238	14	et	et	PROPN
ijpds-4398	238	15	al	al	PROPN
ijpds-4398	238	16	.	.	PROPN
ijpds-4398	238	17	green	green	ADJ
ijpds-4398	238	18	quality	quality	NOUN
ijpds-4398	238	19	by	by	ADP
ijpds-4398	238	20	design	design	NOUN
ijpds-4398	238	21	hplc	hplc	NOUN
ijpds-4398	238	22	approach	approach	NOUN
ijpds-4398	238	23	for	for	ADP
ijpds-4398	238	24	the	the	DET
ijpds-4398	238	25	simultaneous	simultaneous	ADJ
ijpds-4398	238	26	determination	determination	NOUN
ijpds-4398	238	27	of	of	ADP
ijpds-4398	238	28	bilastine	bilastine	NOUN
ijpds-4398	238	29	and	and	CCONJ
ijpds-4398	238	30	montelukast	montelukast	NOUN
ijpds-4398	238	31	.	.	PUNCT
ijpds-4398	239	1	bmc	bmc	ADJ
ijpds-4398	239	2	chemistry	chemistry	NOUN
ijpds-4398	239	3	.	.	PUNCT
ijpds-4398	240	1	2023;17(43):1	2023;17(43):1	NUM
ijpds-4398	240	2	-	-	SYM
ijpds-4398	240	3	23	23	NUM
ijpds-4398	240	4	.	.	PUNCT
ijpds-4398	241	1	19	19	NUM
ijpds-4398	241	2	.	.	PUNCT
ijpds-4398	241	3	shital	shital	PROPN
ijpds-4398	241	4	patel	patel	PROPN
ijpds-4398	241	5	,	,	PUNCT
ijpds-4398	241	6	t	t	PROPN
ijpds-4398	241	7	yunus	yunus	PROPN
ijpds-4398	241	8	pasha	pasha	PROPN
ijpds-4398	241	9	.	.	PUNCT
ijpds-4398	242	1	stability	stability	NOUN
ijpds-4398	242	2	indicating	indicate	VERB
ijpds-4398	242	3	isocratic	isocratic	ADJ
ijpds-4398	242	4	hplc	hplc	NOUN
ijpds-4398	242	5	method	method	NOUN
ijpds-4398	242	6	for	for	ADP
ijpds-4398	242	7	bilastine	bilastine	NOUN
ijpds-4398	242	8	and	and	CCONJ
ijpds-4398	242	9	characterization	characterization	NOUN
ijpds-4398	242	10	of	of	ADP
ijpds-4398	242	11	forced	force	VERB
ijpds-4398	242	12	degradation	degradation	NOUN
ijpds-4398	242	13	products	product	NOUN
ijpds-4398	242	14	by	by	ADP
ijpds-4398	242	15	lc	lc	PROPN
ijpds-4398	242	16	-	-	PUNCT
ijpds-4398	242	17	ms	ms	PROPN
ijpds-4398	242	18	/	/	SYM
ijpds-4398	242	19	ms	ms	PROPN
ijpds-4398	242	20	.	.	PROPN
ijpds-4398	242	21	inter	inter	PROPN
ijpds-4398	242	22	j	j	PROPN
ijpds-4398	242	23	life	life	NOUN
ijpds-4398	242	24	sci	sci	PROPN
ijpds-4398	242	25	pharma	pharma	PROPN
ijpds-4398	242	26	res	re	NOUN
ijpds-4398	242	27	.	.	PROPN
ijpds-4398	242	28	2022	2022	NUM
ijpds-4398	242	29	;	;	PUNCT
ijpds-4398	242	30	13(1):83	13(1):83	NUM
ijpds-4398	242	31	-	-	SYM
ijpds-4398	242	32	93	93	NUM
ijpds-4398	242	33	.	.	PUNCT
ijpds-4398	243	1	20	20	NUM
ijpds-4398	243	2	.	.	PUNCT
ijpds-4398	244	1	shaista	shaista	PROPN
ijpds-4398	244	2	firdous	firdous	PROPN
ijpds-4398	244	3	,	,	PUNCT
ijpds-4398	244	4	sh	sh	PROPN
ijpds-4398	244	5	rizwan	rizwan	PROPN
ijpds-4398	244	6	.	.	PUNCT
ijpds-4398	245	1	development	development	NOUN
ijpds-4398	245	2	and	and	CCONJ
ijpds-4398	245	3	validation	validation	NOUN
ijpds-4398	245	4	of	of	ADP
ijpds-4398	245	5	stability	stability	NOUN
ijpds-4398	245	6	indicating	indicate	VERB
ijpds-4398	245	7	uplc	uplc	ADJ
ijpds-4398	245	8	method	method	NOUN
ijpds-4398	245	9	for	for	ADP
ijpds-4398	245	10	the	the	DET
ijpds-4398	245	11	estimation	estimation	NOUN
ijpds-4398	245	12	of	of	ADP
ijpds-4398	245	13	bilastine	bilastine	NOUN
ijpds-4398	245	14	in	in	ADP
ijpds-4398	245	15	bulk	bulk	NOUN
ijpds-4398	245	16	and	and	CCONJ
ijpds-4398	245	17	pharmaceutical	pharmaceutical	ADJ
ijpds-4398	245	18	dosage	dosage	NOUN
ijpds-4398	245	19	form	form	NOUN
ijpds-4398	245	20	,	,	PUNCT
ijpds-4398	245	21	inter	inter	PROPN
ijpds-4398	245	22	j	j	PROPN
ijpds-4398	245	23	pharm	pharm	PROPN
ijpds-4398	245	24	sci	sci	PROPN
ijpds-4398	245	25	rev	rev	PROPN
ijpds-4398	245	26	res	re	NOUN
ijpds-4398	245	27	.	.	PUNCT
ijpds-4398	246	1	2020;65(1):131	2020;65(1):131	NUM
ijpds-4398	246	2	-	-	SYM
ijpds-4398	246	3	135	135	NUM
ijpds-4398	246	4	.	.	PUNCT
ijpds-4398	247	1	21	21	NUM
ijpds-4398	247	2	.	.	PUNCT
ijpds-4398	247	3	lingareddygari	lingareddygari	PROPN
ijpds-4398	247	4	sr	sr	PROPN
ijpds-4398	247	5	,	,	PUNCT
ijpds-4398	247	6	ravikrindhi	ravikrindhi	PROPN
ijpds-4398	247	7	nr	nr	PROPN
ijpds-4398	247	8	,	,	PUNCT
ijpds-4398	247	9	beludari	beludari	PROPN
ijpds-4398	247	10	i	i	PRON
ijpds-4398	247	11	m	m	PROPN
ijpds-4398	247	12	,	,	PUNCT
ijpds-4398	247	13	et	et	PROPN
ijpds-4398	247	14	al	al	PROPN
ijpds-4398	247	15	.	.	PUNCT
ijpds-4398	248	1	design	design	NOUN
ijpds-4398	248	2	of	of	ADP
ijpds-4398	248	3	experiments	experiment	NOUN
ijpds-4398	248	4	approach	approach	VERB
ijpds-4398	248	5	for	for	ADP
ijpds-4398	248	6	method	method	NOUN
ijpds-4398	248	7	development	development	NOUN
ijpds-4398	248	8	and	and	CCONJ
ijpds-4398	248	9	validation	validation	NOUN
ijpds-4398	248	10	of	of	ADP
ijpds-4398	248	11	bilastine	bilastine	NOUN
ijpds-4398	248	12	in	in	ADP
ijpds-4398	248	13	pure	pure	ADJ
ijpds-4398	248	14	and	and	CCONJ
ijpds-4398	248	15	pharmaceutical	pharmaceutical	ADJ
ijpds-4398	248	16	dosage	dosage	NOUN
ijpds-4398	248	17	form	form	NOUN
ijpds-4398	248	18	using	use	VERB
ijpds-4398	248	19	rpuflc	rpuflc	PROPN
ijpds-4398	248	20	.	.	PUNCT
ijpds-4398	249	1	orient	orient	PROPN
ijpds-4398	249	2	j	j	PROPN
ijpds-4398	249	3	chem	chem	NOUN
ijpds-4398	249	4	.	.	PUNCT
ijpds-4398	250	1	2023;39(3):736	2023;39(3):736	NUM
ijpds-4398	250	2	-	-	SYM
ijpds-4398	250	3	745	745	NUM
ijpds-4398	250	4	.	.	PUNCT
ijpds-4398	251	1	22	22	NUM
ijpds-4398	251	2	.	.	PUNCT
ijpds-4398	252	1	kuldeep	kuldeep	PROPN
ijpds-4398	252	2	singh	singh	PROPN
ijpds-4398	252	3	,	,	PUNCT
ijpds-4398	252	4	et	et	PROPN
ijpds-4398	252	5	al	al	PROPN
ijpds-4398	252	6	.	.	PROPN
ijpds-4398	252	7	validated	validate	VERB
ijpds-4398	252	8	uv	uv	NOUN
ijpds-4398	252	9	spectroscopic	spectroscopic	NOUN
ijpds-4398	252	10	method	method	NOUN
ijpds-4398	252	11	for	for	ADP
ijpds-4398	252	12	estimation	estimation	NOUN
ijpds-4398	252	13	of	of	ADP
ijpds-4398	252	14	montelukast	montelukast	NOUN
ijpds-4398	252	15	sodium	sodium	NOUN
ijpds-4398	252	16	.	.	PUNCT
ijpds-4398	253	1	inter	inter	PROPN
ijpds-4398	253	2	j	j	PROPN
ijpds-4398	253	3	pharma	pharma	PROPN
ijpds-4398	253	4	sci	sci	PROPN
ijpds-4398	253	5	res	re	NOUN
ijpds-4398	253	6	.	.	PROPN
ijpds-4398	253	7	2015	2015	NUM
ijpds-4398	253	8	;	;	PUNCT
ijpds-4398	253	9	6(11):4728	6(11):4728	NOUN
ijpds-4398	253	10	-	-	NOUN
ijpds-4398	253	11	4732	4732	NUM
ijpds-4398	253	12	.	.	PUNCT
ijpds-4398	254	1	23	23	NUM
ijpds-4398	254	2	.	.	PUNCT
ijpds-4398	255	1	shanmukha	shanmukha	PROPN
ijpds-4398	255	2	kumar	kumar	PROPN
ijpds-4398	255	3	jv	jv	PROPN
ijpds-4398	255	4	,	,	PUNCT
ijpds-4398	255	5	geeta	geeta	PROPN
ijpds-4398	255	6	swarupa	swarupa	PROPN
ijpds-4398	255	7	p	p	PROPN
ijpds-4398	255	8	,	,	PUNCT
ijpds-4398	255	9	vardhan	vardhan	PROPN
ijpds-4398	255	10	svm	svm	PROPN
ijpds-4398	255	11	,	,	PUNCT
ijpds-4398	255	12	ramachandran	ramachandran	PROPN
ijpds-4398	255	13	.	.	PUNCT
ijpds-4398	256	1	d2	d2	PROPN
ijpds-4398	256	2	spectrophotometric	spectrophotometric	ADJ
ijpds-4398	256	3	determination	determination	NOUN
ijpds-4398	256	4	of	of	ADP
ijpds-4398	256	5	montelukast	montelukast	NOUN
ijpds-4398	256	6	sodium	sodium	NOUN
ijpds-4398	256	7	in	in	ADP
ijpds-4398	256	8	bulk	bulk	ADJ
ijpds-4398	256	9	and	and	CCONJ
ijpds-4398	256	10	pharmaceutical	pharmaceutical	NOUN
ijpds-4398	256	11	formulations	formulation	NOUN
ijpds-4398	256	12	scholars	scholar	NOUN
ijpds-4398	256	13	res	re	NOUN
ijpds-4398	256	14	library	library	ADJ
ijpds-4398	256	15	der	der	NOUN
ijpds-4398	256	16	pharma	pharma	PROPN
ijpds-4398	256	17	chem	chem	NOUN
ijpds-4398	256	18	.	.	PUNCT
ijpds-4398	257	1	2012;4(2):720	2012;4(2):720	X
ijpds-4398	257	2	-	-	SYM
ijpds-4398	257	3	724	724	NUM
ijpds-4398	257	4	.	.	PUNCT
ijpds-4398	258	1	24	24	NUM
ijpds-4398	258	2	.	.	PUNCT
ijpds-4398	259	1	k	k	PROPN
ijpds-4398	259	2	pallavi	pallavi	PROPN
ijpds-4398	259	3	,	,	PUNCT
ijpds-4398	259	4	p	p	PROPN
ijpds-4398	259	5	srinivasa	srinivasa	PROPN
ijpds-4398	259	6	babu	babu	PROPN
ijpds-4398	259	7	.	.	PUNCT
ijpds-4398	260	1	validated	validate	VERB
ijpds-4398	260	2	uv	uv	NOUN
ijpds-4398	260	3	spectroscopic	spectroscopic	NOUN
ijpds-4398	260	4	method	method	NOUN
ijpds-4398	260	5	for	for	ADP
ijpds-4398	260	6	estimation	estimation	NOUN
ijpds-4398	260	7	of	of	ADP
ijpds-4398	260	8	montelukast	montelukast	NOUN
ijpds-4398	260	9	sodium	sodium	NOUN
ijpds-4398	260	10	from	from	ADP
ijpds-4398	260	11	bulk	bulk	ADJ
ijpds-4398	260	12	and	and	CCONJ
ijpds-4398	260	13	tablet	tablet	NOUN
ijpds-4398	260	14	formulations	formulation	NOUN
ijpds-4398	260	15	,	,	PUNCT
ijpds-4398	260	16	inter	inter	PROPN
ijpds-4398	260	17	j	j	PROPN
ijpds-4398	260	18	adv	adv	PROPN
ijpds-4398	260	19	pharm	pharm	PROPN
ijpds-4398	260	20	bio	bio	PROPN
ijpds-4398	260	21	chem	chem	PROPN
ijpds-4398	260	22	.	.	PUNCT
ijpds-4398	261	1	2012;1(4	2012;1(4	NUM
ijpds-4398	261	2	):	):	PUNCT
ijpds-4398	262	1	450	450	NUM
ijpds-4398	262	2	-	-	SYM
ijpds-4398	262	3	453	453	NUM
ijpds-4398	262	4	.	.	NUM
ijpds-4398	263	1	25	25	NUM
ijpds-4398	263	2	.	.	PUNCT
ijpds-4398	263	3	meenu	meenu	PROPN
ijpds-4398	263	4	chaudhary	chaudhary	PROPN
ijpds-4398	263	5	,	,	PUNCT
ijpds-4398	263	6	praveen	praveen	PROPN
ijpds-4398	263	7	kumar	kumar	PROPN
ijpds-4398	263	8	,	,	PUNCT
ijpds-4398	263	9	divya	divya	PROPN
ijpds-4398	263	10	thapliy	thapliy	PROPN
ijpds-4398	263	11	.	.	PUNCT
ijpds-4398	264	1	analytical	analytical	ADJ
ijpds-4398	264	2	method	method	NOUN
ijpds-4398	264	3	development	development	NOUN
ijpds-4398	264	4	and	and	CCONJ
ijpds-4398	264	5	validation	validation	NOUN
ijpds-4398	264	6	for	for	ADP
ijpds-4398	264	7	determination	determination	NOUN
ijpds-4398	264	8	of	of	ADP
ijpds-4398	264	9	montelukast	montelukast	NOUN
ijpds-4398	264	10	by	by	ADP
ijpds-4398	264	11	uv	uv	NOUN
ijpds-4398	264	12	-	-	PUNCT
ijpds-4398	264	13	spectroscopy	spectroscopy	NOUN
ijpds-4398	264	14	in	in	ADP
ijpds-4398	264	15	api	api	NOUN
ijpds-4398	264	16	&	&	CCONJ
ijpds-4398	264	17	in	in	ADP
ijpds-4398	264	18	pharmaceutical	pharmaceutical	ADJ
ijpds-4398	264	19	dosage	dosage	NOUN
ijpds-4398	264	20	forms	form	NOUN
ijpds-4398	264	21	.	.	PUNCT
ijpds-4398	265	1	intern	intern	PROPN
ijpds-4398	265	2	j	j	PROPN
ijpds-4398	265	3	pharm	pharm	PROPN
ijpds-4398	265	4	bio	bio	PROPN
ijpds-4398	265	5	sci	sci	PROPN
ijpds-4398	265	6	.	.	PUNCT
ijpds-4398	266	1	2018;8(4):482	2018;8(4):482	X
ijpds-4398	266	2	-	-	SYM
ijpds-4398	266	3	487	487	NUM
ijpds-4398	266	4	.	.	NOUN
ijpds-4398	267	1	26	26	NUM
ijpds-4398	267	2	.	.	PUNCT
ijpds-4398	268	1	dlivan	dlivan	PROPN
ijpds-4398	268	2	fattah	fattah	PROPN
ijpds-4398	268	3	aziz	aziz	PROPN
ijpds-4398	268	4	,	,	PUNCT
ijpds-4398	268	5	yehia	yehia	PROPN
ijpds-4398	268	6	ismail	ismail	PROPN
ijpds-4398	268	7	khalil	khalil	PROPN
ijpds-4398	268	8	.	.	PUNCT
ijpds-4398	269	1	newly	newly	ADV
ijpds-4398	269	2	simple	simple	ADJ
ijpds-4398	269	3	quantitative	quantitative	ADJ
ijpds-4398	269	4	determination	determination	NOUN
ijpds-4398	269	5	of	of	ADP
ijpds-4398	269	6	montelukast	montelukast	NOUN
ijpds-4398	269	7	sodium	sodium	NOUN
ijpds-4398	269	8	by	by	ADP
ijpds-4398	269	9	ultraviolet	ultraviolet	NOUN
ijpds-4398	269	10	-	-	PUNCT
ijpds-4398	269	11	spectrophotometry	spectrophotometry	NOUN
ijpds-4398	269	12	.	.	PUNCT
ijpds-4398	270	1	j	j	PROPN
ijpds-4398	270	2	sci	sci	PROPN
ijpds-4398	270	3	tech	tech	NOUN
ijpds-4398	270	4	.	.	PUNCT
ijpds-4398	271	1	2022;6(2):24	2022;6(2):24	NUM
ijpds-4398	271	2	-	-	SYM
ijpds-4398	271	3	28	28	NUM
ijpds-4398	271	4	.	.	PUNCT
ijpds-4398	272	1	27	27	NUM
ijpds-4398	272	2	.	.	PUNCT
ijpds-4398	273	1	kumar	kumar	PROPN
ijpds-4398	273	2	raja	raja	PROPN
ijpds-4398	273	3	jayavarapu	jayavarapu	PROPN
ijpds-4398	273	4	,	,	PUNCT
ijpds-4398	273	5	et	et	PROPN
ijpds-4398	273	6	al	al	PROPN
ijpds-4398	273	7	.	.	PROPN
ijpds-4398	273	8	accurate	accurate	ADJ
ijpds-4398	273	9	and	and	CCONJ
ijpds-4398	273	10	simple	simple	ADJ
ijpds-4398	273	11	uv	uv	NOUN
ijpds-4398	273	12	-	-	PUNCT
ijpds-4398	273	13	vis	vis	X
ijpds-4398	273	14	spectroscopic	spectroscopic	NOUN
ijpds-4398	273	15	method	method	NOUN
ijpds-4398	273	16	for	for	ADP
ijpds-4398	273	17	the	the	DET
ijpds-4398	273	18	estimation	estimation	NOUN
ijpds-4398	273	19	of	of	ADP
ijpds-4398	273	20	montelukast	montelukast	NOUN
ijpds-4398	273	21	sodium	sodium	NOUN
ijpds-4398	273	22	in	in	ADP
ijpds-4398	273	23	pure	pure	ADJ
ijpds-4398	273	24	and	and	CCONJ
ijpds-4398	273	25	marketed	market	VERB
ijpds-4398	273	26	formulations	formulation	NOUN
ijpds-4398	273	27	.	.	PUNCT
ijpds-4398	274	1	j	j	PROPN
ijpds-4398	274	2	glob	glob	PROPN
ijpds-4398	274	3	trnd	trnd	PROPN
ijpds-4398	274	4	pharma	pharma	PROPN
ijpds-4398	274	5	sci	sci	PROPN
ijpds-4398	274	6	.	.	PROPN
ijpds-4398	274	7	2017;8(2):3994	2017;8(2):3994	NUM
ijpds-4398	274	8	-	-	SYM
ijpds-4398	274	9	3997	3997	NUM
ijpds-4398	274	10	.	.	PUNCT
ijpds-4398	275	1	28	28	NUM
ijpds-4398	275	2	.	.	PUNCT
ijpds-4398	276	1	selvadurai	selvadurai	PROPN
ijpds-4398	276	2	muralidharan	muralidharan	PROPN
ijpds-4398	276	3	,	,	PUNCT
ijpds-4398	276	4	et	et	PROPN
ijpds-4398	276	5	al	al	PROPN
ijpds-4398	276	6	.	.	PUNCT
ijpds-4398	276	7	newly	newly	ADV
ijpds-4398	276	8	developed	developed	ADJ
ijpds-4398	276	9	and	and	CCONJ
ijpds-4398	276	10	validated	validated	ADJ
ijpds-4398	276	11	method	method	NOUN
ijpds-4398	276	12	of	of	ADP
ijpds-4398	276	13	montelukast	montelukast	NOUN
ijpds-4398	276	14	sodium	sodium	NOUN
ijpds-4398	276	15	estimation	estimation	NOUN
ijpds-4398	276	16	in	in	ADP
ijpds-4398	276	17	tablet	tablet	ADJ
ijpds-4398	276	18	dosage	dosage	NOUN
ijpds-4398	276	19	form	form	NOUN
ijpds-4398	276	20	by	by	ADP
ijpds-4398	276	21	ultraviolet	ultraviolet	ADJ
ijpds-4398	276	22	spectroscopy	spectroscopy	NOUN
ijpds-4398	276	23	and	and	CCONJ
ijpds-4398	276	24	reverse	reverse	ADJ
ijpds-4398	276	25	phase	phase	NOUN
ijpds-4398	276	26	-	-	PUNCT
ijpds-4398	276	27	high	high	ADJ
ijpds-4398	276	28	performance	performance	NOUN
ijpds-4398	276	29	liquid	liquid	NOUN
ijpds-4398	276	30	chromatography	chromatography	NOUN
ijpds-4398	276	31	.	.	PUNCT
ijpds-4398	277	1	ptb	ptb	PROPN
ijpds-4398	277	2	reports	report	VERB
ijpds-4398	277	3	.	.	PUNCT
ijpds-4398	278	1	2016;2(2	2016;2(2	NUM
ijpds-4398	278	2	):	):	PUNCT
ijpds-4398	278	3	27	27	NUM
ijpds-4398	278	4	-	-	SYM
ijpds-4398	278	5	30	30	NUM
ijpds-4398	278	6	.	.	PUNCT
ijpds-4398	279	1	29	29	NUM
ijpds-4398	279	2	.	.	PUNCT
ijpds-4398	280	1	nitin	nitin	PROPN
ijpds-4398	280	2	kumar	kumar	PROPN
ijpds-4398	280	3	patel	patel	PROPN
ijpds-4398	280	4	,	,	PUNCT
ijpds-4398	280	5	pradeep	pradeep	PROPN
ijpds-4398	280	6	chouhan	chouhan	PROPN
ijpds-4398	280	7	,	,	PUNCT
ijpds-4398	280	8	suresh	suresh	PROPN
ijpds-4398	280	9	kumar	kumar	PROPN
ijpds-4398	280	10	paswan	paswan	PROPN
ijpds-4398	280	11	,	,	PUNCT
ijpds-4398	280	12	et	et	PROPN
ijpds-4398	280	13	al	al	PROPN
ijpds-4398	280	14	.	.	PROPN
ijpds-4398	280	15	development	development	PROPN
ijpds-4398	280	16	and	and	CCONJ
ijpds-4398	280	17	validation	validation	NOUN
ijpds-4398	280	18	of	of	ADP
ijpds-4398	280	19	a	a	DET
ijpds-4398	280	20	uv	uv	NOUN
ijpds-4398	280	21	spectrophotometric	spectrophotometric	ADJ
ijpds-4398	280	22	method	method	NOUN
ijpds-4398	280	23	for	for	ADP
ijpds-4398	280	24	simultaneous	simultaneous	ADJ
ijpds-4398	280	25	estimation	estimation	NOUN
ijpds-4398	280	26	of	of	ADP
ijpds-4398	280	27	combination	combination	NOUN
ijpds-4398	280	28	of	of	ADP
ijpds-4398	280	29	montelukast	montelukast	NOUN
ijpds-4398	280	30	sodium	sodium	NOUN
ijpds-4398	280	31	in	in	ADP
ijpds-4398	280	32	presence	presence	NOUN
ijpds-4398	280	33	of	of	ADP
ijpds-4398	280	34	levocetirizine	levocetirizine	ADJ
ijpds-4398	280	35	dihydrochloride	dihydrochloride	NOUN
ijpds-4398	280	36	.	.	PUNCT
ijpds-4398	281	1	scholars	scholar	NOUN
ijpds-4398	281	2	res	res	PROPN
ijpds-4398	281	3	lib	lib	PROPN
ijpds-4398	281	4	der	der	NOUN
ijpds-4398	281	5	pharmacia	pharmacia	PROPN
ijpds-4398	281	6	lettre	lettre	PROPN
ijpds-4398	281	7	.	.	PUNCT
ijpds-4398	282	1	2014;6	2014;6	PRON
ijpds-4398	282	2	(	(	PUNCT
ijpds-4398	282	3	3):313	3):313	NUM
ijpds-4398	282	4	-	-	SYM
ijpds-4398	282	5	321	321	NUM
ijpds-4398	282	6	.	.	PUNCT
ijpds-4398	282	7	30	30	NUM
ijpds-4398	282	8	.	.	PUNCT
ijpds-4398	283	1	pinkal	pinkal	NOUN
ijpds-4398	283	2	p	p	PROPN
ijpds-4398	283	3	,	,	PUNCT
ijpds-4398	283	4	zinal	zinal	PROPN
ijpds-4398	283	5	ap	ap	PROPN
ijpds-4398	283	6	,	,	PUNCT
ijpds-4398	283	7	sweta	sweta	PROPN
ijpds-4398	283	8	p	p	X
ijpds-4398	283	9	,	,	PUNCT
ijpds-4398	283	10	et	et	PROPN
ijpds-4398	283	11	al	al	PROPN
ijpds-4398	283	12	.	.	PROPN
ijpds-4398	284	1	spectrophotometric	spectrophotometric	ADJ
ijpds-4398	284	2	absorption	absorption	NOUN
ijpds-4398	284	3	correction	correction	NOUN
ijpds-4398	284	4	for	for	ADP
ijpds-4398	284	5	the	the	DET
ijpds-4398	284	6	method	method	ADJ
ijpds-4398	284	7	simultaneous	simultaneous	ADJ
ijpds-4398	284	8	estimation	estimation	NOUN
ijpds-4398	284	9	of	of	ADP
ijpds-4398	284	10	montelukast	montelukast	NOUN
ijpds-4398	284	11	sodium	sodium	NOUN
ijpds-4398	284	12	and	and	CCONJ
ijpds-4398	284	13	bilastine	bilastine	VERB
ijpds-4398	284	14	in	in	ADP
ijpds-4398	284	15	tablet	tablet	ADJ
ijpds-4398	284	16	dosage	dosage	NOUN
ijpds-4398	284	17	form	form	NOUN
ijpds-4398	284	18	,	,	PUNCT
ijpds-4398	284	19	inter	inter	PROPN
ijpds-4398	284	20	j	j	PROPN
ijpds-4398	284	21	educ	educ	PROPN
ijpds-4398	284	22	app	app	PROPN
ijpds-4398	284	23	sci	sci	PROPN
ijpds-4398	284	24	.	.	PUNCT
ijpds-4398	285	1	2022;9(2):20	2022;9(2):20	NUM
ijpds-4398	285	2	-	-	SYM
ijpds-4398	285	3	28	28	NUM
ijpds-4398	285	4	.	.	PUNCT
ijpds-4398	286	1	31	31	NUM
ijpds-4398	286	2	.	.	PUNCT
ijpds-4398	287	1	mandeep	mandeep	PROPN
ijpds-4398	287	2	yadav	yadav	PROPN
ijpds-4398	287	3	,	,	PUNCT
ijpds-4398	287	4	ravi	ravi	PROPN
ijpds-4398	287	5	kant	kant	PROPN
ijpds-4398	287	6	,	,	PUNCT
ijpds-4398	287	7	sonia	sonia	PROPN
ijpds-4398	287	8	yadav	yadav	PROPN
ijpds-4398	287	9	,	,	PUNCT
ijpds-4398	287	10	et	et	PROPN
ijpds-4398	287	11	al	al	PROPN
ijpds-4398	287	12	.	.	PROPN
ijpds-4398	287	13	analytical	analytical	ADJ
ijpds-4398	287	14	method	method	NOUN
ijpds-4398	287	15	development	development	NOUN
ijpds-4398	287	16	and	and	CCONJ
ijpds-4398	287	17	validation	validation	NOUN
ijpds-4398	287	18	by	by	ADP
ijpds-4398	287	19	simultaneous	simultaneous	ADJ
ijpds-4398	287	20	estimation	estimation	NOUN
ijpds-4398	287	21	of	of	ADP
ijpds-4398	287	22	montelukast	montelukast	NOUN
ijpds-4398	287	23	sodium	sodium	NOUN
ijpds-4398	287	24	and	and	CCONJ
ijpds-4398	287	25	bilastine	bilastine	VERB
ijpds-4398	287	26	by	by	ADP
ijpds-4398	287	27	uv	uv	NOUN
ijpds-4398	287	28	spectrophotometry	spectrophotometry	NOUN
ijpds-4398	287	29	.	.	PUNCT
ijpds-4398	288	1	eur	eur	PROPN
ijpds-4398	288	2	chem	chem	NOUN
ijpds-4398	288	3	bull	bull	NOUN
ijpds-4398	288	4	section	section	NOUN
ijpds-4398	288	5	a	a	DET
ijpds-4398	288	6	-	-	PUNCT
ijpds-4398	288	7	res	res	NOUN
ijpds-4398	288	8	paper	paper	NOUN
ijpds-4398	288	9	.	.	PUNCT
ijpds-4398	289	1	2023;12(10):2082	2023;12(10):2082	NUM
ijpds-4398	289	2	–	–	PUNCT
ijpds-4398	289	3	208	208	NUM
ijpds-4398	289	4	.	.	X
ijpds-4398	290	1	32	32	NUM
ijpds-4398	290	2	.	.	PUNCT
ijpds-4398	291	1	detroja	detroja	PROPN
ijpds-4398	291	2	k	k	PROPN
ijpds-4398	291	3	,	,	PUNCT
ijpds-4398	291	4	h	h	PROPN
ijpds-4398	291	5	vekaria	vekaria	NOUN
ijpds-4398	291	6	.	.	PUNCT
ijpds-4398	292	1	advanced	advanced	ADJ
ijpds-4398	292	2	derivative	derivative	ADJ
ijpds-4398	292	3	spectroscopic	spectroscopic	NOUN
ijpds-4398	292	4	method	method	NOUN
ijpds-4398	292	5	for	for	ADP
ijpds-4398	292	6	estimation	estimation	NOUN
ijpds-4398	292	7	of	of	ADP
ijpds-4398	292	8	montelukast	montelukast	NOUN
ijpds-4398	292	9	and	and	CCONJ
ijpds-4398	292	10	bilastine	bilastine	VERB
ijpds-4398	292	11	in	in	ADP
ijpds-4398	292	12	their	their	PRON
ijpds-4398	292	13	tablet	tablet	ADJ
ijpds-4398	292	14	dosage	dosage	NOUN
ijpds-4398	292	15	form	form	NOUN
ijpds-4398	292	16	.	.	PUNCT
ijpds-4398	293	1	inter	inter	PROPN
ijpds-4398	293	2	j	j	PROPN
ijpds-4398	293	3	pharma	pharma	PROPN
ijpds-4398	293	4	sci	sci	PROPN
ijpds-4398	293	5	drug	drug	NOUN
ijpds-4398	293	6	res	re	NOUN
ijpds-4398	293	7	.	.	PUNCT
ijpds-4398	294	1	2021;13(3	2021;13(3	NUM
ijpds-4398	294	2	):	):	PUNCT
ijpds-4398	294	3	268	268	NUM
ijpds-4398	294	4	-	-	SYM
ijpds-4398	294	5	274	274	NUM
ijpds-4398	294	6	.	.	PUNCT
ijpds-4398	295	1	33	33	NUM
ijpds-4398	295	2	.	.	PUNCT
ijpds-4398	296	1	jignesh	jignesh	PROPN
ijpds-4398	296	2	maniya	maniya	PROPN
ijpds-4398	296	3	,	,	PUNCT
ijpds-4398	296	4	hasumati	hasumati	PROPN
ijpds-4398	296	5	raj	raj	PROPN
ijpds-4398	296	6	,	,	PUNCT
ijpds-4398	296	7	hasmukh	hasmukh	PROPN
ijpds-4398	296	8	vaghani	vaghani	PROPN
ijpds-4398	296	9	,	,	PUNCT
ijpds-4398	296	10	et	et	PROPN
ijpds-4398	296	11	al	al	PROPN
ijpds-4398	296	12	.	.	PROPN
ijpds-4398	296	13	development	development	PROPN
ijpds-4398	296	14	and	and	CCONJ
ijpds-4398	296	15	validation	validation	NOUN
ijpds-4398	296	16	of	of	ADP
ijpds-4398	296	17	spectroscopic	spectroscopic	ADJ
ijpds-4398	296	18	method	method	NOUN
ijpds-4398	296	19	for	for	ADP
ijpds-4398	296	20	simultaneous	simultaneous	ADJ
ijpds-4398	296	21	estimation	estimation	NOUN
ijpds-4398	296	22	of	of	ADP
ijpds-4398	296	23	acebrophylline	acebrophylline	NOUN
ijpds-4398	296	24	and	and	CCONJ
ijpds-4398	296	25	montelukast	montelukast	NOUN
ijpds-4398	296	26	sodium	sodium	NOUN
ijpds-4398	296	27	in	in	ADP
ijpds-4398	296	28	combined	combine	VERB
ijpds-4398	296	29	dosage	dosage	NOUN
ijpds-4398	296	30	form	form	NOUN
ijpds-4398	296	31	.	.	PUNCT
ijpds-4398	297	1	indo	indo	PROPN
ijpds-4398	297	2	american	american	PROPN
ijpds-4398	297	3	j	j	PROPN
ijpds-4398	297	4	pharma	pharma	PROPN
ijpds-4398	297	5	res	re	NOUN
ijpds-4398	297	6	.	.	PUNCT
ijpds-4398	298	1	2012;2(10):1027	2012;2(10):1027	NUM
ijpds-4398	298	2	-	-	SYM
ijpds-4398	298	3	1036	1036	NUM
ijpds-4398	298	4	.	.	PUNCT
ijpds-4398	299	1	34	34	NUM
ijpds-4398	299	2	.	.	PUNCT
ijpds-4398	299	3	pintu	pintu	PROPN
ijpds-4398	299	4	prajapati	prajapati	PROPN
ijpds-4398	299	5	,	,	PUNCT
ijpds-4398	299	6	jayesh	jayesh	NOUN
ijpds-4398	299	7	tamboli	tamboli	NOUN
ijpds-4398	299	8	,	,	PUNCT
ijpds-4398	299	9	ashish	ashish	PROPN
ijpds-4398	299	10	mishra	mishra	PROPN
ijpds-4398	299	11	,	,	PUNCT
ijpds-4398	299	12	et	et	PROPN
ijpds-4398	299	13	al	al	PROPN
ijpds-4398	299	14	risk	risk	NOUN
ijpds-4398	299	15	assessment	assessment	NOUN
ijpds-4398	299	16	-	-	PUNCT
ijpds-4398	299	17	based	base	VERB
ijpds-4398	299	18	enhanced	enhanced	ADJ
ijpds-4398	299	19	analytical	analytical	ADJ
ijpds-4398	299	20	quality	quality	NOUN
ijpds-4398	299	21	-	-	PUNCT
ijpds-4398	299	22	by	by	ADP
ijpds-4398	299	23	-	-	PUNCT
ijpds-4398	299	24	design	design	NOUN
ijpds-4398	299	25	approach	approach	NOUN
ijpds-4398	299	26	to	to	ADP
ijpds-4398	299	27	eco	eco	NOUN
ijpds-4398	299	28	-	-	PUNCT
ijpds-4398	299	29	friendly	friendly	ADJ
ijpds-4398	299	30	and	and	CCONJ
ijpds-4398	299	31	economical	economical	ADJ
ijpds-4398	299	32	multicomponent	multicomponent	ADJ
ijpds-4398	299	33	spectrophotometric	spectrophotometric	ADJ
ijpds-4398	299	34	methods	method	NOUN
ijpds-4398	299	35	for	for	ADP
ijpds-4398	299	36	simultaneous	simultaneous	ADJ
ijpds-4398	299	37	estimation	estimation	NOUN
ijpds-4398	299	38	of	of	ADP
ijpds-4398	299	39	montelukast	montelukast	NOUN
ijpds-4398	299	40	sodium	sodium	NOUN
ijpds-4398	299	41	and	and	CCONJ
ijpds-4398	299	42	bilastine	bilastine	NOUN
ijpds-4398	299	43	.	.	PUNCT
ijpds-4398	300	1	j	j	PROPN
ijpds-4398	300	2	aoac	aoac	PROPN
ijpds-4398	300	3	inter	inter	PROPN
ijpds-4398	300	4	.	.	PUNCT
ijpds-4398	301	1	2021;104(5	2021;104(5	NUM
ijpds-4398	301	2	):	):	PUNCT
ijpds-4398	301	3	1453	1453	NUM
ijpds-4398	301	4	-	-	SYM
ijpds-4398	301	5	1463	1463	NUM
ijpds-4398	301	6	.	.	PUNCT
ijpds-4398	302	1	35	35	NUM
ijpds-4398	302	2	.	.	PUNCT
ijpds-4398	303	1	akiful	akiful	PROPN
ijpds-4398	303	2	haque	haque	PROPN
ijpds-4398	303	3	m	m	PROPN
ijpds-4398	303	4	,	,	PUNCT
ijpds-4398	303	5	et	et	PROPN
ijpds-4398	303	6	al	al	PROPN
ijpds-4398	303	7	.	.	PROPN
ijpds-4398	303	8	stability	stability	PROPN
ijpds-4398	303	9	indicating	indicate	VERB
ijpds-4398	303	10	rp	rp	NOUN
ijpds-4398	303	11	-	-	PUNCT
ijpds-4398	303	12	hplc	hplc	NOUN
ijpds-4398	303	13	method	method	NOUN
ijpds-4398	303	14	for	for	ADP
ijpds-4398	303	15	the	the	DET
ijpds-4398	303	16	estimation	estimation	NOUN
ijpds-4398	303	17	of	of	ADP
ijpds-4398	303	18	montelukast	montelukast	NOUN
ijpds-4398	303	19	in	in	ADP
ijpds-4398	303	20	pharmaceutical	pharmaceutical	ADJ
ijpds-4398	303	21	dosage	dosage	NOUN
ijpds-4398	303	22	form	form	NOUN
ijpds-4398	303	23	.	.	PUNCT
ijpds-4398	304	1	iosr	iosr	PROPN
ijpds-4398	304	2	j	j	PROPN
ijpds-4398	304	3	pharm	pharm	PROPN
ijpds-4398	304	4	bio	bio	PROPN
ijpds-4398	304	5	sci	sci	PROPN
ijpds-4398	304	6	.	.	PUNCT
ijpds-4398	305	1	2012;1(6):31	2012;1(6):31	NUM
ijpds-4398	305	2	-	-	SYM
ijpds-4398	305	3	36	36	NUM
ijpds-4398	305	4	.	.	PUNCT
ijpds-4398	306	1	36	36	NUM
ijpds-4398	306	2	.	.	PUNCT
ijpds-4398	307	1	k	k	PROPN
ijpds-4398	307	2	naga	naga	PROPN
ijpds-4398	307	3	raju	raju	PROPN
ijpds-4398	307	4	,	,	PUNCT
ijpds-4398	307	5	t	t	PROPN
ijpds-4398	307	6	gopala	gopala	PROPN
ijpds-4398	307	7	swamy	swamy	PROPN
ijpds-4398	307	8	a	a	DET
ijpds-4398	307	9	lakshmana	lakshmana	PROPN
ijpds-4398	307	10	rao	rao	PROPN
ijpds-4398	307	11	.	.	PUNCT
ijpds-4398	308	1	development	development	NOUN
ijpds-4398	308	2	and	and	CCONJ
ijpds-4398	308	3	validation	validation	NOUN
ijpds-4398	308	4	of	of	ADP
ijpds-4398	308	5	rp	rp	NOUN
ijpds-4398	308	6	-	-	PUNCT
ijpds-4398	308	7	hplc	hplc	NOUN
ijpds-4398	308	8	method	method	NOUN
ijpds-4398	308	9	for	for	ADP
ijpds-4398	308	10	the	the	DET
ijpds-4398	308	11	determination	determination	NOUN
ijpds-4398	308	12	of	of	ADP
ijpds-4398	308	13	montelukast	montelukast	NOUN
ijpds-4398	308	14	sodium	sodium	NOUN
ijpds-4398	308	15	in	in	ADP
ijpds-4398	308	16	bulk	bulk	NOUN
ijpds-4398	308	17	and	and	CCONJ
ijpds-4398	308	18	in	in	ADP
ijpds-4398	308	19	pharmaceutical	pharmaceutical	ADJ
ijpds-4398	308	20	formulation	formulation	NOUN
ijpds-4398	308	21	,	,	PUNCT
ijpds-4398	308	22	intern	intern	NOUN
ijpds-4398	308	23	j	j	PROPN
ijpds-4398	308	24	pharma	pharma	PROPN
ijpds-4398	308	25	,	,	PUNCT
ijpds-4398	308	26	chem	chem	NOUN
ijpds-4398	308	27	biological	biological	ADJ
ijpds-4398	308	28	sci	sci	PROPN
ijpds-4398	308	29	.	.	PUNCT
ijpds-4398	309	1	2011;1(1):12	2011;1(1):12	NUM
ijpds-4398	309	2	-	-	SYM
ijpds-4398	309	3	16	16	NUM
ijpds-4398	309	4	.	.	PUNCT
ijpds-4398	310	1	37	37	NUM
ijpds-4398	310	2	.	.	PUNCT
ijpds-4398	311	1	singh	singh	PROPN
ijpds-4398	311	2	r	r	PROPN
ijpds-4398	311	3	m	m	PROPN
ijpds-4398	311	4	,	,	PUNCT
ijpds-4398	311	5	saini	saini	PROPN
ijpds-4398	311	6	p	p	PROPN
ijpds-4398	311	7	k	k	PROPN
ijpds-4398	311	8	,	,	PUNCT
ijpds-4398	311	9	mathur	mathur	PROPN
ijpds-4398	311	10	s	s	PROPN
ijpds-4398	311	11	c	c	PROPN
ijpds-4398	311	12	,	,	PUNCT
ijpds-4398	311	13	et	et	PROPN
ijpds-4398	311	14	al	al	PROPN
ijpds-4398	311	15	.	.	PROPN
ijpds-4398	311	16	development	development	PROPN
ijpds-4398	311	17	and	and	CCONJ
ijpds-4398	311	18	validation	validation	NOUN
ijpds-4398	311	19	of	of	ADP
ijpds-4398	311	20	a	a	DET
ijpds-4398	311	21	rp	rp	NOUN
ijpds-4398	311	22	-	-	PUNCT
ijpds-4398	311	23	hplc	hplc	NOUN
ijpds-4398	311	24	method	method	NOUN
ijpds-4398	311	25	for	for	ADP
ijpds-4398	311	26	estimation	estimation	NOUN
ijpds-4398	311	27	of	of	ADP
ijpds-4398	311	28	montelukast	montelukast	NOUN
ijpds-4398	311	29	sodium	sodium	NOUN
ijpds-4398	311	30	in	in	ADP
ijpds-4398	311	31	bulk	bulk	NOUN
ijpds-4398	311	32	and	and	CCONJ
ijpds-4398	311	33	in	in	ADP
ijpds-4398	311	34	tablet	tablet	ADJ
ijpds-4398	311	35	dosage	dosage	NOUN
ijpds-4398	311	36	form	form	NOUN
ijpds-4398	311	37	.	.	PUNCT
ijpds-4398	312	1	india	india	PROPN
ijpds-4398	312	2	j	j	PROPN
ijpds-4398	312	3	pharm	pharm	PROPN
ijpds-4398	312	4	sci	sci	PROPN
ijpds-4398	312	5	.	.	PUNCT
ijpds-4398	313	1	2010;72(2):235	2010;72(2):235	NUM
ijpds-4398	313	2	-	-	SYM
ijpds-4398	313	3	237	237	NUM
ijpds-4398	313	4	.	.	PUNCT
ijpds-4398	314	1	38	38	NUM
ijpds-4398	314	2	.	.	PUNCT
ijpds-4398	315	1	mandeep	mandeep	PROPN
ijpds-4398	315	2	yadav	yadav	PROPN
ijpds-4398	315	3	,	,	PUNCT
ijpds-4398	315	4	vikas	vikas	PROPN
ijpds-4398	315	5	jogpal	jogpal	PROPN
ijpds-4398	315	6	,	,	PUNCT
ijpds-4398	315	7	jyoti	jyoti	PROPN
ijpds-4398	315	8	gupta	gupta	PROPN
ijpds-4398	315	9	,	,	PUNCT
ijpds-4398	315	10	et	et	PROPN
ijpds-4398	315	11	al	al	PROPN
ijpds-4398	315	12	.	.	PROPN
ijpds-4398	316	1	analytical	analytical	ADJ
ijpds-4398	316	2	method	method	PROPN
ijpds-4398	316	3	development	development	NOUN
ijpds-4398	316	4	and	and	CCONJ
ijpds-4398	316	5	validation	validation	NOUN
ijpds-4398	316	6	of	of	ADP
ijpds-4398	316	7	montelukast	montelukast	NOUN
ijpds-4398	316	8	sodium	sodium	NOUN
ijpds-4398	316	9	and	and	CCONJ
ijpds-4398	316	10	bilastine	bilastine	NOUN
ijpds-4398	316	11	by	by	ADP
ijpds-4398	316	12	hplc	hplc	PROPN
ijpds-4398	316	13	.	.	PUNCT
ijpds-4398	317	1	eur	eur	PROPN
ijpds-4398	317	2	chem	chem	NOUN
ijpds-4398	317	3	bull	bull	NOUN
ijpds-4398	317	4	sec	sec	PROPN
ijpds-4398	317	5	a	a	DET
ijpds-4398	317	6	-	-	PUNCT
ijpds-4398	317	7	res	res	NOUN
ijpds-4398	317	8	paper	paper	NOUN
ijpds-4398	317	9	.	.	PUNCT
ijpds-4398	318	1	2023	2023	NUM
ijpds-4398	318	2	;	;	PUNCT
ijpds-4398	319	1	22(3):517	22(3):517	PROPN
ijpds-4398	319	2	-	-	SYM
ijpds-4398	319	3	526	526	NUM
ijpds-4398	319	4	.	.	PUNCT
ijpds-4398	319	5	39	39	NUM
ijpds-4398	319	6	.	.	PUNCT
ijpds-4398	320	1	varun	varun	PROPN
ijpds-4398	320	2	dasari	dasari	PROPN
ijpds-4398	320	3	,	,	PUNCT
ijpds-4398	320	4	et	et	PROPN
ijpds-4398	320	5	al	al	PROPN
ijpds-4398	320	6	.	.	PROPN
ijpds-4398	320	7	development	development	PROPN
ijpds-4398	320	8	and	and	CCONJ
ijpds-4398	320	9	validation	validation	NOUN
ijpds-4398	320	10	of	of	ADP
ijpds-4398	320	11	anti	anti	ADJ
ijpds-4398	320	12	-	-	ADJ
ijpds-4398	320	13	allergic	allergic	ADJ
ijpds-4398	320	14	drugs	drug	NOUN
ijpds-4398	320	15	:	:	PUNCT
ijpds-4398	320	16	rp	rp	NOUN
ijpds-4398	320	17	-	-	PUNCT
ijpds-4398	320	18	hplc	hplc	NOUN
ijpds-4398	320	19	.	.	PUNCT
ijpds-4398	321	1	dogo	dogo	PROPN
ijpds-4398	321	2	rangsang	rangsang	PROPN
ijpds-4398	321	3	res	res	PROPN
ijpds-4398	321	4	j.	j.	PROPN
ijpds-4398	321	5	2023;13(3):97	2023;13(3):97	PROPN
ijpds-4398	321	6	-	-	PUNCT
ijpds-4398	321	7	107	107	NUM
ijpds-4398	321	8	.	.	PUNCT
ijpds-4398	322	1	40	40	NUM
ijpds-4398	322	2	.	.	PUNCT
ijpds-4398	323	1	n.	n.	NOUN
ijpds-4398	323	2	rashmitha	rashmitha	PROPN
ijpds-4398	323	3	,	,	PUNCT
ijpds-4398	323	4	et	et	PROPN
ijpds-4398	323	5	al	al	PROPN
ijpds-4398	323	6	.	.	PUNCT
ijpds-4398	324	1	a	a	DET
ijpds-4398	324	2	validated	validate	VERB
ijpds-4398	324	3	rp	rp	NOUN
ijpds-4398	324	4	-	-	PUNCT
ijpds-4398	324	5	hplc	hplc	NOUN
ijpds-4398	324	6	method	method	NOUN
ijpds-4398	324	7	for	for	ADP
ijpds-4398	324	8	the	the	DET
ijpds-4398	324	9	determination	determination	NOUN
ijpds-4398	324	10	of	of	ADP
ijpds-4398	324	11	impurities	impurity	NOUN
ijpds-4398	324	12	in	in	ADP
ijpds-4398	324	13	montelukast	montelukast	NOUN
ijpds-4398	324	14	sodium	sodium	NOUN
ijpds-4398	324	15	.	.	PUNCT
ijpds-4398	325	1	e	e	X
ijpds-4398	325	2	-	-	PROPN
ijpds-4398	325	3	j	j	PROPN
ijpds-4398	325	4	chem	chem	NOUN
ijpds-4398	325	5	.	.	PUNCT
ijpds-4398	326	1	2010;7(2):555	2010;7(2):555	NUM
ijpds-4398	326	2	-	-	SYM
ijpds-4398	326	3	563	563	NUM
ijpds-4398	326	4	.	.	NOUN
ijpds-4398	327	1	41	41	NUM
ijpds-4398	327	2	.	.	PUNCT
ijpds-4398	328	1	akshaya	akshaya	PROPN
ijpds-4398	328	2	g.	g.	PROPN
ijpds-4398	328	3	sinhe	sinhe	PROPN
ijpds-4398	328	4	,	,	PUNCT
ijpds-4398	328	5	neelam	neelam	PROPN
ijpds-4398	328	6	khan	khan	PROPN
ijpds-4398	328	7	.	.	PUNCT
ijpds-4398	329	1	stability	stability	NOUN
ijpds-4398	329	2	indicating	indicate	VERB
ijpds-4398	329	3	rp	rp	NOUN
ijpds-4398	329	4	-	-	PUNCT
ijpds-4398	329	5	hplc	hplc	NOUN
ijpds-4398	329	6	method	method	NOUN
ijpds-4398	329	7	development	development	NOUN
ijpds-4398	329	8	and	and	CCONJ
ijpds-4398	329	9	validation	validation	NOUN
ijpds-4398	329	10	of	of	ADP
ijpds-4398	329	11	few	few	ADJ
ijpds-4398	329	12	bulk	bulk	ADJ
ijpds-4398	329	13	drug	drug	NOUN
ijpds-4398	329	14	combinations	combination	NOUN
ijpds-4398	329	15	and	and	CCONJ
ijpds-4398	329	16	their	their	PRON
ijpds-4398	329	17	formulation	formulation	NOUN
ijpds-4398	329	18	.	.	PUNCT
ijpds-4398	330	1	bulletin	bulletin	NOUN
ijpds-4398	330	2	of	of	ADP
ijpds-4398	330	3	environment	environment	NOUN
ijpds-4398	330	4	,	,	PUNCT
ijpds-4398	330	5	pharm	pharm	PROPN
ijpds-4398	330	6	life	life	PROPN
ijpds-4398	330	7	sci	sci	PROPN
ijpds-4398	330	8	.	.	PUNCT
ijpds-4398	331	1	2021;10(6):80	2021;10(6):80	X
ijpds-4398	331	2	-	-	SYM
ijpds-4398	331	3	88	88	NUM
ijpds-4398	331	4	.	.	PUNCT
ijpds-4398	332	1	42	42	NUM
ijpds-4398	332	2	.	.	PUNCT
ijpds-4398	333	1	v	v	X
ijpds-4398	333	2	padhiyar	padhiyar	NOUN
ijpds-4398	333	3	,	,	PUNCT
ijpds-4398	333	4	p	p	NOUN
ijpds-4398	333	5	patani	patani	NOUN
ijpds-4398	333	6	,	,	PUNCT
ijpds-4398	333	7	n	n	PRON
ijpds-4398	333	8	tiwari	tiwari	NOUN
ijpds-4398	333	9	.	.	PUNCT
ijpds-4398	334	1	development	development	NOUN
ijpds-4398	334	2	and	and	CCONJ
ijpds-4398	334	3	validation	validation	NOUN
ijpds-4398	334	4	of	of	ADP
ijpds-4398	334	5	stability	stability	NOUN
ijpds-4398	334	6	indicating	indicate	VERB
ijpds-4398	334	7	rp	rp	NOUN
ijpds-4398	334	8	-	-	PUNCT
ijpds-4398	334	9	hplc	hplc	NOUN
ijpds-4398	334	10	method	method	NOUN
ijpds-4398	334	11	for	for	ADP
ijpds-4398	334	12	simultaneous	simultaneous	ADJ
ijpds-4398	334	13	estimation	estimation	NOUN
ijpds-4398	334	14	of	of	ADP
ijpds-4398	334	15	montelukast	montelukast	NOUN
ijpds-4398	334	16	sodium	sodium	NOUN
ijpds-4398	334	17	and	and	CCONJ
ijpds-4398	334	18	bilastine	bilastine	VERB
ijpds-4398	334	19	from	from	ADP
ijpds-4398	334	20	its	its	PRON
ijpds-4398	334	21	pharmaceutical	pharmaceutical	ADJ
ijpds-4398	334	22	dosage	dosage	NOUN
ijpds-4398	334	23	form	form	NOUN
ijpds-4398	334	24	,	,	PUNCT
ijpds-4398	334	25	j	j	PROPN
ijpds-4398	334	26	eme	eme	NOUN
ijpds-4398	334	27	tech	tech	PROPN
ijpds-4398	334	28	innov	innov	PROPN
ijpds-4398	334	29	res	re	NOUN
ijpds-4398	334	30	.	.	PROPN
ijpds-4398	334	31	2021	2021	NUM
ijpds-4398	334	32	;	;	PUNCT
ijpds-4398	334	33	8(6	8(6	NUM
ijpds-4398	334	34	):	):	PUNCT
ijpds-4398	334	35	865	865	NUM
ijpds-4398	334	36	-	-	SYM
ijpds-4398	334	37	877	877	NUM
ijpds-4398	334	38	.	.	PUNCT
ijpds-4398	335	1	43	43	NUM
ijpds-4398	335	2	.	.	PUNCT
ijpds-4398	336	1	rajeswari	rajeswari	ADJ
ijpds-4398	336	2	sunkara	sunkara	NOUN
ijpds-4398	336	3	,	,	PUNCT
ijpds-4398	336	4	m	m	PROPN
ijpds-4398	336	5	ajitha	ajitha	ADJ
ijpds-4398	336	6	.	.	PUNCT
ijpds-4398	337	1	stabilty	stabilty	PROPN
ijpds-4398	337	2	indicating	indicate	VERB
ijpds-4398	337	3	rp	rp	NOUN
ijpds-4398	337	4	-	-	PUNCT
ijpds-4398	337	5	hplc	hplc	NOUN
ijpds-4398	337	6	method	method	NOUN
ijpds-4398	337	7	development	development	NOUN
ijpds-4398	337	8	and	and	CCONJ
ijpds-4398	337	9	validation	validation	NOUN
ijpds-4398	337	10	for	for	ADP
ijpds-4398	337	11	simultaneous	simultaneous	ADJ
ijpds-4398	337	12	estimation	estimation	NOUN
ijpds-4398	337	13	of	of	ADP
ijpds-4398	337	14	montelukast	montelukast	NOUN
ijpds-4398	337	15	and	and	CCONJ
ijpds-4398	337	16	bilastine	bilastine	VERB
ijpds-4398	337	17	in	in	ADP
ijpds-4398	337	18	bulk	bulk	ADJ
ijpds-4398	337	19	and	and	CCONJ
ijpds-4398	337	20	pharmaceutical	pharmaceutical	ADJ
ijpds-4398	337	21	dosage	dosage	NOUN
ijpds-4398	337	22	form	form	NOUN
ijpds-4398	337	23	.	.	PUNCT
ijpds-4398	338	1	world	world	PROPN
ijpds-4398	338	2	j	j	PROPN
ijpds-4398	338	3	pharma	pharma	PROPN
ijpds-4398	338	4	sci	sci	PROPN
ijpds-4398	338	5	.	.	PROPN
ijpds-4398	338	6	2022	2022	NUM
ijpds-4398	338	7	;	;	PUNCT
ijpds-4398	338	8	10(01):90–97	10(01):90–97	NUM
ijpds-4398	338	9	.	.	PUNCT
ijpds-4398	339	1	44	44	NUM
ijpds-4398	339	2	.	.	PUNCT
ijpds-4398	340	1	rathore	rathore	PROPN
ijpds-4398	340	2	a	a	DET
ijpds-4398	340	3	s	s	PROPN
ijpds-4398	340	4	,	,	PUNCT
ijpds-4398	340	5	sathiyanarayanan	sathiyanarayanan	ADV
ijpds-4398	340	6	l	l	NOUN
ijpds-4398	340	7	,	,	PUNCT
ijpds-4398	340	8	mahadik	mahadik	PROPN
ijpds-4398	340	9	k	k	PROPN
ijpds-4398	340	10	r.	r.	PROPN
ijpds-4398	340	11	development	development	PROPN
ijpds-4398	340	12	of	of	ADP
ijpds-4398	340	13	validated	validate	VERB
ijpds-4398	340	14	hplc	hplc	NOUN
ijpds-4398	340	15	and	and	CCONJ
ijpds-4398	340	16	hptlc	hptlc	NOUN
ijpds-4398	340	17	methods	method	NOUN
ijpds-4398	340	18	for	for	ADP
ijpds-4398	340	19	simultaneous	simultaneous	ADJ
ijpds-4398	340	20	determination	determination	NOUN
ijpds-4398	340	21	of	of	ADP
ijpds-4398	340	22	levocetirizine	levocetirizine	ADJ
ijpds-4398	340	23	dihydrochloride	dihydrochloride	NOUN
ijpds-4398	340	24	and	and	CCONJ
ijpds-4398	340	25	montelukast	montelukast	NOUN
ijpds-4398	340	26	sodium	sodium	NOUN
ijpds-4398	340	27	in	in	ADP
ijpds-4398	340	28	bulk	bulk	ADJ
ijpds-4398	340	29	drug	drug	NOUN
ijpds-4398	340	30	and	and	CCONJ
ijpds-4398	340	31	pharmaceutical	pharmaceutical	ADJ
ijpds-4398	340	32	dosage	dosage	NOUN
ijpds-4398	340	33	form	form	NOUN
ijpds-4398	340	34	.	.	PUNCT
ijpds-4398	341	1	pharm	pharm	NOUN
ijpds-4398	341	2	anal	anal	PROPN
ijpds-4398	341	3	acta	acta	PROPN
ijpds-4398	341	4	.	.	PUNCT
ijpds-4398	342	1	2010;1(1):1	2010;1(1):1	NUM
ijpds-4398	342	2	-	-	PUNCT
ijpds-4398	342	3	6	6	NUM
ijpds-4398	342	4	.	.	NOUN
ijpds-4398	342	5	45	45	NUM
ijpds-4398	342	6	.	.	PUNCT
ijpds-4398	342	7	indian	indian	ADJ
ijpds-4398	342	8	pharmacopoeia	pharmacopoeia	NOUN
ijpds-4398	342	9	,	,	PUNCT
ijpds-4398	342	10	8th	8th	ADJ
ijpds-4398	342	11	ed	ed	NOUN
ijpds-4398	342	12	.	.	PUNCT
ijpds-4398	342	13	govt	govt	PROPN
ijpds-4398	342	14	.	.	PUNCT
ijpds-4398	343	1	of	of	ADP
ijpds-4398	343	2	india	india	PROPN
ijpds-4398	343	3	,	,	PUNCT
ijpds-4398	343	4	ministry	ministry	PROPN
ijpds-4398	343	5	of	of	ADP
ijpds-4398	343	6	health	health	PROPN
ijpds-4398	343	7	and	and	CCONJ
ijpds-4398	343	8	family	family	NOUN
ijpds-4398	343	9	welfare	welfare	NOUN
ijpds-4398	343	10	,	,	PUNCT
ijpds-4398	343	11	the	the	DET
ijpds-4398	343	12	indian	indian	ADJ
ijpds-4398	343	13	pharmacopoeia	pharmacopoeia	PROPN
ijpds-4398	343	14	commission	commission	PROPN
ijpds-4398	343	15	ghaziabad	ghaziabad	PROPN
ijpds-4398	343	16	.	.	PUNCT
ijpds-4398	344	1	2018;2;2628	2018;2;2628	PROPN
ijpds-4398	344	2	.	.	PUNCT
ijpds-4398	345	1	46	46	NUM
ijpds-4398	345	2	.	.	PUNCT
ijpds-4398	346	1	british	british	ADJ
ijpds-4398	346	2	pharmacopoeia	pharmacopoeia	PROPN
ijpds-4398	346	3	,	,	PUNCT
ijpds-4398	346	4	medicines	medicine	NOUN
ijpds-4398	346	5	and	and	CCONJ
ijpds-4398	346	6	healthcare	healthcare	NOUN
ijpds-4398	346	7	products	product	NOUN
ijpds-4398	346	8	regulatory	regulatory	ADJ
ijpds-4398	346	9	agency	agency	NOUN
ijpds-4398	346	10	,	,	PUNCT
ijpds-4398	346	11	london	london	PROPN
ijpds-4398	346	12	.	.	PUNCT
ijpds-4398	347	1	2019;3:331	2019;3:331	NUM
ijpds-4398	347	2	.	.	PUNCT
ijpds-4398	348	1	47	47	NUM
ijpds-4398	348	2	.	.	PUNCT
ijpds-4398	349	1	international	international	ADJ
ijpds-4398	349	2	conference	conference	NOUN
ijpds-4398	349	3	on	on	ADP
ijpds-4398	349	4	harmonization	harmonization	NOUN
ijpds-4398	349	5	.	.	PUNCT
ijpds-4398	350	1	ich	ich	PROPN
ijpds-4398	350	2	harmonized	harmonize	VERB
ijpds-4398	350	3	tripartite	tripartite	ADJ
ijpds-4398	350	4	guideline	guideline	NOUN
ijpds-4398	350	5	-	-	PUNCT
ijpds-4398	350	6	pharmaceutical	pharmaceutical	NOUN
ijpds-4398	350	7	development	development	NOUN
ijpds-4398	350	8	,	,	PUNCT
ijpds-4398	350	9	q8	q8	PROPN
ijpds-4398	350	10	r2	r2	PROPN
ijpds-4398	350	11	.	.	PUNCT
ijpds-4398	351	1	4	4	NUM
ijpds-4398	351	2	version	version	NOUN
ijpds-4398	351	3	.	.	PUNCT
ijpds-4398	352	1	2009;1	2009;1	PROPN
ijpds-4398	352	2	-	-	SYM
ijpds-4398	352	3	28	28	NUM
ijpds-4398	352	4	.	.	PUNCT
ijpds-4398	353	1	d	d	NOUN
ijpds-4398	353	2	kolekar	kolekar	PROPN
ijpds-4398	353	3	et	et	PROPN
ijpds-4398	353	4	al	al	PROPN
ijpds-4398	353	5	.	.	PROPN
ijpds-4398	353	6	chemometric	chemometric	PROPN
ijpds-4398	353	7	assisted	assist	VERB
ijpds-4398	353	8	qbd	qbd	NOUN
ijpds-4398	353	9	method	method	NOUN
ijpds-4398	353	10	for	for	ADP
ijpds-4398	353	11	estimation	estimation	NOUN
ijpds-4398	353	12	of	of	ADP
ijpds-4398	353	13	bilastine	bilastine	NOUN
ijpds-4398	353	14	and	and	CCONJ
ijpds-4398	353	15	montelukast	montelukast	NOUN
ijpds-4398	353	16	sodium	sodium	NOUN
ijpds-4398	353	17	vol	vol	NOUN
ijpds-4398	353	18	3	3	NUM
ijpds-4398	353	19	|	|	NOUN
ijpds-4398	353	20	issue	issue	VERB
ijpds-4398	353	21	1	1	NUM
ijpds-4398	354	1	|	|	ADV
ijpds-4398	354	2	jan	jan	PROPN
ijpds-4398	354	3	–	–	PUNCT
ijpds-4398	354	4	mar	mar	PROPN
ijpds-4398	354	5	2024	2024	NUM
ijpds-4398	355	1	indian	indian	PROPN
ijpds-4398	355	2	j	j	PROPN
ijpds-4398	355	3	pharm	pharm	PROPN
ijpds-4398	355	4	drug	drug	PROPN
ijpds-4398	355	5	studies	study	NOUN
ijpds-4398	355	6	|	|	ADV
ijpds-4398	355	7	23	23	NUM
ijpds-4398	355	8	48	48	NUM
ijpds-4398	355	9	.	.	PUNCT
ijpds-4398	356	1	ich	ich	NOUN
ijpds-4398	356	2	expert	expert	NOUN
ijpds-4398	356	3	working	working	NOUN
ijpds-4398	356	4	group	group	NOUN
ijpds-4398	356	5	.	.	PUNCT
ijpds-4398	357	1	ich	ich	PROPN
ijpds-4398	357	2	harmonized	harmonize	VERB
ijpds-4398	357	3	tripartite	tripartite	ADJ
ijpds-4398	357	4	guidelinequality	guidelinequality	NOUN
ijpds-4398	357	5	risk	risk	NOUN
ijpds-4398	357	6	management	management	NOUN
ijpds-4398	357	7	q9	q9	PROPN
ijpds-4398	357	8	.	.	PUNCT
ijpds-4398	358	1	in	in	ADP
ijpds-4398	358	2	current	current	ADJ
ijpds-4398	358	3	step	step	NOUN
ijpds-4398	358	4	4	4	NUM
ijpds-4398	358	5	version	version	NOUN
ijpds-4398	358	6	.	.	PUNCT
ijpds-4398	359	1	2005;123	2005;123	NUM
ijpds-4398	359	2	.	.	PUNCT
ijpds-4398	360	1	49	49	NUM
ijpds-4398	360	2	.	.	PUNCT
ijpds-4398	361	1	ich	ich	NOUN
ijpds-4398	361	2	expert	expert	NOUN
ijpds-4398	361	3	working	working	NOUN
ijpds-4398	361	4	group	group	NOUN
ijpds-4398	361	5	.	.	PUNCT
ijpds-4398	362	1	ich	ich	PROPN
ijpds-4398	362	2	harmonized	harmonize	VERB
ijpds-4398	362	3	tripartite	tripartite	ADJ
ijpds-4398	362	4	guideline	guideline	NOUN
ijpds-4398	362	5	-	-	PUNCT
ijpds-4398	362	6	pharmaceutical	pharmaceutical	ADJ
ijpds-4398	362	7	quality	quality	NOUN
ijpds-4398	362	8	system	system	NOUN
ijpds-4398	362	9	q	q	PROPN
ijpds-4398	362	10	10	10	NUM
ijpds-4398	362	11	.	.	PUNCT
ijpds-4398	363	1	in	in	ADP
ijpds-4398	363	2	current	current	ADJ
ijpds-4398	363	3	step	step	NOUN
ijpds-4398	363	4	4	4	NUM
ijpds-4398	363	5	version	version	NOUN
ijpds-4398	363	6	.	.	PUNCT
ijpds-4398	364	1	2008;1	2008;1	NUM
ijpds-4398	364	2	-	-	SYM
ijpds-4398	364	3	21	21	NUM
ijpds-4398	364	4	.	.	PUNCT
ijpds-4398	365	1	50	50	NUM
ijpds-4398	365	2	.	.	X
ijpds-4398	366	1	ich	ich	NOUN
ijpds-4398	366	2	expert	expert	NOUN
ijpds-4398	366	3	working	working	NOUN
ijpds-4398	366	4	group	group	NOUN
ijpds-4398	366	5	.	.	PUNCT
ijpds-4398	367	1	ich	ich	PROPN
ijpds-4398	367	2	harmonized	harmonize	VERB
ijpds-4398	367	3	tripartite	tripartite	ADJ
ijpds-4398	367	4	guideline	guideline	NOUN
ijpds-4398	367	5	-	-	PUNCT
ijpds-4398	367	6	validation	validation	NOUN
ijpds-4398	367	7	of	of	ADP
ijpds-4398	367	8	analytical	analytical	ADJ
ijpds-4398	367	9	procedures	procedure	NOUN
ijpds-4398	367	10	:	:	PUNCT
ijpds-4398	367	11	text	text	NOUN
ijpds-4398	367	12	and	and	CCONJ
ijpds-4398	367	13	methodology	methodology	NOUN
ijpds-4398	367	14	q	q	PROPN
ijpds-4398	367	15	2	2	NUM
ijpds-4398	367	16	r1	r1	NOUN
ijpds-4398	367	17	.	.	PUNCT
ijpds-4398	368	1	in	in	ADP
ijpds-4398	368	2	current	current	ADJ
ijpds-4398	368	3	step	step	NOUN
ijpds-4398	368	4	4	4	NUM
ijpds-4398	368	5	version.2005;1	version.2005;1	NOUN
ijpds-4398	368	6	-	-	PUNCT
ijpds-4398	368	7	17	17	NUM
ijpds-4398	368	8	.	.	PUNCT
ijpds-4398	368	9	51	51	NUM
ijpds-4398	368	10	.	.	PUNCT
ijpds-4398	368	11	schweitzer	schweitzer	PROPN
ijpds-4398	368	12	m	m	PROPN
ijpds-4398	368	13	,	,	PUNCT
ijpds-4398	368	14	et	et	PROPN
ijpds-4398	368	15	al	al	PROPN
ijpds-4398	368	16	.	.	PUNCT
ijpds-4398	368	17	implications	implication	NOUN
ijpds-4398	368	18	and	and	CCONJ
ijpds-4398	368	19	opportunities	opportunity	NOUN
ijpds-4398	368	20	of	of	ADP
ijpds-4398	368	21	applying	apply	VERB
ijpds-4398	368	22	qbd	qbd	NOUN
ijpds-4398	368	23	principles	principle	NOUN
ijpds-4398	368	24	to	to	ADP
ijpds-4398	368	25	analytical	analytical	ADJ
ijpds-4398	368	26	measurements	measurement	NOUN
ijpds-4398	368	27	.	.	PUNCT
ijpds-4398	369	1	pharm	pharm	NOUN
ijpds-4398	369	2	tech	tech	PROPN
ijpds-4398	369	3	.	.	PUNCT
ijpds-4398	370	1	2010	2010	NUM
ijpds-4398	370	2	;	;	PUNCT
ijpds-4398	370	3	34:12	34:12	NUM
ijpds-4398	370	4	-	-	SYM
ijpds-4398	370	5	29	29	NUM
ijpds-4398	370	6	.	.	PUNCT
ijpds-4398	371	1	52	52	NUM
ijpds-4398	371	2	.	.	PUNCT
ijpds-4398	372	1	vogt	vogt	PROPN
ijpds-4398	372	2	f	f	PROPN
ijpds-4398	372	3	g	g	PROPN
ijpds-4398	372	4	,	,	PUNCT
ijpds-4398	372	5	kord	kord	PROPN
ijpds-4398	372	6	a	a	DET
ijpds-4398	372	7	s.	s.	PROPN
ijpds-4398	372	8	development	development	PROPN
ijpds-4398	372	9	of	of	ADP
ijpds-4398	372	10	quality	quality	NOUN
ijpds-4398	372	11	-	-	PUNCT
ijpds-4398	372	12	by	by	ADP
ijpds-4398	372	13	-	-	PUNCT
ijpds-4398	372	14	design	design	NOUN
ijpds-4398	372	15	analytical	analytical	ADJ
ijpds-4398	372	16	methods	method	NOUN
ijpds-4398	372	17	.	.	PUNCT
ijpds-4398	373	1	j	j	PROPN
ijpds-4398	373	2	pharm	pharm	PROPN
ijpds-4398	373	3	sci	sci	PROPN
ijpds-4398	373	4	.	.	PUNCT
ijpds-4398	374	1	2011;100:797	2011;100:797	X
ijpds-4398	374	2	-	-	SYM
ijpds-4398	374	3	812	812	NUM
ijpds-4398	374	4	.	.	PUNCT
ijpds-4398	375	1	53	53	NUM
ijpds-4398	375	2	.	.	PUNCT
ijpds-4398	376	1	bhatt	bhatt	PROPN
ijpds-4398	376	2	d	d	PROPN
ijpds-4398	376	3	a	a	PROPN
ijpds-4398	376	4	,	,	PUNCT
ijpds-4398	376	5	rane	rane	PROPN
ijpds-4398	376	6	s	s	PROPN
ijpds-4398	376	7	i.	i.	PROPN
ijpds-4398	376	8	qbd	qbd	PROPN
ijpds-4398	376	9	approach	approach	NOUN
ijpds-4398	376	10	to	to	ADP
ijpds-4398	376	11	analytical	analytical	ADJ
ijpds-4398	376	12	rp	rp	NOUN
ijpds-4398	376	13	-	-	PUNCT
ijpds-4398	376	14	hplc	hplc	NOUN
ijpds-4398	376	15	method	method	NOUN
ijpds-4398	376	16	development	development	NOUN
ijpds-4398	376	17	and	and	CCONJ
ijpds-4398	376	18	its	its	PRON
ijpds-4398	376	19	validation	validation	NOUN
ijpds-4398	376	20	,	,	PUNCT
ijpds-4398	376	21	int	int	NOUN
ijpds-4398	376	22	journal	journal	NOUN
ijpds-4398	376	23	of	of	ADP
ijpds-4398	376	24	pharma	pharma	PROPN
ijpds-4398	376	25	science	science	NOUN
ijpds-4398	376	26	.	.	PUNCT
ijpds-4398	377	1	2011	2011	NUM
ijpds-4398	377	2	;	;	PUNCT
ijpds-4398	377	3	(	(	PUNCT
ijpds-4398	377	4	3):179	3):179	NUM
ijpds-4398	377	5	-	-	SYM
ijpds-4398	377	6	187	187	NUM
ijpds-4398	377	7	.	.	PUNCT
ijpds-4398	378	1	how	how	SCONJ
ijpds-4398	378	2	to	to	PART
ijpds-4398	378	3	cite	cite	VERB
ijpds-4398	378	4	this	this	DET
ijpds-4398	378	5	article	article	NOUN
ijpds-4398	378	6	:	:	PUNCT
ijpds-4398	378	7	bhagyashri	bhagyashri	PROPN
ijpds-4398	378	8	d	d	PROPN
ijpds-4398	378	9	kolekar	kolekar	PROPN
ijpds-4398	378	10	,	,	PUNCT
ijpds-4398	378	11	namrata	namrata	PROPN
ijpds-4398	378	12	n	n	PRON
ijpds-4398	378	13	gawade	gawade	NOUN
ijpds-4398	378	14	,	,	PUNCT
ijpds-4398	378	15	g	g	PROPN
ijpds-4398	378	16	k	k	PROPN
ijpds-4398	378	17	dyade	dyade	PROPN
ijpds-4398	378	18	,	,	PUNCT
ijpds-4398	378	19	nilesh	nilesh	PROPN
ijpds-4398	378	20	y	y	PROPN
ijpds-4398	378	21	jadhav	jadhav	PROPN
ijpds-4398	378	22	.	.	PUNCT
ijpds-4398	379	1	chemo	chemo	PROPN
ijpds-4398	379	2	metric	metric	ADJ
ijpds-4398	379	3	assisted	assist	VERB
ijpds-4398	379	4	spectrophotometric	spectrophotometric	ADJ
ijpds-4398	379	5	method	method	NOUN
ijpds-4398	379	6	development	development	NOUN
ijpds-4398	379	7	through	through	ADP
ijpds-4398	379	8	qbd	qbd	NOUN
ijpds-4398	379	9	approach	approach	NOUN
ijpds-4398	379	10	for	for	ADP
ijpds-4398	379	11	the	the	DET
ijpds-4398	379	12	estimation	estimation	NOUN
ijpds-4398	379	13	of	of	ADP
ijpds-4398	379	14	bilastine	bilastine	NOUN
ijpds-4398	379	15	and	and	CCONJ
ijpds-4398	379	16	montelukast	montelukast	NOUN
ijpds-4398	379	17	sodium	sodium	NOUN
ijpds-4398	379	18	in	in	ADP
ijpds-4398	379	19	combined	combine	VERB
ijpds-4398	379	20	solid	solid	ADJ
ijpds-4398	379	21	dosage	dosage	NOUN
ijpds-4398	379	22	form	form	NOUN
ijpds-4398	379	23	.	.	PUNCT
ijpds-4398	380	1	indian	indian	PROPN
ijpds-4398	380	2	j	j	PROPN
ijpds-4398	380	3	pharm	pharm	PROPN
ijpds-4398	380	4	drug	drug	PROPN
ijpds-4398	380	5	studies	study	NOUN
ijpds-4398	380	6	.	.	PUNCT
ijpds-4398	380	7	2024	2024	NUM
ijpds-4398	380	8	;	;	PUNCT
ijpds-4398	380	9	3(1):16	3(1):16	NUM
ijpds-4398	380	10	-	-	SYM
ijpds-4398	380	11	23	23	NUM
ijpds-4398	380	12	.	.	PUNCT
ijpds-4398	381	1	funding	funding	NOUN
ijpds-4398	381	2	:	:	PUNCT
ijpds-4398	381	3	none	none	NOUN
ijpds-4398	381	4	conflict	conflict	NOUN
ijpds-4398	381	5	of	of	ADP
ijpds-4398	381	6	interest	interest	NOUN
ijpds-4398	381	7	:	:	PUNCT
ijpds-4398	381	8	none	none	NOUN
ijpds-4398	381	9	stated	state	VERB
ijpds-4398	381	10	key	key	ADJ
ijpds-4398	381	11	words	word	NOUN
ijpds-4398	381	12	:	:	PUNCT
ijpds-4398	381	13	bilastine	bilastine	ADJ
ijpds-4398	381	14	,	,	PUNCT
ijpds-4398	381	15	montelukast	montelukast	NOUN
ijpds-4398	381	16	sodium	sodium	NOUN
ijpds-4398	381	17	,	,	PUNCT
ijpds-4398	381	18	qbd	qbd	NOUN
ijpds-4398	381	19	,	,	PUNCT
ijpds-4398	381	20	ich	ich	NOUN
ijpds-4398	381	21	,	,	PUNCT
ijpds-4398	381	22	simultaneous	simultaneous	ADJ
ijpds-4398	381	23	equation	equation	NOUN
ijpds-4398	381	24	method	method	NOUN